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1ABSTRACT
This Thesis describes ligand binding, molecular and
reconstitution studies of the rat and guinea pig lung
nucleoside transporters.' Nitrobenzylthioinosine (NBMPR), a
potent inhibitor of nucleoside transport, binds tightly
(apparent Kd 0.2-0.4 nM) but reversibly to both rat and
guinea pig lung membranes, the guinea pig lung membranes
possessing a higher density of NBMPR binding sites.
Binding was inhibited by nitrobenzylthioguanosine (NBTGR),
adenosine and uridine. Dipyridamole, a coronary
vasodilator known to be a potent inhibitor of nucleoside
transport, was also an effective inhibitor of NBMPR
binding to guinea pig membranes (Ki 20 nM). In contrast,
NBMPR binding to rat lung membranes were- relatively
insensitive to dipyridamole (Ki 8.5 uM). Inhibition of
NBMPR binding to membranes by dipyr.idamole,was competitive
in both species. Species differences in inhibition of
NBMPR binding by various other vasodilators such as
dilazep, lidoflazine and hexobendine was also observed,
with the rat always displaying the lower sensitivity.
Membranes from guinea pig lung exhibited high-
affinity binding of[ H]dipyridamole (apparent Kd 2 nM).
Binding was inhibited by NBMPR, d i lazep and lidoflazine and
by the transported nucleosides uridine and adenosine. In
contrast, there was no detectable high-affinity binding of
[3H]dipyridamole to lung membranes from the rat, a result
consistent with the low sensitivity of rat lung to NBMPR
binding to dipyridamole inhibition. Bmax values for
high-affinity binding of[ H]dipyridamole and[ H]NBMPR
to guinea pig membranes were similar, suggesting that these
structurally unrelated ligands bind to the NBMPR-sensitive
nucleoside transporter with the same stoichiometry.
Parallel kinetic studies on NBMPR binding and dipyridamole
binding suggest that the two ligands binding to
topographically separate sites.
Data presented in Chapter 4 demonstrate that NBMPR
can also be used as a covalent probe of lung nucleoside
transporters. Exposure of site-bound[ H]NBMPR to high
intensity UV light resulted in the photoaffinity labelling
of lung proteins with apparent molecular weights similar to
that of the well characterized human erythrocyte nucleoside
transporter (Mr 45,000-66,000). Covalent labelling was
inhibited by NBTGR and adenosine equally 'in both species
while dipyridamole inhibited covalent labelling in guinea
pig lung membranes much more effectively than in the rat.
The rat lung nucleoside transport protein had a
significantly higher apparent molecular weight than that of
the guinea pig (Mr 63,000 vs. 55,000). Enzyme digestion
experiments with endoglycosidase-F revealed that both the
rat and guinea pig lung nucleoside transporters are
glycoproteins containing N-linked oligosaccharides. The
data provide evidence that the molecular weight difference
between the rat and guinea pig lung nucleoside transporters
can be accounted for by different degrees of glycosylation
of the two transporters. These experiments and additional
trypsin digestion studies provide evidence of molecular
similarities between the guinea pig lung and human
erythrocyte nucleoside transporters.
The methodology of reconstltution was employed to
study the kinetic properties of the lung nucleoside
transporter. Uridine transport into vesicles reconstituted
with an a-octylglucoside extract from guinea-pig lung
plasma membranes was inhibited by NBMPR, dilazep and
dipyridamole. The kinetic properties of uridine transport
by the reconstituted lung nucleoside transporter were
consistent with the simple carrier model (Lieb, 1982) and
compared favourably with those of the reconstituted human
erythrocyte nucleoside transporter.
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Nucleoside transport plays a key role in the
cellular action of physiological and cytotoxic nucleosides,
and inhibition of nucleoside transport is responsible for
the pharmacological actions of several drugs, including
dipyridamole, a clinically available vasodilator (Young and
Jarvis, 1983). In human erythrocytes, nucleoside transport
occurs by a rapid, facilitated diffusion process mediated
by nucleoside-specific transport elements of the plasma
membrane (Canbantchik and Ginsburg, 1977; Koren £t aJl,
1978; Wohlhueter e_t al, 1979a; Jarvis g£. al, 1982b). This
transport mechanism exhibits a broad substrate specificity,
accepting a wide variety of nucleoside derivatives with
very diverse nucleobase moieties. A number of potent
inhibitors of nucleoside transport are known. The best
studied of these is nitrobenzylthioinosine (NBMPR), a
member of a family of S -substituted 6-thiopurine
nucleosides that interact strongly with the nucleoside
transport mechanism in both erythrocytes and a wide variety
of other cell types (Paterson el al, 1981; Young and
Jarvis, 1983). NBMPR inhibition of nucleoside transport is
associated with tight, but reversible, high-affinity
binding of inhibitor to the cell membrane. This
association represents a specific interaction with
components of the nucleoside transport machinery, probably
via direct binding to the substrate permeation site (Jarvis
and Young, 1980, 1982; Jarvis et al, 1982a,b).
The development of NBMPR and related compounds as
specific high-affinity probes of the nucleoside transporter
has allowed recent rapid progress in studies of the.
molecular properties of the carrier mechanism in
erythrocytes. In human erythrocytes, the transporter has
been partially purified by ion-exchange chromatography
3
using reversible[ HjNBMPR binding activity as an assay
of transporter functions (Jarvis and Young, 1981). The
purified material consisted largely of band 4.5
polypeptides (nomenclature of Steck (1974); Mn 45,000-
66,000 on SDS-polyaerylamide gels). Subsequently it was
3
established that exposure of site-bound[ H]NBMPR to
high-intensity UV light results in specific covalent
radiolabelling of band 4.5 polypeptides (Wu§£!_, 1983;
Young e_t aJL, 1983), providing further evidence to implicate
this class of integral membrane proteins in nucleoside
permeation. More recently, it has been shown that isolated
band 4.5 polypeptides from human and pig erythrocytes
catalyse NBMPR-sensitive uridine transport when
reconstituted into phospholipid vesicles (Tse et. aJL, 1985;
Kwong eJi 1, 1987). Endoglycosidase-F digestion
3
experiments in combination with[ H]NBMPR photolabelling
have established that the erythrocyte nucleoside
transporter is a glycoprotein (Kwong ei. aJL, 1986), while
protease studies have been performed to investigate the
4.
transmembrane topology of the transporter (Kwong et. al.
1987).
At the beginning of the present project in 1983,
information concerning the molecular properties of the
membrane components responsible for NBMPR-sensitive
nucleoside transport was very limited and restricted to
erythrocytes. Also, the mechanism by which dipyridamole
interacts with the nucleoside transporter was unclear and
controversial (Hammond elu aJL 1981; Jarvis and Young,
1983). In the present project, this latter topic was
studied by investigating in detail the effect of
dipyridamole on reversible[ H]NBMPR binding and
dissociation. These experiments were subsequently
extended by parallel kinetic studies of reversible
[ H]dipyridamole binding. Another primary objective of
the present project was to extend erythrocyte NBMPR
photolysis and enzyme digestion studies to a non-erythroid
tissue as a first step towards a molecular comparison of
NBMPR-sensitive nucleoside transporters in different cell
types. The lung was chosen for the series of
investigations both because of its high density of
high-affinity NBMPR binding sites (Marangos ejt a5, 1982)
and because of this tissue's role as a major site for .the
removal of circulating adenosine, a potent endogenous
vasodilator (Kolassa gJL sJL, 1971; Bakhle and Vane, 1977).
Two species were compared, one with a normal sensitivity to
dipyridamole inhibition (guinea pig) and one whose
NBMPR-sensitive nucleoside transporters are resistant to
inhibition by this vasodilator (rat). In a final series of
experiments, the guinea pig lung nucleoside transporter was
reconstituted into liposomes and its kinetic properties
studied.
The major section of the present Chapter is a brief
review of the literature on molecular and kinetic aspects
of nucleoside transport in animal cells. This is followed
by a description of the importance of the lung's
physiological role as a major site for removal of
circulating adenosine. The experimental strategy adopted
in the present investigation and its objectives are then
detailed. Finally, the organisation of the remainder of
the Thesis is outlined.
1.2
1.2.1
PHYSIOLOGICAL AND PHARMACOLOGICAL IMPORTANCE QF
NUCLEOSIDES
Biologi oal Effects of Physiological Nucleosides
Nucleosides have a multitude of biochemical and
physiological effects. For example, adenosine is believed
to participate in processes such as modulation of immune
responses, regulation of blood flow, platelet aggregation,
renal function, neuromodulation in the central nervous
system, neurotransmission, muscle contraction and numerous
other biological processes (Harmon ai. 1, 1978, Walker ei.
al. 1979; Stone, 1981; Daly, 1982; Berne et. aJL., 1983). Its
unique mechanism of formation has led to the suggestion
that adenosine functions as a novel form of cellular
regulator for which the term retaliatory metabolite has
been proposed (Newby, 1984). In addition, adenosine is
also a physiological precursor of erythrocyte ATP in man
(Valentine aJL, 1977). Adenosine appears to produce most
of its effects through specific extracellular adenosine
receptors (Stone, 1981) and it is removed from the
extracellular medium by transport into cells followed by
metabolism (Fox and Kelly, 1978). Inhibition of the
nucleoside transport system would, therefore, be expected
to potentiate the biological effects of adenosine. Many
structurally unrelated, pharmacologically active compounds
such as NBMPR and the coronary vasodilators dipyridamole,
dilazep, hexobendine and lidoflazine share an ability to
inhibit cellular accumulation of adenosine and potentiate
adenosine effects.
Inosine has been shown to be an in. vivo energy
source for adult pig erythrocytes, cells unable to
metabolise glucose (Young fit. al., 1985; 1986; Zeidler at. 1,
1985). In these cells, NBMPR functions as an in. vivo
inhibitor of energy metabolism (Young at. al, 1986).
1.2.2 Nucleoside Analogues
Nucleoside analogues are widely used as therapeutic
agents for the treatment of human neoplastic and viral
diseases (Walker at 1, 1979; De Clercq at. al 1980; Gauri,
1981; Tattersall and Fox, 1981; De Clercq, 1984). Of
various cytotoxic nucleosides with clinical application as
antineoplastic agents, the best known is cytosine
arabinoside (ara C) which is an essential part of the
current treatment of acute myeloid leukaemia (Wiemik, 1980;
Hess and Zirkle, 1980). As well, 5-aracytidine has
established clinical applications. Several nucleoside
derivatives, notably acyclovir, are effective inhibitors of
the proliferation of DNA viruses (De Clercq at. aJL, 1980-; De
Clercq, 1984) and 3'-azido-3 'deoxythymidine has potential'
therapeutic application in the treatment of acquired
immunodeficiency syndrome (AIDS) (see Nature(1987), vol.
325, p564). Nucleoside analogues may also have application
in the chemotherapy of parasitic infections (el Kouni et
al, 1983; 1986;).
As seen from the foregoing account, nucleosides
exhibit a multitude of biochemical, physiological and
pharmacological effects. Each of these actions of
nucleosides and nucleoside analogues require their
transport into or out of cells. The nucleoside transport
capacity of target cells and the 'transportability' of a
nucleoside analogue, that is, its acceptability as a
substrate for the nucleoside transporter, are important
determinants of cytotoxicity. For example, measurements of
NBMPR binding capacity (Section 1.3.2a) are likely to prove
useful in assessing the therapeutic potential of ara C in
human acute leukaemias (Wiley et al, 1983; 1985).
1.3 TRANSPORT OF NUCLEOSIDES BY ANIMAL CELLS
The entry of nucleosides and nucleoside analogues
into mammalian cells occurs mainly by way of facilitated
diffusion nucleoside-specific transport elements in the
plasma membrane. The substrate specificity of the
nucleoside transport machinery in mammalian cells is very
broad in that a single type of transport mechanism mediates
entry of (i) the physiological nucleosides (purine or
pyrimidine ribosides and deoxyribonucleosides), and (ii) a
variety of nucleoside derivatives with very diverse
nucleobase moieties. Transporter function is typically
inhibited by low concentrations (0.1-10 nM) of NBMPR
(Section 1.3.2a), NBMPR-insensitive facilitated diffusion
nucleoside transport systems that are inhibited only by
micromolar (1 uM) concentrations of NBMPR and also
sodium-dependent nucleoside transport systems are present
in some cell types.
1.3.1 Kinetic Studies
Nucleoside transport is a rapid, reVersible,
non-concentrative facilitated-diffusion process. in
erythrocytes and in cultured cells of various types
(Cabantchik and Ginsburg, 1977; Wohlhueter et. al., 1979a;
Harle.y et al, 1982; Jarvis et al, 1983a). The kinetics of
nucleoside transport have been most extensively studied in
mammalian erythrocytes using radioactively-labelled
uridine, a nucleoside that is not metabolized by red blood
cells (Cabantchik and Ginsburg, 1977; Jarvis et aj,, 1983a;
1983b). The results of these studies indicate that the
kinetic properties of the human erythrocyte system are
consistent with a simple carrier model (Cabantchik and
Ginsburg, 1977; Jarvis ejt aJ, 1983a; Lieb et. aJL, 1982;
Young and Jarvis, 1983). Using erythrocytes from human
fresh blood, the Km. and Vmax values for zero-trans uridine
influx are identical to those determined for zero-trans
uridine efflux, demonstrating that the carrier is
symmetrical (Jarvis ei aJL 1983a; Jarvis and Martin,
1986). However, the kinetics of uridine transport in
erythrocytes from outdated blood are asymmetrical, with
efflux having a three- to four-fold higher Km and Vmax than
influx (Jarvis ei 1, 1983a; Plagemann and Wohlhueter,
1984a). Molecular rate constants, estimated using the
procedures described by Lieb (1982) (see also Stein, 1986)
and interpreted in terms of a two-complex formulation of
the simple carrier model (Fig. 1.1) can be used to explain
for the above observations. The carrier is symmetrical in
erythrocytes from fresh, blood, kl being equal fro k2,
but is asymmetrical in cells from out-dated blood, k2
being approximately 4-fold larger than kl. This kinetic
difference between nucleoside transport in fresh and
outdated, erythrocytes is attributed to differences in the
mobility that is, conformational change, of the
unloaded carrier and is accentuated at low temperature
(Plagemann and Wohlhueter, 1984b; Jarvis and Martin,










E represents the substrate-free form of the carrier, ES
represents the carrier-substrate complex. Rate constants
as .indicated next to the appropiate reaction steps.
Subscripts represent carrier forms available at, or steps
originating in, sides 1 or 2 of the membrane, respectively.
1986). Interestingly, uridine equilibrium exchange, that
is, the unidirectional flux of radioactively-labelled
nucleoside at equal concentrations of uridine on the two
sides of the membrane, has higher Km. and Vmax values than
net flux (Jarvis£. sJL, 1983a; 1983b; Jarvis and Martin,
1986). This can be explained by the simple carrier model
if the rate-limiting step in zero-trans transport is the
mobility of the unloaded carrier, a step that is bypassed
in exchange. Vmax for uridine equilibrium exchange influx
is similar in both fresh and outdated blood.
Nucleoside transport in erythrocytes from other
mammalian species has also been extensively studied
particularly in pig, guinea pig, rat and sheep (Young,
1978; Jarvis fii. aJL, 1980a; Young qJl 1, 1985; 1986; Jarvis
and Martin, 1986; Jarvis and Young, 1986a). The rates of
nucleoside transport vary over two orders of magnitude
between species with human pig rat sheep (nucleoside
permeable type) guinea-pig sheep (nucleoside
impermeable type) (Duhm, 1974; Jarvis al, 1982b; Young
and Jarvis, 1983). These differences in transport capacity
are largely due to species differences in the cellular
density of nucleoside transporters as determined by'
measurements of NBMPR binding (Jarvis and Young, 1982;
Young• and Jarvis, 1983) (see also Section 1.3.2a and
Table 1.1).
Kinetic studies with cultured cells indicate that
the facilitated diffusion nucleoside transporters in these
cells also exhibit directional symmetry (Wohlhueter and
Plagemann, 1982). Transport of nucleosides in HeLa and
Novikoff rat hepatoma cells are consistent with a simple
carrier model (Wohlhueter £jt al, 1979a; Wohlhueter and
Plagemann, 1982). However, in contrast to human
erythrocytes, uridine transport parameters in Novikoff rat
hepatoma cells for zero-trans and equilibrium exchange
influx are similar, demonstrating equal mobility of the
substrate-loaded and empty (i.e.substrate-unloaded) carrier
(Wohlhueter and Plagemann, 1982). However, nucleoside
transporters in erythrocytes and cultured animal cells
differ significantly in their translocation capacities, the
calculated translocation capacities for uridine zero-trans
influx of cultured cell lines are generally 10-fold lower
than for erythrocytes (Young and Jarvis, 1983) (Table
1.1). Another difference in nucleoside transporter
properties between cultured cells and erythrocytes is that
nucleoside transporters from some cell types may, in
addition, exhibit a significant affinity for free
nucleosbases (Wohlhueter et. aJL, 1979a; Slaughter et. al.
1981; Plagemann and Wohlhueter, 1984a).
.Specific inhibitors of carrier-mediated membrane
transport of nucleosides have proved invaluable in attempts
to isolate and identify nucleoside transport components.
Table 1.1 Comparison of Vmax for zero-trans uridine influx
with Bmax for the binding of nitrobenzvlthio-
inosine (NBMPR) in erythrocytes and cultured
cells

























Vmax values at 22-25 C for uridine influx and maximum high-
affinity NBMPR-binding activities for cells were taken from
Young and Jarvis (1983). Translocation capacities are
calculated from the ratio uridine Vmax: NBMPR Bmax.
Figure 1.2 Chemical Structures

























The best characterised and most useful inhibitor in
the study of nucleoside transport is NBMPR (Fig. 1.2).
6.
NBMPR and certain related S -derivatives of 6-thiopurine
nucleosides are very potent, reversible inhibitors of
nucleoside transport in a wide variety of cell types and
tissues (Paterson slL al, 1981; Young and Jarvis, 1983).
Inhibition by NBMPR in erythrocytes is associated with
tight, but reversible, high-affinity binding of inhibitor
to the cell membrane (apparent Kd. 0.1-1 nM) (Cass £i. al.
1974; Jarvis and Young, 1980; Dahlig-Harley e£_ al., 1981;
Jarvis g_t al_, 1982a; Plagemann and Wohlhueter, 1984a).
0«
Transported nucleosides such as uridine and adenosine (Fig.
1.2) are competitive inhibitors of high-affinity NBMPR
binding (Jarvis gJL al» 1982; 1983). A direct proportion¬
ality between binding site occupancy by NBMPR and
fractional inhibition of uridine transport in human
erythrocytes has been demonstrated (Cass at. sJl, 1974), and
instances have been described in which absences of
nucleoside transporter activity in erythrocytes and in
cultured cells were reflected in the corresponding absences
of site-specific binding of NBMPR. Thus, genetic variants
of both sheep erythrocytes and S49 mouse lymphoma cells
that do not exhibit carrier-mediated nucleoside transport
also do not possess high-affinity NBMPR sites (Jarvis and
Young, 1980, Cass e£ 1, 1981). As well, in erythrocytes
from various species, the maximum cellular transport
capacity (Vmax) for uridine was found to be directly
related to the number of membrane transporter elements
(NBMPR binding sites) present in each of the cell types
studied (Jarvis and Young, 1980, 1982; Jarvis aJ.,
1982b).
Kinetically, NBMPR is a simple competitive inhibitor
of zero-trans uridine influx and equilibrium exchange in
human, nucleoside-permeable sheep and guinea pig
erythrocytes, but a non-competitve inhibitor of uridine
zero-trans efflux (Eilam and Cabantchik, 1977; Jarvis £i_
al. 1982a; 1983b). Conversely, transported nucleosides are
competitive inhibitors of high-affinity NBMPR binding
(Jarvis at. slL, 1982a, b). Together, these findings are
consistent with a model proposed by Jarvis and Young (1982)
in which the erythrocyte NBMPR binding site is located
partially or totally within the outward facing conformation
of the transporter nucleoside permeation site, this binding
being stabilized by the interaction of the nitrobenzene
ring with an adjacent hydrophobic domain on the
transporter (Jarvis and Young, 1982; Jarvis q±_ a±L 1982a;
1983b; see Fig. 1.3). It is considered that high-affinity
NBMPR binding activity represents a specific quantitative
assay of nucleoside transport protein in those cells where
NBMPR has been shown to totally inhibit transport activity.
Although there is strong evidence that NBMPR binds
directly to the nucleoside permeation site on the
nucleoside transporter, the possibility that NBMPR binds to

















When the transport site is in the outwArd-facing
conformation (A) (panel 1), it can bind nucleoside (2) and
then undergo a re-orientation to the inward-facing form (3)
after which the nucleoside is released (4) (conformation
B).. The conformational change can occur both in the
presence and absence of bound nucleoside. NBMPR occupies
the transport site in the outward-facing form (5).
a separate allosteric inhibitor site cannot be ruled out.
In this separate site model of the NBMPR-sensitive
nucleoside transporter, binding of NBMPR at one site
allosterically alters the affinity of permeant at another
site and vice versa. Evidence that NBMPR binds to a
separate allosteric site derives from the finding that both
nucleosides and vasodilators such as dipyridamole and
dilazep are able to modulate the rate of NBMPR dissociation
from the transporter (Koren at. aL, 1983; Hammond and
Clanachan, 1985). Additional evidence comes from a cloned
line of cultured Novikoff rat hepatoma cells (Novikoff-UA)
possessing high-affinity NBMPR sites that apparently do not
block nucleoside transport (Gati at. JL 1986). This
controversial issue is considered further in later Chapters
of this Thesis.
A new and important perspective on nucleoside
transport has been provided by the recent recognition of
the existence of NBMPR-insensitive facilitated-diffusion
nucleoside transport mechanisms in several lines of
neoplastic cells. Studies with Novikoff rat hepatoma cells
and Walker 256 carcinosarcoma cells have shown that these
cells transport nucleosides by a non-concentrative
(sodium-independent) system that is not inhibited by
nanomolar concentrations of NBMPR (Wohlhueter ei al 1978;
Belt, 1983a; 1983b). These cells also lack high-affinity
NBMPR binding sites. Other cultured neoplastic cells such
as L1210, L5178Y and P388 murine leukaemia cells,
transformed hamster fibroblasts and HeLa cells exhibit
mixed NBMPR-sensitive and NBHPR-insensitive transport
(Dahlig-Harley ai, 1981; Belt, 1983; Eilam and
Cabantchik, 1977, Plagemann and Wohlhueter, 1985). These
two transporters are indistinguishable with respect to
substrate specificity, affinity for nucleosides and
dipyridamole sensitivity (Belt, 1983; Plagemann and
Wohlhueter, 1984a). The low sensitivity of some facilitated
diffusion nucleoside transporters to NBMPR inhibition may
reflect small structural or conformational changes in the
transporter protein, resulting in a decrease in affinity of
NBMPR binding and hence transport inhibition. Indeed,
NBMPR-sensitive and NBMPR-insensitive, facilitated-
diffusion nucleoside transport may reflect different
functional states of the same transporter polypeptide.
However, the molecular properties of NBMPR-insensitive
nucleoside transport systems remain to be elucidated.
1.3.2b Sodium-dependent nucleoside transport
Recent studies- of nucleoside uptake by rat renal
brush border vesicles (Le Hir and Dubach, 1984; 1985), in
intestinal enterocytes from guinea pigs (Schwenk ei. al.
1984) and rabbit intestinal brush border membranes vesicles
(Jarvis, 1985) have shown the existence of a separate
sodium-dependent, concentrative, NBMPR-insensitive
nucleoside transport system. This sodium-dependent
nucleoside transporter also exhibits a broad specificity
for both purine and pyrimidine nucleosides and displays a
high-affinity (Km. lOuM) for physiological nucleoside
permeants (Le Hir and Dubach, 1984). A joint presence of
the sodium-dependent, concentrative (NBMPR-insensitive)
nucleoside transporter and the NBMPR-sensitive, apparently
equilibrative nucleoside transport system has been reported
in cultured rat intestinal epithelial cells (Jakobs and
Paterson, 1986). The detailed properties of the sodium-
dependent nucleoside transport system remain to be
investigated. It seems likely that this transporter will
be found to be more widely distributed than renal and
intestinal brush border membranes.
1.3.2c Coronary vasodilators
Dipyridamole and several other vasoactive drugs such
as dilazep, hexobendine and lidoflazine were introduced as
coronary vasodilators (Kinsella et sJL, 1962) and have
subsequently had their pharmacological effects attributed
to an inhibition of nucleoside transport (Kolassa aJL,
1970; Sano, 1974). These coronary vasodialtors are potent
inhibitors of nucleoside transport in many cell types and
tissues. They inhibit adenosine transport, thus
potentiating the actions of adenosine. on coronary blood
flow.
Dipyridamole. the most extensively studied coronary
vasodilator, potentiates adenosine-induced increases in
coronary blood flow in man (Kinsella e£ aJL, 1962, Feldman
et al. 1981). Other pharmacological responses to adenosine
which are potentiated by dipyridamole include relaxation of
the smooth muscle of trachea (Davies et. al, 1982),
depression of nerve cell firing rates (Phillis el al 1979)
and adenosine-elicited accumulation of cyclic AMP in brain
slices (Nimit el al, 1981;). All these effects of
dipyridamole can be abolished by adenosine receptor
antagonists which supports the theory that dipyridamole may
be producing an increase in the extracellular concentration
of adenosine available to interact with adenosine
receptors.
Dipyridamole is a poor inhibitor (Ki 100 uM) of
adenosine deaminase (Kubler el al, 1970; Schrader el al,
1972) and adenosine kinase (Schrader et al, 1972), enzymes
involved in the inactivation of adenosine. Therefore, the
adenosine-potentiating action of dipyridamole was
attributed to an inhibition of the cellular uptake of
adenosine (Hopkins, 1973; Coleman, 1976; Huang and
Drumraond, 1976). Inhibition of nucleoside uptake by
dipyridamole has been described in a variety ofcell types
including erythrocytes (Turnheim al al, 1978; Rogler-Brown
and Parks, 1980; Jarvis et al, 1982), platelets (Lips -siL
al, 1980), lymphocytes (Pazdur et al, 1980), cardiac tissue
(Kolassa el a1, 1970; Mustafa, 1979), Novikoff rat hepatoma
cells (Plagemann, 1971), guinea pig smooth muscle (Kolassa
et. al, 1978b) and guinea pig and rat cortical synaptosomes
(Bender el 1980; Barberis ai. al, 1981).
The mechanism by which dipyridamole produces its
inhibition of nucleoside transport is still a matter of
some dispute (see for example Jarvis and Young, 1983).
Competitive, non-competitive and mixed type inhibition by
dipyridamole has been reported in different cell types.
Nucleoside transporter heterogeneity is also apparent with
respect to inhibition by dipyridamole. For example,
several studies suggest that there may be significant
species variation in the potency of dipyridamole as an
inhibitor of nucleoside transport. Thus, in all instances
so far studied, rat tissues have been found to be resistant
to dipyridamole inhibition (Kolassa et al, 1971; Hopkins
and Goldie, 1971; Sakai £i. al, 1981; Wu et al, 1981; Barker
and Clanachan, 1982). Furthermore, nucleoside transport in
JPA4 cells (a mutagenized clone derived form S49 murine
T-lymphoma cells, cells exhibiting pure NBMPR-sensitive
nucleoside trasnport) is partially insensitive to
dipyridamole inhibition. It should be noted that
dipyridamole appears to be a relatively non-specific
inhibitor of membrane transport processes because it also
inhibits the transport of anions, purine bases,
2-deoxy-D-glucose and D-glucosamine (Plagemann and Richey,
1974). NBMPR-insensitive facilitated nucleoside transport
is generally sensitive to dipyridamole inhibition (Belt,
1983; Belt and Noel, 1986) while the sodium-dependent
nucleoside transporter is not (Jarvis, personal
communication).
Dilazep and the structurally related compound
hexobendine have been shown to increase coronary and
cerebral blood flow in dogs (Sano, 1974; Fujii slL a_L,
1981). These coronary vasodilators are also potent
inhibitors of adenosine uptake (i. 0.1 uM) in human
erythrocytes (Turnheim ei. al., 1978), cardiac cells
(Mustafa, 1979), guinea pig epithelium (Kolassa e_fc_ al,
1978b), and rat brain capillaries (Wu and Phillis, 1982).
Lidoflazine is a long-acting coronary vasodilator
which acts both directly on the smooth muscle Of coronary
vessels (VanNeuten and Vanhoutte, 1980) and indirectly via
a potentiation of adenosine-induced vasodilation (Van
Belle, 1970). The direct effect of lidoflazine appears to
be due to an inhibition of calcium influx, thereby
inhibiting smooth muscle contraction. Lidoflazine has been
shown to decrease the rate of disappearance of adenosine
from whole blood of various species (Van Belle, 1970) and
these effects were attributed to an inhibition of adenosine
uptake. Lidoflazine has also been shown to inhibit the
uptake of adenosine by guinea pig epithelial cell£ (Kolassa
et al. 1978b) and cardiac cells (Mustafa, 1979).
Lidoflazine is generally 10-fold less potent than
dipyridamole as an inhibitor of adenosine uptake (Mustafa,
1979).
Fig. 1.4 compares the chemical structures of the
various coronary vasodilators.





































A number of other substances chemically unrelated to
nucleosides, such as organomercurials, have been found to
inhibit the uptake of nucleosides by cultured animal cells
and erythrocytes (Belt and Noel, 1985; Jarvis et al, 1986).
In human erythrocytes, p.-chloromecur iphenyl sulphonate
(PCHBS) inhibits uridine transport and NBMPR binding by
interacting with nucleoside transporter thiol group(s)
exposed to the cytoplasmic membrane surface (Tse nt. al.,
1985). These thiol group(s) are located within the
inward-facing conformation of the nucleoside transporter
permeation site. In contrast, the PCMBS-reactive thiol(s)
in NBMPR-insensitive transporters are accessible from the
external membrane surface (Belt, 1983a; Belt and Noel,
1985; Jarvis and Young, 1986a).
1-3.3 Regulation of Nucleoside Transport
Early studies demonstrating that nucleoside uptake
by cultured cells could be modified by a variety of factors
including hormones and cyclic nucleotides (Plageinann and
Pichey, 1974) can be attributed to effects on intracellular
nucleoside phosphorylation rather than transport per se
(Koren et. al., 1978; Rozengurt et. al., 1978; Wohlhueter et.
sJc, 1979b). Physiological regulation of nucleoside
transport activity does, however, occur during reticulocyte
maturation (Tucker and Young, 1980; Jarvis and Young,
1982). Maturation of sheep reticulocytes during in vitro
culture results in the parallel loss of transport activity
and NBMPR binding (Jarvis and Young, 1982). This loss of
transport activity and NBMPR binding during reticulocyte
maturation is restricted to certain species (e.g. sheep but
not pig or human) and may involve release from the cell of
transporter polypeptides in vesicular form (Johnstone
et al 1985).
1.3.4 Molecular Properties of the NBMPR-sensitive
Nucleoside Transporter
The protein nature of the erythrocyte nucleoside
transporter was formally demonstrated by studies of the
effects of proteases and organomercurials on NBMPR bindirtg
and nucleoside transport (Paterson et. a!l, 1980; Jarvis and
Young, 1982). The transporter has been shown to exhibit
chemical asymmetry, with trypsin and PCMBS-sensitive sites
located on the inner surface of the cell membrane (Jarvis
and Young, 1982; Tse at. al, 1985).
The first successful approach towards transporter
isolation used high-affinity NBMPR-binding as an essay for
the carrier and resulted in a 13-fold purification of,the
transporter from human erythrocyte 'ghosts' by a
combination of detergent extraction and fractionation on a
DEAE-cellulose ion-exchange column. The partially-purified
preparation consisted largely of band 4.5 polypeptides
(nomenclature of Steck (1974)) as detected on SDS-
polyacrylamide electropherograms. Band 4.5 polypeptides
have also been implicated in glucose transport (see e.g.
Wheeler and Hinkle, 1985). As a result, partially-purified
band 4.5 preparations from human erythrocytes consist
largely of glucose transporter, with the nucleoside
transporter present as a minor component. In human
erythrocytes the nucleoside carrier represents at most 0.2%
of the total membrane protein.
The use of NBMPR as a probe for exploring the
molecular properties of the NBMPR-sensitive nucleoside
transport system is complicated by the reversible nature of
its binding to the carrier protein and by the finding that
some detergents, such as Triton X-100, are potent
inhibitors of NBMPR binding (Cass£. 1, 1974; Jarvis and
Young, 1980, 1981; Koren e_t al, 1983). To overcome these
limitations. a photoaffinitv analogue of NBMPR.
adenosine (ABA), was synthesized
and tested for its ability to photoaffinity label the
nucleoside transporter in human erythrocytes (Young gJL,
1983). At the same time, NBMPR itself was shown to be
cross-linked to its binding site simply by exposure to
high-intensity UV light (Young et. gJ, 1983). Since NBMPR
has a higher affinity for the NBMPR-sensitive nucleoside
transport system (apparent Kd. 0.1-1.0 nM) than ABA
(apparent Kd. 15 nM), and because it is readily available
in radioactive form with a high specific activity,
[ H'jNBMPR has become the preferred radioligand in
photoaffinity labelling studies. Photoactivation of
3 3
site-bound[ H]NBMPR or[ H]ABA of human erythrocyte
'ghosts' in the presence of dithiothreitol as free radical
scavenger results in selective incorporation of
radioactivity into band 4.5 polypeptides (apparent Mr.
45,000-66,000). This radiolabelling is blocked by
transported nucleosides, and by nucleoside inhibitors such
as nitrobenzylthioguanosine (NBTGR) and dipyridamole (Wu ei
3
al. 1983). Also,[ H]NBMPR selectively labels band 4.5
polypeptides in membranes from pig erythrocytes (Wu eJL aJL,
1983a; Young ei aJL, 1985), cells which transport
nucleosides rapidly, but which lack a functional glucose
transporter (Kim and McManus, 1971; Jarvis ejt aJ, 1980a;
Young at. aJL, 1985). The pig erythrocyte nucleoside
transporter migrates with a significantly higher apparent
molecular weight on SDS-polyacrylamide gels than the human
transporter (Mr. (average) 64,000 c.f. 55,000) (Kwong at. aJL,
1985). The specificity of covalent labelling by
3 3
[ H]NBMPR was further demonstrated by the, absence of H
incorporation into membranes prepared from nucleoside
transport-deficient sheep erythrocytes, cells which lack
functional nucleoside transporters (Wu et_ aJL, 1983a).
Partially-purified band 4.5 polypeptides isolated from
human erythrocyte membranes were .also found to be
covalently labelled by NBMPR (Wu et_ al. 1983b). These
results provide strong evidence that the erythrocyteA.
nucleoside transporter is a band 4.5 polypeptide.
Radiation-inactivation analysis of both reversible
NBMPR-binding and uridine transport estimate that the
erythrocyte transporter has an in. situ molecular weight of
120,000, suggesting that the carrier may exist in the
membrane as a dimer (Jarvis, 1980b; 1984).
To explore the transmembrane topology of the
erythrocyte nucleoside transporter,[ H]NBMPR
covalently-labelled intact cells and unsealed membrane
'ghosts' have been subjected to controlled proteolysis. Low
concentrations of trypsin under iso-osmotic saline
conditions were found to have no effect on
[ H]NBMPR-photolabelled band 4.5 in intact human
erythrocytes (Janmohamed et_ al., 1985). In contrast, two
radioactive fragments of apparent Me. 38,000 and 23,000 were
produced when unsealed erythrocyte membranes are treated
with trypsin (Janmohamed£. 1, 1985). The Me. 38,000
fragment migrates as a braod peak, suggesting that
carbohydrate is attached to this fragment. These results
suggest that the trypsin-sensitive regions of the
transporter are exposed on the inner surface of the human
erythrocyte membrane;' Subsequent studies of trypsin
treatment of the pig nucleoside transporter established
that the transport polypeptide in this species is also not
susceptible to proteolysis from the extracellular surface
of the membrane but is again cleaved by trypsin at the
cytoplasmic surface.
Enzyme digestion studies have also been performed
with endoglycosidase-F, an enzyme that cleaves glycans of
both the high-mannose and the complex types. Following
endoglycosidase-F treatment, the[ H]NBMPR-labelled peak
and the Coomassie blue staining profile on
SDS-polyacrylamide gels of partially-purified human
erythrocyte band 4.5 polypeptides shifts from the broad
band of Mil 55,000 to a sharp Mr 46,000 band, providing
evidence that the nucleoside transporter of human
erythrocytes is a glycoprotein (Kwong e£ si, 1986). The pig
erythrocyte nucleoside transporter has also been shown to
be a glycoprotein but the carbohydrate structures in the
two species are different; endo-5-galactosidase cleaves
only the human transporter and not the pig, while
endoglycosidase F cleaves both (Kwong el al, 1985). The
polypeptide structures of the two transporters also
differ, the deglycosylated pig protein migrating on
SDS-polyacrylamide gels with an apparent Mr. of 57,000
compared with 44,000 for the deglycosylated human
erythrocyte nucleoside transporter (Kwong el al, 1985).
A partially-purified preparation of human
erythrocyte NBMPR-binding protein (consisting 95% of band
4.5 polypeptides) was reconstituted into soybean
phospholipid vesicles by a freeze-thaw-sonication procedure
(Tse el al, 1985). The reconstituted proteoliposomes
exhibited NBTGR-sensitive[ C]uridine influx that was
inhibited by adensoine, inosine, dipyridamole and dilazep.
Uridine transport by the reconstituted band 4.5 preparation
was saturable (apparent Ka for influx 0.21 mM with a Vmax
value of 1.8 nmolmg protein per s at 15°C) (Tse ai. al,
1985). Similarly, partially-purified pig erythrocyte band
4.5 polypeptides exhibit NBTGR-sensitive uridine transport
when reconstituted into phospholipid vesicles, but, unlike
human band 4.5 polypeptides, are incapable of
stereospecific glucose transport (Kwong e_t al, 1986).
Specific antibodies to the glucose transporter
(Boyle qJu. 1985) have been used to 'negatively' purify
the nucleoside transporter from human erythrocyte band 4.5
polypeptides. Preliminary experiments have demonstrated a
76-fold enrichment of human erythrocyte nucleoside
transporter by this method (Kwong et al., 1986), a value
which is 6-fold greater than that achieved by ion-exchange
chromatography (Jarvis and Young, 1981).
1.4 LUNG'S RELEVANCE TO NUCLEOSIDE TRANSPORT
The lung is thought of primarily as an organ for gas
exchange and the biochemical properties of the pulmonary
circulation are often neglected. The importance of the
metabolic functions of the lung and the effect of the
pulmonary circulation on blood-borne substances should be
emphasized since it may have important physiological and
clinical implications (Bakhle and Vane, 1974; Bakhle and
Vane, 1977). The biochemical processes occuring within the
pulmonary circulation result in the removal or release of
many biologically active substances. Both endogenous and
exogenous substances are removed during passage through the
pulmonary circulation (see e.g. Fishman and Pietra, 1963;
Bakhle and Vane, 1977). Three unique properties of the
pulmonary circulation are relevant to this role:
(i) It is the only vascular system in the body which
receives the entire cardiac output.
(ii) It contains the largest capillary bed .in the body.
(iii) It occupies a unique position between the venous and
arterial circulations.
For these reasons, venous blood will come into
contact with an enormous area of pulmonary endothelium,
known to be biochemically active, before it reaches the
systemic circulation. Thus, the blood levels of
physiologically important substances are likely to be
modified before they reach the heart and systemic
circulation. Compounds for which this is known to occur
include 5-hydroxytryptamine, noradrenaline, prostaglandins,
bradykinin, adenine nucleotides, endogenous hormones e.g.
steroids, insulin and a number of circulating vasoactive
agents (e.g. adenosine), and this process is believed to be
important in maintaining vascular homeostasis (Gillis and
Roth, 1976). In the context of this Thesis, only the
lung's role in the removal of nucleosides, in particular,
adenosine will be discussed.
Binet and Burnstein (1950) first described the
disappearance of ATP on passage through the lung, and in
subsequent studies in which radiolabelled nucleotides were
infused (Ryan and Smith, 1971; Cooper el el, 1979), it was
shown that the pulmonary bed degrades ATP to adenosine via
specific enzymes on the surface of the capillary
endothelium. The possiblity of cellular uptake and
metabolism of the adenosine thus formed was not, however,
investigated. It was not until 1971 that the removal of
adenosine from the pulmonary circulation was first
reported. These early In vivo experiments (Kolassa el
1971) demonstrated that,, in the rat and guinea pig, the
majority of radioactivity following intravenous injection
of labelled adenosine was retained by the lungs. In
addition, it was observed that there was a significant
difference in the ability of lungs from the two animals to
dispose of adenosine. Thus, Kolassa el ai (1971) observed
that guinea pig lung was able to remove 50% more adenosine
than rat lung. These authors also reported a marked
difference between the two species with respect to the
ability of dipyridamole to inhibit adenosine uptake. In
subsequent isolated lung perfusion studies (Bakhle and
Chelliah, 1983), it was shown that both rat and guinea pig
perfused lung were capable of removing adenosine from the
vascular space by a combined process of uptake and
subsequent intracellular metabolism. Similar dipyridamole
sensitivity differences between guinea pig and rat lung
were also reported, dipyridamole being more potent in
decreasing uptake in guinea pig lung than in rat lung.
Therefore, at least in guinea pig and rat, the
pulmonary endothelium appears to play a major role in the
•»
removal of circulating adenosine. Support for this view
comes from work by Pearson £i. 1 (1978) who found that pig
aortic endothelial cells in culture rapidly transported
adenosine in a manner which was inhibited by dipyridamole.
The high uptake capacity of these cells led the authors to
conclude that pulmonary endothelial cell? are the major
route for the removal of circulating adenosine in the pig.
Subsequent studies in isolated piglet perfused lung also
demonstrated that adenosine was efficiently taken up from
the pulmonary vascular bed, and that the process was
potently inhibited by dipyridamole (Hellewell and Pearson,
1983).
1.5 EXPERIMENTAL APPROACH AND OBJECTIVES
Physiologically, lung is important for adenosine
removal as detailed in the previous Section. Hence there
is a need to characterize nucleoside transport in this
tissue, both with respect to kinetic behaviour and alsc
with respect to pharmacology. However, transport experi¬
ments using perfused whole lung suffer certain inherent
limitations. For example, kinetic values for tissue
nucleoside uptake based on such studies do not report
initial rates of permeation across the endothelial cell
membrane and are likely to reflect net effects of several
metabolic processes, in addition to that of membran
transport. Also, the isolation of pulmonary endothelia
cells is inherently difficult. Therfore, in this presen
study, I have attempted to study functional aspects o
nucleoside transport in lung by alternative approaches
Lung tissues possesses a very high density of NBMPR binding
sites (Marangos ei. 1982). Hence, my initial series of
experiments developed the use of reversible NBMPR binding
to study nucleoside transporter function in s?lasma
membranes of rat and guinea pig lung. In the course of
these experiments, I found that the rat and guinea pig lung
nucleoside transporters differed significantly in
dipyridamole sensitivity.[ H]dipyridamole binding
studies and kinetic experiments on[ H]NBMPR binding were
subsequently carried out in an attempt to obtain a better
understanding of the mechanism by which dipyridamole
interacts with the transporter and in particular
relationship between NBMPR and dipyridamole binding sites
in the two species.
In a complementary series of experiments, nucleoside
transport in lung was studied directly, making use of
reconstitution methodology. These studies were necessary
to ensure that the NBMPR binding protein characterized in
other experiments did in fact represent the NBMPR-sensitive
nucleoside transporter. To do this, the NBMPR binding
protein from guinea pig lung plasma membranes was
solubilised in detergent and reconstituted into
proteoliposomes. A major advantage of this technique is
that it was possible to perform detailed kinetic
experiments, permitting an in depth comparison of transport
parameters in lung and erythrocytes.
Another major objective of my study was to
investigate the molecular properties of the NBMPR-sensitive
nucleoside transporter in the lung as a first step towards
a molecular comparison of nucleoside transporters in
non-erythroid tissues with those well characterized systems
present in human and pig erythrocytes. For these
investigations, radiolabelled NBMPR was used as a covalent
probe to photoaffinity label the NBMPR binding sites in
lung plasma membranes, the labelled proteins being
characterized by SDS-polyacrylamide gel electrophoresis.
Labelling patterns were compared with that given by red
blood cells. It was observed that rat and guinea pig lung
nucleoside transporters have significantly different
apparent molecular weights on SDS-polyacrylamide gels. The
origin of this molecular weight difference in the two
species was explored by limited proteolysis and
endoglycosidase-F digestion experiments.
1.6 ORGANIZATION OF THESIS
The remainder of the thesis is divided into six
Chapters. In Chapter Two, a detailed investigation of NBMPR
binding to rat and guinea pig lung crude membranes is
presented. The kinetics of NBMPR binding and dissociation
are also described. A parallel chracterization of
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[ H]dipyridamole binding to guinea pig and rat lung crude
membranes is described in Chapter Three.
In Chapter Four, an in depth study of the photo-
affinity labelling of lung crude plasma membranes by
3
[ H]NBMPR is presented. Conditions for photo-
3
incorporation of[ H]NBMPR into lung membranes are
described and the identity of the membrane polypeptides
3
radiolabelled by[ H]NBMPR is investigated. This Chapter
also presents evidence that the rat and guinea pig lung
nucleoside transporters are glycoproteins and explores the
origin of a molecular weight difference between the
nuclensiHfi transDorters from these two SDecies.
Chapter Five describes conditions for the
preparation of a more enriched lung plasma membrane
Preparation possessing a higher specific activity of NBMPR
binding. This Chapter also describes the characterisation
of reversible and covalent NBMPR binding in this enriched
Plasma membrane preparation.
In Chapter Six, the NBMPR binding protein extracted
from the enriched guinea pig lung membranes is shown to
catalyse NBTGR-sensitive uridine transport when
reconstituted into proteoliposomes. The system's kinetic
properties are characterized in detail and compared with
those of the reconstituted human erythrocyte nucleoside
transporter.
Finally, Chapter Seven presents a general discussion
of the results presented in preceding Chapters.
CHAPTER 2
NITROBENZYLTHIOINOSINE BINDING TO RAT AND
GUINEA PIG LUNG CRUDE PLASMA MEMBRANES
2.1 INTRODUCTION
In recent years, functions other than respiration
have been attributed to the lung. One such nonrespiratory
function is a pharmacokinetic role in the disposition of
endogenous and exogenous compounds in the blood. Of
particular interest is the physiological role of the lung
in the removal of adenosine, a potent vasodilator and
endogenous regulator of the microcirculation (Drury and
Szent-Gyorgi, 1929; Baer and Drummond, 1979). La vivo
Perfusion studies by Kolassa eiL aJL (1971) suggest that, at
least in the guinea pig and the rat, the pulmonary
endothelium plays a major role in the removal of
circulating adenosine. Kolassa ei dJL (1971) observed that
guinea pig lung was able to remove 50% more adenosine than
rat lung, and reported significant differences between the
two species in the ability of dipyridamole to inhibit
uptake of adenosine. Similar differences between guinea
Pig and rat lung were also reported more recently by Bakhle
and Chelliah (1983).
As detailed in the General Introduction, it ie well
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established that high-affinity binding of[ H]NBMPR to
human erythrocyte 'ghosts' represents a specific
interaction with functional elements of the erythrocyte
nucleoside transporter (Cass et. a_l, 1974; Jarvis and Young,
1980, 1982; Young and Jarvis, 1983). Preliminary
experiments by Marangos gJi al (1982) have also revealed a
high density of high-affinity NBMPR binding sites in rat
lung. The aim of the experiments described in this Chapter
was to investigate NBMPR binding to membrane preparations
from lung tissue as a first step towards a molecular and
functional characterization of NBMPR-sensitive nucleoside
transporters in this tissue. A detailed characterization
of reversible NBMPR binding to rat and guinea pig lung
crude plasma membranes is presented. Kinetic studies of
NBMPR binding in the presence and in the absence of
dipyridamole were used to explore the origin of the
species difference in dipyridamole sensitivity.
2.2 METHODS
2.2.1 Tissue and Membrane Preparation
Male Sprague-Dawley rats (400-450g) and
Dunkin-Hartley guinea pigs (700-800 g) were anaesthetised
with ether and the lungs perfused in. situ with heparinized
saline to remove trapped erythrocytes. Lung tissue was then
removed from the animals, washed twice in ice-cold saline
and homogenized in 25 volumes (wv) of ice-cold 50 mM
Tris-HCl (pH 7.4 at 22°C) using a Brinkmann Polytron PT-10
(setting 5, 6s). Samples were centrifuged at 3000g. for 10
min and the pellet discarded. The supernatant was then
centrifuged at 45,000 g. for 10 min, and the pellets washed
3 times in 25 volumes of Tris-HCl before resuspension in
the same volume of buffer. This crude membrane preparation
was used without further purification.
Protein was determined by the method of Lowry et. al
(1951).
2.2.2 Equilibrium High Affinity NBMPR Binding
Rat and guinea-pig lung membranes in 50 mM Tris-HCl
(0.05- 0.08 mg protein) were incubated with graded-
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concentrations of[ H]NBMPR (final equilibrium
concentrations 0.05- 10 nM) in a total volume of 1 ml for
30 min at 22 C in the presence or in the absence of 20 uM
NBTGR as competing non-radioactive ligand. Incubations
were terminated by filtration on glass fibre filters
(Whatman GFB, which were washed with ice-cold buffer
before sample filtration) under suction. The filters were
washed four times with 3 ml aliquots of ice-cold buffer,
the entire procedure being completed within 15 s. The
filters were dried and added to 10 ml of scintillation
fluid. Vials were shaken at room temperature overnight
before counting.[ H]NBMPR binding to membranes was
expressed per mg protein. Nonspecific binding was defined
as binding in the presence of 20 uM NBTGR (corrected for
absorption of radioactive ligand by the filters). Specific
binding was calculated as the difference in binding in the
presence and in the absence of NBTGR. Equilibrium
concentrations of unbound[ H]NBMPR were calculated from
the differences between the starting[ H]NBMPR
concentrations and the amounts of ligand bound to membranes
and filters.
2.2.3 Kinetic Studies of NBMPR-binding
2.2.3a Dissociation kinetics of NBMPR binding
Rat and guinea pig lung membranes were incubated
with[ H]NBMPR (final equilibrium concentration 2 nM) for
30 min at 22C. Incubations were terminated by
centrifugation at 40,000 g for 15 min. The membrane
pellets were washed once with 10 ml of ice-cold 50 mM
Tris-HCl buffer (pH 7.4 at 22'C) and resuspended at a
protein concentration of 2 mgml. The[ H]NBMPR-labelled
membranes were kept on ice for up to 3 h. Control
experiments demonstrated that the amount of[ H]NBMPR
bound to the lung crude membranes of both species remained
constant during this period. Dissociation was initiated by
adding 250 ul of ice-cold[ H]NBMPR-labelled membrane to
60 ml of 50 mM Tris buffer, pH7.4 at 22°C containing no
addition or graded concentrations of dipyridamole
100 nM- 100 uM) either in the presence or in the absence
of 20 nM NBTGR. The medium was continuously stirred and at
various time intervals (0.5-20 min) after the addition of
the membranes, 5 ml portions were removed and filtered
immediately through glass-fibre filters under suction. The
filters were washed four times with 3 ml aliquots of
ice-cold buffer, the entire procedure being completed
within 15 s. The filters were dried and counted for
radioactivity as described above. Dissociation of
radioligand from non-specific binding sites was determined
by labelling the lung membranes with[ H]NBMPR in the
presence of 5 uM NBTGR and then measuring the rate of
dissociation by the above procedure. Dissociation of
non-specific[ HJNBMPR binding was limited to the first
1 min of incubation. Thereafter, no further dissociation
of radioligand occured. Non-specific binding was typically
less than 5% of the total binding. Specific[ H]NBMPR
binding was calculated as the difference between total
binding and non-specific binding measured in the presence
of excess nonradioactive NBTGR.
The suspension medium used in the majority of
dissociation experiments contained 20 nM nonradioactive
NBTGR so as to prevent re-binding of dissociated
3
[ H]NBMPR (Jarvis ei al, 1983). Results obtained were
evaluated by using the following equation derived for a
simple bimolecular reaction:
equation (1)
where Bgq. is the specific binding at time zero, BJl is the
specific binding at time t, and Koff is the dissociation
rate constant.
2.2.3b Association kinetics of NBMPR binding
The experimental conditions for measuring the
3
association kinetics of[ H]NBMPR binding were designed
to be pseudo-first order, that is, the concentration of
free radioactive ligand, [L] in equation (2) below is
constant throughout the reaction (Bennett, 1978). A low
protein concentration in a relatively large volume of
3
[ H]NBMPR was used so as to achieve the above condition.
Binding was started by adding 50 ug of lung membrane to
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60 ml of 0.5 nM[ H]NBMPR(+ 10 -10 M dipyridamole)
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obtained as the difference in binding in the absence and in
the presence of 5uM NBTGR.
To analyse the data, values obtained were plotted
according to the rate equation:
equation (2)
where Baa. and B£. are the concentrations of bound receptor
at equilibrium and at time t, Kon and Koff are the
association and dissociation rate constants, respectively
and [L] is the free radiolabelled-ligand concentration at
steady state. The percentage of total ligand bound at the
3
0.5nH[ H]NBMPR used was less than 10%, hence, [L] in




2.3.1 Characterisation of NBMPR Binding to Lung Membranes
Fie. 2.1 shows representative data for the
3
concentration-dependence of[ H]NBMPR binding to rat and
guinea-pig lung membranes, demonstrating the presence of
both high-affinity saturable (NBTGR-sensitive) and
nonsaturable (NBTGR-insensitive) binding components in the
two species. Specific binding saturated at about 2.5 nM
3
[ H]NBMPR, Scatchard analyses of the data indicating a
single population of binding sites with a similar
dissociation constant (K) in the two species (0.2-0.4 nM),
but a 2-fold difference in the number of binding sites
(Bmax), guinea pig being higher than rat (Table 2.1 and
Fig. 2.2). Calculated Hill coefficients for specific high
affinity NBMPR binding were 1.03 and 0.98 for rat and
guinea pig lung membranes, respectively (Fig. 2.2 and Table
2.1). Both species exhibited the same amount of
3
non-specific (NBTGR-insensitive)[ H]NBMPR binding
(1i5 pmolmg protein at 10 nM NBMPR). Dissociation
experiments confirmed that high-affinity NBMPR binding to
lung membranes was reversible (see Section 2.3.2a).
The effects of two physiological nucleosides,
adenosine and uridine, on NBTGR-sensitive NBMPR binding to
rat and guinea pig lung crude membranes are shown in
Fig. 2.3. The concentrations of nucleosides required to
induce 50% inhibition (IC) of high-affinity NBMPR
50
Figure 2.1 Concentration dependence of NBMPR binding to
rat and guinea-pig lung crude membranes
10
5
0 2.5 5.0 7.5 10
NBMPR (nM)
[3H]NBMPR binding to rat(,) and guinea-pig(•, O]
lung membranes was measured in the absence(,•) and ir
the presence(, O) of 20 uM NBTGR as competing ligand.
Values are means of duplicate estimates.
Figure 2.2 Scatchard and Hill plots of site-specific NBMPR
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log NBMPR Cone. (nM)
Scatchard (A) and Hill (B) plots of site specific binding
of NBMPR to rat and guinea-pig lung PMF. These plots were
obtained using data for guinea pig() and rat(•) lung
t.
crude membranes presented in Fig. 2.1.
Table 2.1 Binding parameters for NBMPR binding to lung
crude membranes
Kd. Bmax Hill
(nM) (pmolmg protein) coefficient
Rat 0.22+0.08 8.1+1.1 1.03+0.18
Guinea pig 0.38+ 0.12 19.3+ 5.2 0.98+ 0.13
Kd. and Bmax values were estimated by Scatchard analysis.
Values are means (+SEM) of 4 experiments.
Figure 2.3 Dipyridamole. adenosine and uridine inhibition
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The effects of varying concentrations of dipyridamole
adenosine and uridine on
equilibrium NBTGR-sensitive [3H]NBMPR binding (NBMPR
concentration 0.5 nM) to rat (closed symbols) and
guinea-pig (open symbols) lung membrane preparations were
determined as described in the text. Data are expressed as
percentages of control values and are means (+SEM) of
triplicate estimates.
binding (0.5 nM) were similar in the two species: 7 mM and
0.8 mM for uridine and adenosine, respectively. High
concentrations of adenosine, a more effective inhibitor of
NBMPR binding than uridine, induced essentially complete
inhibition of NBMPR binding activity (estimated Ki. of
0.28 mM and 2 mM for adenosine and uridine in both species,
respectively, Table 2.2).
The properties of NBMPR binding to rat and
guinea-pig lung crude membranes were investigated further
by studying the effects of dipyridamole on high-affinity
binding activity in the two species. High-affinity NBMPR
binding activity in guinea-pig lung was essentially
abolished in the presence of 1 uM dipyridamole (Fig. 2.3).
In marked contrast, this concentration of dipyridamole had
no detectable effect on NBMPR binding to rat lung
membranes. Higher concentrations of dipyridamole caused
only partial inhibition of binding activity. The effects
of other vasodilators, dilazep, lidoflazine and
hexobendine, on NBMPR binding to lung crude membranes were
also investigated. Table 2.3 presents the IC values of
50
various vasodilators on equilibrium NBTGR-sensitive
3
[ H]NBMPR binding. IC values were 10-300 fold lower
50
in guinea-pig than in rat. However, the order of potency
9
of these compounds as inhibitors of NBMPR binding were
ft
similar in the two species (dilazep dipyridamole,
hexobendine lidoflazine). This order of potency
correlates with the relative abilities of these compounds
Table 2.2 Estimated Ki values for adenosine and uridine
inhibition of NBHPR binding to rat and guinea-




Ki calculated according to
IC50 values extracted from Fig. 2.3.
Table 2.3 ICGQ values for various vasnd i la tors as.
inhibitors of NBMPR binding to rat and guinea-
pig lung crude membranes
IC5Q (nM) Ratio
Guinea-pig Rat (RatGuinea pig)
Dipyridamole 45.0+3.2 13400+1410 297
Dilazep 4.8+0.28 83+7.4 17.3
Lidoflazine 300.0+19 10,000 33
Hexobendine 43.0+3.9 1400+110 13.7
IC50 values were determined by testing eight to 'ten drug
concentrations for inhibition of [3H]NBMPR binding
(0.5 nM). Each compound was tested at least three times.
Values are means (+SEM). See Table 2.4 for estimated Ki.
values..
Table 2.4 Estimated Ki values for various vasodilators as
inhibitors of NBMPR binding to guinea pig and







Ki. values estimated by
IC50 values are from data presented in Table 2.3.
to inhibit adenosine uptake in other tissues (Kolassa et.
al. 1978; Mustafa, 1979).
In order to assess the nature of dipyridamole
inhibiton of NBMPR binding to guinea pig and rat lung crude
membranes, measurements of equilibrium NBMPR binding
3
(0.05-5 nM[ H]NBMPR) were made in both species in the
presence and in the absence of graded concentrations of
-8 -4
dipyridamole (10 -10 M). Figs. 2.4(a) and (b) are
Lineweaver-Burke plots of representative inhibition
experiments in the two species. In both cases,
dipyridamole functioned as a competitive inhibitor of
3
[ H]NBMPR binding. Mean apparent Kx values from several
-8
experiments were 1.8+ 0.46 (x 10 )M and 8.53+ 2.00 (x
-6
10 )M for guinea pig and rat membranes, respectively, a
difference of 470-fold.
3
Kinetic studies of[ H]NBMPR dissociation and
association were subsequently undertaken to investigate the
mechanism of action of dipyridamole in the two species in
more detail (see Section 2.3.2).
2.3.2 Kinetic Studies of NBMPR Binding to Lung Membranes
2.3.2a Dissociation kinetics of NBMPR binding
In initial experiments, the dissociation of bound
[ H]NBMPR was measured by resuspending[ H]NBMPR-
labelled membranes in a large volume of ligand-free 50 mM
Tris-HCl buffer, pH 7.4 at 22°C. When these data were
Figure 2.4 Inhibition of equilibrium NBMPR binding £3.


























Equilibrium [3H]NBMPR binding to lung membranes was
determined as described in the text. Dipyridamole
concentrations (rat): control; ,10-6M ,10-5M
,10-4 M. Dipyridamole concentrations (guinea-pig):
,contro1 ,10-8 M 10-7 Hj ,10-6 M.
plotted in accordance with equation (1), curvilinear plots
3
of time course y ln(dissociation of[ H]NBMPR-lung
membrane complex) was observed (Figs. 2.5(a) and (b)),
suggestive of either the presence of two or more components
3
of dissociation or the re-binding of free[ H]NBMPR.
Inorder to eliminate the latter possibility, nonradioactive
NBTGR (20nM), sufficient to saturate the high-affinity
NBMPR sites, was added to the buffer to prevent re-binding
3
by displaced[ H]NBMPR. As shown in Figs. 2.5(a) and
(b), this resulted in linear plots of time. course ys.
3
ln(dissociation of[ H]NBMPR-lung membrane complex) in
both species, with the calculated dissociation rate
constants being similar to those obtained from the initial
phases of dissociation in the presence of buffer alone.
Therefore, all further dissociations experiments, unless
noted otherwise, were carried out in the presence of 20 nM
NBTGR.
3
Representative dissociation curves for[ H]NBMPR
«-•
in the presence and in the absence of dipyridamole
(0-50 uM) are shown in Figs. 2.6(a) and (b). Forboth the
•t
rat and the guinea pig, dipyridamole decreased the rate of
3
[ H]NBMPR dissociation. Figs. 2.7(a) and (b) demonstrate.
the concentration dependence of this effect. In contrast
0
to the equilibrium binding experiments (Figs. 2.4(a) and
%
(b)), dipyridamole was equally effective as inhibitor of
3
[ HJNBMPR dissociation in the two species. The apparent
3
rates of dissociation of[ H]NBMPR (app. Koff in the
Figure 2.5 Time course of dissociation of NBMPR-lung





































Lung crude membranes were pre-equilibrated with 2 nM
[3H]NBMPR at 22°C for 30 min, washed free of unbound
ligand and dissociation (also at 22°C) initiated by the
addition of 50 ul of labelled membranes to 60 mlof 50 mM
Tris-HCl, pH 7-4, containing no addition or
20 nM NBMPR The percentage of the remaining
specifically-bound [3H]NBMPR at various times was plotted
as described in the text (equation 1). At time zero there
was 7.2 pmol and 17.3 pmol of [3H]NBMPR bound per mg of
































Lung crude membranes were pre-equilibrated with[ H]NBMPR
and washed free of -excess unbound ligand as described in
the legend to Fig. 2.5. Dissociation at 22°C was initiated
by the addition of 50 ul of labelled membranes to 60 ml of
50 mM Tris-HCl buffer containing 20 nM NBTGR, with no
addition 2.5 uM-dipyridamole 10 uM-dipyridamole
or 50 uM-dipyridamole The percentage of
remaining specifically-bound [3H]NBMPR at various times
was plotted as described in the text (equation 1).
Figure 2.7 Dissociation of bound NBMPR from rat (A) and



























Apparent dissociation rate constants (apparent Koff) were
determined from experiments similar to those presented in'
Fig. 2.6. and plotted as a function of dipyridamole
concentration. Results are the means(±SEM) of fouri
independent experiments. For most of the values, error
A.
bars fell within the data points.
absence of inhibitor were 0.123+ 0.010 min and
0.034+ 0.006 min for guinea pig and rat lung crude
membranes, respectively. The decrease in app. Koff by
dipyridamole in both species appeared to plateau off at a
dipyridamole concentration of 50 uM and the concentration
of dipyridamole required to induce half-maximal reduction
in Koff was approximately 5 uM for both guinea pig and rat
lung membranes. It would therefore seem that the
difference in dipyridamole sensitivity in the two species
cannot be attributed to differential effects of
dipyridamole on the rate of[ H]NBMPR dissociation, since
in both species dipyridamole decreased the app. Koff
similarly.
2.3.2b Association Kinetics of NBMPR Binding
The association reaction between[ H]NBMPR and
lung crude membranes was studied under pseudo-first-order
conditions (see Section 2.2.3b). Association was initiated
by incubating lung membrane with 0.5 nM[ H]NBMPR at 22 C
in the presence and- in the absence of dipyridamole. The
rate of complex-formation was measured as a function of
time and representative plots are shown in Figs. 2.8(a)
and (b). In the absence of any inhibitor, binding of
[ H]NBMPR to lung membranes in both species reached a
steady state within 10 min after the reaction was
initiated, and the time required to reach 50% saturation
was approximately 1.5 min. In the presence of dipyridamole,
Figure 2.8 Time course of NBMPR binding to rat (A) and


























Rat and guinea pig ..lung membranes were incubated with
0.5 nM [3H]NBMPR in the presence and in the absence of
various concentrations of dipyridamole. Dipyridamole
concentrations (rat): , control; O ,10-6 M: 10-5 M;
,10-4 M. Dipyridamole concentrations (guinea-pig):
,control; 10-8 M; ,10-7 M. Values are the
means of duplicate estimates.
3binding of[ HJNBMPR to lung membranes in the two species
3
behaved differently. Association of[ H]NBMPR to
guinea-pig lung membranes was slowed down even in the
-8
presence of 10 H dipyridamole, and association was
-6
totally abolished in the presence of 10 H dipyridamole.
In the rat, association was not affected by dipyridamole
-7
concentrations of less than 10 M. The apparent
association rate constants (Kon) in the presence and in the
absence of inhibitor as calculated according to equation(2)
are presented in Table 2.5.
Table 2.5 Apparent association rate eonstants for NRMPR
















Apparent association rate constants (Kqil) were determined
as described in text. Values are means (+SEM) of 3
experiments.
2.4 DISCUSSION
Kinetic studies of nucleoside transport in a variety
of cell types have established that physiological and
cytotoxic nucleoside molecules cross the plasma membrane of
animal cells mainly by an NBMPR-sensitive nucleoside-
specific facilitated diffusion process which is independent
of subsequent intracellular nucleoside metabolism
(Plagemann and Wohlheuter, 1980; Paterson et. 1, 1981;
Young and Jarvis, 1983). In this Chapter, I have been able
to demonstrate the presence of saturable, high-affinity
binding sites for NBMPR in crude membrane preparations from
both rat and guinea-pig lung. K± values for NBMPR binding
to these sites were very similar in the two species (0.22
and 0.38 nM in rat and guinea pig, respectively). However,
Bmax values for high-affinity NBMPR binding to rat and
guinea-pig lung crude membranes differed significantly,
guinea pig membranes having the higher density of NBMPR
binding sites (approximately 19 pmolmg protein compared
with 8 pmolmg protein for rat lung membranes).
As predicted from studies of nucleoside transporters
in other cell types, high-affinity NBMPR binding to lung
plasma membranes was inhibited by adenosine, uridine,.
dipyridamole, dilazep and other vasodilators. Adenosine
was a more effective inhibitor of NBMPR binding than
uridine, a result consistent with the known relative
affinities of these two nucleosides for the transporter in
other systems, adenosine usually having the lower apparent
Km. For example, human erythrocytes exhibit apparent Km
values of 61 uM and 0.8 mM for adenosine and uridine
equilibrium exchange influx at 25'C, respectively (Jarvis
et 1, 1983; Plagemann at, sii, 1985).
As shown in Fig. 2.2, NBMPR binding to rat and
guinea pig lung crude membranes were equally susceptible to
nucleoside inhibition. In contrast, there was a large
species difference in dipyridamole sensitivity, Ki values
in the two preparations differed by more than two orders of
magnitude (20 nM and 5.6 uM for guinea pig and rat lung
membranes, respectively, Table 2.4). It has previously
been shown that adenosine uptake by intact rat lung is
approximatedly 100 times less sensitive to dipyridamole
than guinea pig lung (Kolassa 1, 1971). Lung NBMPR
binding sites in the two species therefore have the
properties expected of nucleoside transport proteins in
this tissue.
Like dipyridamole, dilazep, another vasodilator, was
also found to be a less potent inhibitor of equilibrium
[ H]NBMPR binding to- rat lung membranes (Ki values of 2
and 35 nM for guinea pig and rat membranes, respectively.
See Table 2.4). Lidoflazine and hexobendine were also less
effective in rat lung membranes (Ki. values of 110 and
18 nM-, 4.2 uM and 0.59 uM for lidoflazine and hexobendine
in guinea pig and rat lung membranes, respectively, see
Table 2.4).
The mechanism by which dipyridamole (and other
vasodilators) inhibits nucleoside transport has been a
matter of dispute. Competitive (Lips et. al_, 1980; Jarvis
et al. 1982), mixed (Turnheim et. al., 1978) and non¬
competitive (Meunier and Morel, 1978; Rogler-Brown and
Parks, 1980) inhibition kinetics have been reported in
different systems. A more recent study, published after
the experiments reported in this Chapter were completed,
has shown that dipyridamole being a competitive inhibitor
of uridine equilibrium exchange influx into guinea pig
erythrocytes (apparent Ki. 1 nM) (Jarvis, 1986). In the
present series of experiments, dipyridamole was found to be
3
a competitive inhibitor of equilibrium[ H]NBMPR binding
fl«
to guinea-pig lung membranes with an apparent Ki value of
-8
1.8 x 10 M. Dipyridamole was considerably less effective
3
at inhibiting[ H]NBMPR binding to rat lung membranes,
3
but again, inhibition of equilibrium[ H]NBMPR binding
-6
was competitive, with an apparent Ki value of 8.5x10 M.
As shown in Fig. 2.8, low concentrations of
-8 -7
dipyridamole (10- 10 M) had a marked effect on the
3
association of[ H]NBMPR with its binding site on
guinea-pig lung membranes. In contrast, much higher
-6 -4
concentrations (10 -10 M) were required to produce
comparable effects in rat lung membranes. The effects of
various concentrations of dipyridamole on NBMPR
dissociation from rat and guinea-pig lung membranes was
also compared. As presented in Fig. 2.7, concentrations of
dipyridamole 1 uM had no significant effect on NBMPR
dissociation in either species, while higher concentrations
of vasodilator were equally effective at slowing down the
rate of NBMPR dissociation in the two species (half-maximal
inhibition of dissociation at 5 uM dipyridamole). In the
guinea pig, dipyridamole concentrations of 10 -10 M
exert their effects on NBMPR binding affinity (Kd.) by only
decreasing Kqh (Table 2.6). In the rat, dipyridamole
concentrations of 10 -10 M decreased both Kof f and
Kon. but decreasing Kon_ to a larger extent and therefore
producing an increase in Kd for NBMPR binding with
increasing concentrations of dipyridamole (Table 2.7). The
determined kinetic constants for NBMPR association and
dissociation (Section 2.3.2) are in close agreement with
the equilibrium binding measurements in Section 2.3.1, that
is, Koff Kon= Kd., as summarized in Tables 2.6 and 2.7.
In human erythrocytes, dipyridamole (200 nM) has also been
shown to decrease the rate of dissociation of[ H]NBMPR
from its binding sites (Jarvis e_L al. 1983).. Similarly,
dilazep has also been reported to decrease the rate of
dissociation of NBMPR from the binding-site complex of
cultured hamster cell (Nil SV) membrane preparations (Koren
£_t aJL, 1983).
In conclusion, I have demonstrated the presence of
high-affinity NBMPR sites in guinea pig and rat lung crude
membranes which display similar characteristics to those
found in erythrocyte membranes. As expected from previous
studies, there was a marked species difference in the
ability of dipyridamole to inhibit NBMPR binding, the
guinea pig association rate constant being considerably
more sensitive to dipyridamole inhibition than the
corresponding rate constant for the association of NBMPR
with rat lung membranes. Possible mechanisms by which
dipyridamole interacts with NBMPR-sensitive nucleoside
transporters in these two species are discussed in detail
in the General Discussion.
Table 2.6 Summary of kinetics parameters of NBMPR binding

























Values of Koff and Kohl are taken from Section 2.3.2a and
Table 2.5, respectively.
»•
tTable 2.7 Summary of kinetics parameters of NBMPR binding











0 0.034 0.53 0.06
-6
10 0.028 0.30 0.09
-5
10 0.010 0.04 0.25
-4
10 0.009 0.01 0.9
Values of Koff and Kon are taken from Section 2.3.2a and
Table 2.5, respectively.
CHAPTER 3
DIPYRIDAMOLE BINDING TO RAT AND GUINEA PIG
LUNG CRUDE PLASMA MEMBRANES
3.1 INTRODUCTION
The results presented in Chapter 2, established that
guinea-pig and rat lung membranes possess a high density of
nucleoside transporters, as judged by assays of
high-affinity[ H]NBMPR binding activity. Species
differences in inhibition of NBMPR binding by dipyridamole
and various other vasodilators were observed. Other
investigators have also reported significant species
variation in the potency of dipyridamole as an inhibitor of
nucleoside transport, with rat tissues exhibiting a low
sensitivity to this vasodilator (Hopkins and Goldie, 1971;
Kolassa and Pfleger, 1975; Wu and Young, 1984; Williams e£
al. 1984; Jarvis and Young, 1986). In the rat, the uptake
of adenosine into intact perfused lung is about 100 times
less sensitive to dipyridamole inhibition than in guinea
pig (Kolassa al, 1971; Kolassa and Pfleger, 1974; Bakhle
and Chelliah, 1983).
During the course of the present project,
high-specific activity[ H]dipyridamole became
commercially available. In the present Chapter, the
characteristics of equilibrium[ H]dipyridamole binding
to guinea-pig and rat lung crude membranes are described
and results compared with the NBMPR-binding experiments
presented in Chapter 2. Dipyridamole dissociation
experiments using guinea pig lung membranes were also
performed in an attempt to explore the topographical
relationship between NBMPR and dipyridamole nucleoside
transporter binding sites. Results from these experiments
suggest that NBMPR and dipyridamole bind to the
NBMPR-sensitive nucleoside transporter with the same
stoichiometry, but at separate sites.
3.2 METHODS
3.2.1 Tissue and Membrane Preparation
Rat and guinea pig lung crude membranes were
prepared as described in Chapter 2 (Section 2.2.1).
3.2.2 Dipyridamole and NBMPR Binding
Rat and guinea-pig lung crude membranes in 50 mM-
TrisHCl (0.05-0.08 mg of protein) were incubated with
[ H]dipyridamole (final equilibrium concentrations 0.05-
30 nM) in a total volume of 1 ml at 22°C in the absence and
in the presence of 20 uM NBMPR or 50 uM-dipyridamole as
competing non-radioactive ligands. Incubations (typically
30 min) were terminated on glass-fibre filters (Whatman
GFB, which were washed with ice-cold buffer before sample
filtration). The filters were processed and radioactivity
counted as described previously for equilibrium NBMPR
binding (Chapter 2, Section 2.2.2).[ H]Dipyridamole
binding to membranes was expressed per mg of protein.
Equilibrium concentrations of unbound[ H]lgand were
estimated from the differences between total[ H]dipy-
ridamole concentrations and the amounts of ligand bound to
membranes and filters. Control time-course experiments
confirmed that equilibrium was reached for all radioligand
concentrations during the 30 min incubation period. Bmax
values for[ HJNBMPR binding were determined at 5 nM-
radioactive ligand (+20 uM non-radioactive NBMPR) as
described previously (Chapter 2, section 2.2).
It was noticed in the course of this series of
3
experiments that[ H]dipyridamole, in contrast with
NBMPR, had a tendency to stick to the disposable
polypropylene tubes and pipette tips used in the binding
3
experiments. For this reason,[ HJdipyridamole
concentrations in the concentration-dependence experiments
were determined directly by counting for radioactivity
aliquots (0.1 ml) from each incubation immediately before
3
filtration. H radioactivity present in these aliquots
(including that adsorbed by the pipette tips used in the
transfer) was converted first to d.p.m. by using
3
n.-[ H]hexadecane as internal standard and then to ligand
3
concentration (nM) by using the[ H]dipyridamole specific
radioactivity value supplied by the manufacturer (see
Appendix). A similar procedure was used to convert
membrane-bound c.p.m. into pmol. For the sake of
3
consistency, values for membrane-bound[ H]NBMPR quoted
in the present Chapter were determined in th'e same way.
3.2.3 Dissociation Kinetics of Dipyridamole Binding
Guinea-pig lung crude membranes were incubated with
3
[ H]dipyridamole (20 nM) for 30 min at 22°C. Incubations
were terminated by centrifugation at 40,000g. for 15 min.
ft
The membrane pellets were washed once with 10 ml of
ice-cold 50 mM Tris-HCl buffer, pH 7.4 at 22 C and
resuspended at a protein concentration of 2 mgml. The
3[ H]dipyridamole-labelled membranes were kept on ice for
up to 2 h. Control experiments demonstrated that the
3
amount of[ H]dipyridamole bound to the lung crude
membranes remained constant during this period.
Dissociation (22°C) was initiated by adding 250 ul of
3
ice-cold[ H]dipyridamole-labelled membrane to 60 ml of
50 mM Tris buffer, containing no addition, graded
concentrations of NBMPR in the presence of dipyridamole (20
nM or 20 uM) or dipyridamole alone (20nM or 20 uM). The
•
medium was continuously stirred and at various time
intervals (0.5-2.5 min) after the addition of membrane,
5 ml portions were removed and filtered through glass-fibre
t•
filters under suction. The filters were washed four times
with 3 ml aliquots of ice-cold buffer, the entire procedure
being completed within 15 s. The filters were dried and
added to 10 ml of scintillation fluid and counted for
radioactivity. Dissociation of radioligand from
non-specific binding sites was determined by labelling the
3
membranes with[ H]dipyridamole in the presence of 20 uM
.
NBMPR and then measuring the rate of dissociation by the
%
above procedures. Non-specific binding was typically less
%
than 10% of the total binding. Specific binding was
calculated as the difference between total binding and
non-specific binding. Results obtained were evaluated
according to equation (1) as described in Chapter 24.
(Section 2.2.3a).
3.3 RESULTS
3.3.1 Time-course of Dipyridamole Binding Lo Rat, and
Guinea-pig Lung Crude Membranes
3
A representative time course for[ H]dipyridamole
binding (initial concentration 5 nM) to guinea-pig lung
membranes, measured both in the absence and in the presence
of 20 uM-NBMPR as competing non-radioactive ligand is shown
in Fig. 3.1 (a). The results demonstrate the presence of a
large component of NBMPR-sensitive binding (12.8 pmolmg of
3
protein). The half-time for[ H]dipyridamole binding to
these sites at 22°C was approximately 2 min, full
3
equilibration occuring within 15 min.[ H]dipyridamole
binding in the presence of NBMPR, which includes adsorption
of radioactive ligand by the filters as well as
non-specific (NBMPR-insensitive) binding to membranes, was
not time-dependent and accounted for 19.8% of the total
binding at equilibrium. In control experiments,
3
[ H]ligand binding to glass-fibre filters was unaffected
by NBMPR.
In marked contrast with guinea-pig membranes, there
3
was no detectable NBMPR-sensitive binding of[ H]-
dipyridamole to membranes from rat lung (Fig. 3.1 (b)).
This, result is in accord with the species difference in
dipyridamole inhibition of NBMPR binding in lung crude
membranes described in Chapter 2 (Ki 5.6 uM and 20 nM in
rat and guinea pig lung crude membranes, respectively).
Figure 3.1 Time-course of dipyridamole binding to guinea-




































Binding of 5 nM-[ H]dipyridamole was measured at 22°C in
the absence
%
and in the presence of 20 uM-NBMPR as
competing non-radioactive ligand. Values are means of
duplicate determinations.
3.3.2 Concentration-dependence of Dipyridamole—Binding
t o Jung Membranes
Fig. 3.2(a) presents the concentration-dependence of
3
[ H]dipyridamole binding to guinea-pig lung membranes,
measured at equilibrium (30 min incubation) in the absence
and in the presence of 20 uM-NBMPR. Binding activity is
plotted against the calculated free concentrations of
unbound ligand in the medium. NBMPR-sensitive binding of
3
[ H]dipyridamole to the membranes was saturable, with a
Hill coefficient of 1.12. Scatchard analysis of the data
gave an apparent Kd. value of 1.9 nM. This affinity
3
constant compares with an apparent Kd of 3.5 nM for[ H]-
•«
dipyridamole binding to guinea-pig brain membranes
(Marangos g_t. al, 1985) and an apparent Ki value of 18 nM
determined for dipyridamole inhibition of equilibrium
3
[ H]NBMPR binding to guinea-pig lung membranes (see
Chapter 2). The latter value was determined by using
non-radioactive dipyridamole and therefore takes no account
of ligand depletion by membranes or adsorption of ligand by
incubation tubes etc. The Bmax value for NBMPR-sensitive
3
[ H]dipyridamole binding in the experiment shown in
••
Fig. 3.2(a) was 25.5 pmolmg of protein, compared with a.
3
Bmax of 17.1 pmolmg of protein for-[ H]NBMPR binding to
V
the same membrane preparation. Mean Bmax values for four
different guinea pig lung membrane preparations were 24.8
3
and 19.9 pmolmg of protein for[ H]dipyridamole and
3
[ H]NBMPR respectively (Table 3.1). As also shown in
Figure 3.2 Concent rat ion-dependence of dipyridamole





































Binding of [3H]dipyridamole was measured at 22°C (30min
incubation) in the absence and in the presence of-
20 uM-NBMPE or 50 uM-nonradioactive dipyridamole
Values are means of triplicate determinations. Standard
errors (not shown) were typically less than 10% of mean
values.
Figure 3.3 Scatchard and Hill plots of site-specific
dipyridamole binding to guinea pig lung crude
Scatchard (A) and Hill (B) plots of site specific binding
of dipyridamole to guinea pig lung crude membranes. These
plots were obtained using data from Fig. 3.2.
Table 3.1 Bmax for dipyridamole and NBMPR binding to






NBMPR binding 19.9+ 1.5
Values are means(±SEM) of 4 preparations.
3Fig. 3.2(a), high-affinity binding of[ H]dipyridamole to
guinea-pig lung membranes was abolished in the presence of
excess non-radioactive dipyridamole (50 uM). Non-saturable
3
[ H]ligand binding in the presence of dipyridamole was
less than with NBMPR, indicating the occurrence of low
affinity radioligand binding (to membranes or filters)
unrelated to NBMPR-sensitive nucleoside transport. Data
from a comparable experiment using membranes prepared from
rat lung are shown in Fig. 3.2(b). As expected from the
results presented in Fig. 3.1(b), no NBMPR-sensitive
3
binding of[ H]dipyridamole binding was detected. Thus,
3
[ H]-dipyridamole binding was non-saturable and
co-plotted with radioligand binding measured in the
presence of 20uM-NBMPR. As in guinea-pig membranes,
3
[ H]ligand binding in the presence of 50 uM-dipyridamole
was lower, the difference amounting to the equivalent of
3
2.5 pmolmg of protein (10 nM-[ H]ligand) in both
3
species. The f H1NBMPR binding capacity of the rat
membranes used in this experiment was 82 pmolmg of
protein. .tf
3.3.3 Inhibitor Studies
The transported nucleosides adenosine and uridine
and the vasodilators dilazep and lidoflazine were tested
»
for their ability to inhibit high-affinity (NBMPR-
3
sensitive) binding of[ H]-dipyridamole to guinea-pig
lung membranes. As shown in Table 3.2, both nucleosides
Table 3.2 Effects of nucleosides on high-affinitv binding


















Binding of [3H]dipyridamole (5 nM) was measured at 22°C
(30 min incubation) in the absence and in the presence of
various concentrations of competing nucleoside and
corrected for non-specific radioligand binding measured in
the presence of 20 uM-NBMPR (see Fig. 3.2). Values are
%
means(+SEM) of triplicate determinations.
competed with the[ Hjligand for binding to the
high-affinity sites. Adenosine was more effective than
uridine (IC 0.95 and 7.2 mM respectively at 5 nM-
[ H]dipyridamole), in agreement with their relative
potency as inhibitors of NBMPR binding to guinea pig lung
crude membranes (IC 0.8 mM and 7 mM for adenosine and
uridine, respectively, at 0.5 nM NBMPR). Similarly,
dilazep and lidoflazine inhibited high-affinity
(NRMPR-sfinsitive) binding of f Hldipyridamole to
guinea-pig membranes (Fig. 3.4). IC values for this
inhibition were 16 and 140 nM respectively (5 nM-
f Hldipyridamole). These results again correlate well
with IC values for these drugs as inhibitors of NBMPR
binding to guinea pig lung crude membranes (IC 4 and
300 nM for dilazep and lidoflazine, respectively, 0.5 nM
[ H]NBMPR). For comparison, the estimated IC value
for NBMPR inhibition of f Hldipyridamole binding was 3.2
nM (see also Fig. 3.4). Within experimental error, dilazep,
lidoflazine and NBMPR displaced maximally the same amount
of radioligand. Pseudo-Hill coefficients for this
inhibition were 0.82, 0.86 and 0.88 respectively. None of
these compounds had significant effects on NBMPR-
insensitive[ Hldipyridamole binding (Table 3.3.),
additional evidence that this component of radioligand
binding is not related to nucleoside transport.
Figure 3.4 Effects of dilazep, lidoflazine and NBMPR on
high-affinity binding of dipyridamole to
guinea-pig lung membranes
Binding of [3H]dipyridamole (5 nM) was measured at 22°C
(30 min incubation) in the absence and in the presence of
various concentrations of dilazep(•), lidoflazine()
and NBMPR( A) and corrected for non-specific radioligand
binding measured in the presence of 20 uM NBMPR. Values are
means(+SEM) of triplicate determinations.
Table 3.3 Effects of nucleosides and vasodilators on
NBHPR- insensitive dipyridamole binding to











Binding of[ H]dipyridamole (5 nM) was measured
at 22°C as described in the text. Values are
means(+SEM) of triplicate determinatiohs.
3.3.4 Dissociation Kinetics of Dipyridamole Binding
In the representative dissociation experiments showi
3
in Fig. 3.5, dissociation of bound[ H]dipyr idamol
3
(0-20 min) was first measured by resuspending[ H]dipy-
ridamole-labelled membranes in a large volume o:
ligand-free 50 mM Tris-HCl buffer, pH 7.4 at 22C. Whei
these data were plotted in accordance with equation (1)
(Chapter 2, Section 2.2.3a), a curvilinear plot of time y
3
ln([ H]dipyridamole bound) was observed, suggestive of
3
re-binding of free[ H]dipyridamole and also nonspecific
absorption of radioligand by filters (see also Section
3.2.2 for problems associated with non-specific binding of
3
[ H]dipyridamole to glass and plastic). Inorder to
3
eliminate membrane rebinding of[ H]dipyridamole,
nonradioactive dipyridamole (20 nM), sufficient to saturate
high-affinity dipyridamole sites, was added to the
dissociation buffer. As also shown in Fig. 3.5, this
3
substantially extended the linear phase of[ H]dipy-
ridaraole dissociation, with the dissociation rate being
similar to that observed for the initial phase of
dissociation in the presence of buffer alone (see also Fig.
3.6 and Table 3.6). Under this experimental condition
(i.e. in the presence of 20 nM dipyridamole), it was found
that NBMPR at a concentration of 20 nM. had no significant
3
effnn T HlHinvrirlnmnlp fiiRRnnintinn Hnwpvsr. at hhfi
higher concentration of 20 uM, NBMPR substantially
increased the rate of dissociation of dipyridamole from the
guinea pig lung crude membranes (Fig. 3.5). In the same
experiment, it was also observed that inclusion of 20 uM
nonradioactive dipyridamole in the dissociation buffer also
induced an apparent increase in the rate of[ dipyri¬
damole dissociation, but this was attributed to competition
between cold dipyridamole and the[ H]ligand for low-
affinity binding sites on the glass-fibre filters. As
detailed previously (Section 3.3.1), NBMPR had no
significant effect on retention of[ H]dipyridamole by
fiIters.
A representative dissociation experiment for a
shorter period of time (up to 2 min) is presented in
Fig. 3.6. The dissociation of[ H]dipyridamole from its
binding sites in guinea-pig lung membranes was much faster
than the corresponding dissociation rate for[ H]NBMPR.
Dissociation of[ H]dipyridamole from its binding sites
into buffer alone plotted according to equation (1) was
again curvilinear, the app. Koff for the initial phase of
dissociation being 0.528 min. Dissociation of
[ H]dipyridamole in the presence of 20 nM non-radioactive
dipyridamole was linear for the 2 min incubation period
with an apparent Koff of 0.60 min, a value very similar
to that obtained for the initial phase of[ H]dipyri-
damole dissociation into buffer alone. In contrast, the
inclusion of 20 uM non-radioactive dipyridamole in the
dissociation buffer again induced a substantial increase in
the apparent rate of[ H]dipyridamole dissociation (see
Figure 3.5 Time-course (20 min) of di ssooiation of.
























Guinea pig lung crude membranes were incubated with
[3H]dipyridamole (20 nM) at 22°C for 30 min. [3H]dipy-
ridamole-labe1led membranes were washed free of excess
3 0
H-ligand and dissociation (22 C) was initiated by the
addition of 50 ul of labelled membranes to 60 ml of pre-
9
warmed 50 mM Tris-HCl buffer containing no addition
I
20nM-dipyridamole 20nM-dipyridamole+2OnM-NBMPR
20hM-dipyridamo1e+20uM-NBMPR (O-) or 20uM-dipyridamole
Figure 3.6 Time-course (2 min) of dissociation of









Guinea-pig membranes were incubated with[ H]dipyridamole
(20 nM) at 22°C for 30 min. [3H]dipyridamole-labelled
membranes were washed free of excess H-ligand and
dissociation (22 C) was initiated by the addition of 50 ul
of labelled membranes to 60 ml of prewarmed 50 mM Tris-HCl
buffer, containing no addition 20 nM-dipyridamole
20nM-dipyridamole+20nM-NBMPR 20nM-dipyridamole
+20uM-NBMPR , 20uM-dipyridamole 20uM-dipyridamole
+20nM-NBMPR 20uM-dipyridamole+20uH-NBHPR
also Table 3.4).
As mentioned in the previous paragraph, this
2.5-fold increase in app. Koff in the presence of a high
concentration of non-radioactive dipyridamole is most
probably a consequence of nonspecific binding of
3
f Hldipyridamole to filters and its displacement by high
levels of nonradioactive ligand. Considerable efforts were
made to reduce non-specific binding (e.g. by pretreating
filters with polyethylenimine to reduce non-specific
binding due to ionic interactions), but with little
success. In this context, it was found that nonspecific
3
filter binding of[ H]dipyridamole to filters alone
was much higher than in the presence of membranes making
accurate correction for filter blanks virtually impossible.
As shown in Fig. 3.6, and in agreement with the data
presented in Fig. 3.5, the rate of dissociation of
3
[ H]dipyridamole from guinea pig lung membranes in the
presence of either concentration of dipyridamole was
unaffected by inclusion of 20 nM NBMPR in the dissociation
buffer. However, increasing the NBMPR concentration to
3
20 uM accelerated the rate of[ H]-dipyridamole
dissociation from guinea-pig lung membranes by 2.5-3.1 fold
as compared with the corresponding dissociation rates of
3
[ H]-dipyridamole in the presence of either 20 nM or
20 uM non-radioactive dipyridamole alone (Table 3.4).
Thus, the ability of high concentrations of NBMPR to
3
accelerate[ H]dipyridamole dissociation from its binding
sites was independent of the concentration of nonradio¬
active dipyridamole in the dissociation buffer.
Table 3.4 Summary of apparent Koff of dissociation of




20 nM dipyridamole (dip)
20 nM dip+ 20 nM NBMPR
20 nM dip+ 20 uM NBMPR
20 uM dip only
20 uM dip+ 20 nM NBMPR








Apparent Koff calculated according to equation (1)
described in the text. Data taken from Fig. 3.6.
3.4 DISCUSSION
The results presented in Chapter 2 establish that
guinea-pig and rat lung membranes possess a high density of
nucleoside transporters, as judged by assays of
3
high-affinity[ H]NBMPR binding activity. Bmax values
3
for[ H]NBMPR binding were determined to be in the region
of 20 and 10 pmolmg of protein for guinea-pig and rat lung
membranes respectively, with apparent Kd. values in the
range 0.2-0.4 nM. In the series of experiments presented
in this Chapter, I have demonstrated the existence of
NBMPR-sensitive dipyridamole binding to guinea-pig lung
membranes (Fig. 3.1). In marked contrast, corresponding
NBMPR-sensitive dipyridamole binding sites were not9•
detected in rat lung membranes. This result is consistent
with the NBMPR-binding studies described in Chapter 2 where
it was established that non-radioactive dipyridamole is a
3
competitive inhibitor of[ H]NBMPR binding with an
apparent Ki_ of 18 nM for guinea pig lung membranes compared
with a value of 8.5 uM for rat membranes,, a difference of
470-fold. Therefore, it would not be expected to detect
3
NBMPR-sensitive binding of[ H]dipyridamole to rat lung
nucleoside transporters, membranes from this species
•-
effectively representing a negative control for
transporter-associated ligand binding.•
Fig. 3.2 confirms the presence of NBMPR-sensitive
dipyridamole binding in guinea-pig lung membranes only.
3
Binding of[ H]dipyridamole to lung crude membranes of
this species was of high-affinity with a Kd of 1.9 nM,
3
comparable to the reported Kd of 3.5 nM[ H]dipyridamole
to guinea pig brain membranes (Marangos et_ al., 1985). In
contrast, there was no detectable high-affinity saturable
3
[ Hldipyridamole binding to guinea pig erythrocyte
membranes (Jarvis, 1986), the level of nonspecific
3
[ H]dipyridamole binding to guinea pig erythrocyte
membranes being too high to make it possible to detect the
low number of nucleoside transporters in erythrocyte
membranes of this species (Jarvis, 1986). Mean Bmax values
3
of 24.8 and 19.9 pmolmg of protein for[ H]dipyridamole
3
and[ H]NBMPR to guinea pig lung crude membranes,
respectively (Table 3.1) suggest that dipyridamole and
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In contrast, a study of[ H]dipyridamole binding
to guinea-pig brain membranes by Marangos el. aJL (1985)
reported a 3.2 fold higher Bmax for dipyridamole than for
NBMPR (320 vs. 100 fmolmg protein). However, unlike the
present investigation, that of Marangos iLt (1985) used
non-radioactive dipyridamole to correct for non-specific
binding. The experiments reported in this Chapter suggest
that this might give an erroneously high estimate of
high-affinity binding of dipyridamole, particularly in
tissues such as the central nervous system with a low
density of binding sites (for guinea pig lung membranes,
34.
the Bmax for[ H]dipyridamole binding is in the region of
24 pmolmg protein compared with a Bmax of 320 fmolmg
protein for guinea pig brain, a difference of 75 fold.
Physiological explanations for the discrepancy
between dipyridamole and NBMPR binding to brain membranes
include the possibility of high-affinity dipyridamole
binding to NBMPR-insensitive nucleoside transporters of the
type described by Belt (1983) and Belt and Noel (1985). Wu
et al (1986) have reported mixed NBMPR-sensitive and
NBMPR-insensitive uridine transport in primary cultures of
differentiated mouse astrocytes. Additional support that
dipyridamole and NBMPR bind to the NBMPR-sensitive
nucleoside transporter with the same stoichiometry comes
from a recent study of dipyridamole binding to human
3
erythrocyte membranes.[ H]Dipyridamole was found to•«
bind to a single class of high affinity sites on plasma
membranes from human erythrocytes (apparent KcL 0.65 nM)
with a maximum number of binding sites similar to that
determined for NBMPR binding (Jarvis, 1986).
Both nucleosides and other nucleoside transport
inhibitors were found to block- high-affinity
3
[ Hjdipyridamole binding to guinea pig lung membranes.
«
IC concentrations estimated from the data presented in
50
Table 3.2 and Fig. 3.4 were used to determine apparent Ki
values from the relationship
ft
where [L]- is the free radioligand concentration and Kd its
binding affinity. Calculated inhibitor constants were:
adenosine, 0.26 mM; uridine, 1.93 mM; dilazep, 4.4 nM;
lidoflazine, 39 nM; NBMPR, 0.9 nM. Although these Ki
values, based on a single[ H]dipyridamole concentration,
can only be regarded as approximate, they correspond well
with equivalent Ki. values determined for inhibition of
high-affinity[ H]NBMPR binding to guinea-pig lung
membranes: adenosine, 0.28 mM; uridine, 2.0 mM; dilazep,
2.0 nM; lidoflazine, 110 nM (see Chapter 2, Tables 2.2 and
2.4). The apparent Ki. for NBMPR inhibition of
[ H]dipyridamole binding (0.9 nM) also agrees well with
the apparent Kd value for[ H]NBMPR binding, to these
membranes (0.4 nM). Similarly, in human erythrocyte
membranes, equilibrium dipyridamole binding in the presence
of adenosine and uridine was reduced in an apparent
competitive manner with apparent Ki values of 0.1 and 0.9
mM, respectively (Jarvis, 1986), inhibitor constants
similar to those obtained previously for adenosine and
uridine inhibition of NBMPR binding to human erythrocyte
membranes (Ki values for inhibition of[ H]NBMPR binding
to erythrocyte membranes are 0.1 mM for adenosine (Jarvis
et al. 1983) and 1.0-1.3 mM for uridine (Jarvis e_t al.
1982)). NBMPR and dilazep also effectively inhibited
saturable[ H]dipyridamole binding to human erythrocyte
membranes (IC values of 1.7 nM for both inhibitors)
(Jarvis, 1986). There is, therefore strong evidence to
indicate that high-affinity dipyridamole binding to guinea
pig lung and human erythrocyte membranes represents binding
to the NBMPR-sensitive nucleoside transporter.
Figs. 3.5 and 3.6 (Table 3.4) show the kinetic
pattern of[ H]dipyridamole dissociation from the guinea
pig lung binding-site complex in the presence of
non-radioactive NBMPR. Generally, changes in the rate of
dissnninhinn mnv he suestive of site to site
interactions. Thus, the observed ability of 20 uM NBMPR to
induce a 3.2-4.2-fold enhancement of the rate of
[ H]dipyridamole dissociation from guinea-pig lung
membranes either in the presence of 20 nM or 20 uM
dipyridamole would appear to indicate that NBMPR and
dipyridamole bind to the nucleoside transporter at
topographically separate sites. Support for this view
comes from the finding that high concentrations of
dipyridamole decrease the rate of NBMPR dissociation in
human erythrocyte membranes (Jarvis et al. 1983) as well as
in lung membranes as described in Chapter 2 (Section
2.3.2). The mechanism by which these two ligands interact







The experiments described in Chapter 2 establish
that NBMPR binds reversibly to high-affinity sites on both
rat and guinea pig lung crude membranes and that this
binding can be blocked by physiological nucleosides and by
vasodilator drugs such as dipyridamole. Guinea pig
membranes were more sensitive to dipyridamole inhibition
than rat membranes. These sites therefore have the
properties expected of NBMPR binding to nucleoside
transporter polypeptides in the two species. As detailed
in the General Introduction, for human erythrocyte
3
'ghosts', exposure of site-bound[ HjNBMPR to UV light
results in covalent attachment of ligand to membranes.
Radiolabelling is selective for band 4.5 polypeptides,
proteins that migrate as a broad band on SDS-polyacrylamide
gels with an apparent Me. of 45,000-66,000 (Young gt_ 1,
1983; Wu gJi si, 1983). The human erythrocyte glucose
transporter is also a band 4.5 polypeptide, both
transporters having an apparent Me. (average) of 55,000
(Kwong gjb aJL 1986). The pig erythrocyte nucleoside
transporter migrates on SDS-polyacrylamide Igels as a
sharper band than the human erythrocyte nucleoside and
glucose transporters and with a significantly higher
apparent molecular weight (apparent Mr. (average) 64,000)
(KWong ei aJL 1986).
The human erythrocyte glucose transporter
polypeptide has been shown to be heterogenously
glycosylated. Partial or essentially complete removal of
oligosaccharide following endo-5-galactosidase or
endoglycosidase-F treatment of the isolated transporter
results in a sharpening of its band on SDS-polyacrylamide
gels and corresponding shifts to lower apparent molecular
weight regions of the gel (Cairns 1, 1984; Lienhard
al. 1984). In addition, it has been established that the
human and pig erythrocyte nucleoside transporters are both
glycoproteins containing H-linked oligosaccharide. The
oligosaccharide and polypeptide structures from the two
sources are, however, different (Kwong ejt si, 1986).
This Chapter describes the photoaffinity labelling
of guinea pig and rat lung crude membranes by[ H]NBMPR.
It is demonstrated that photoactivated[ H]NBMPR
selectively labels polypeptides in the band 4.5 region of
both the rat and guinea pig lung crude membranes, with the
rat radiolabelled peak migrating on SDS-polyacrylamide gels
with a higher apparent molecular weight than the
corresponding guinea pig protein. Covalept attachment of
ligand to lung crude membranes under equilibrium binding
conditions is shown to be inhibited by NBTGR, adenosine and
dipyridamole. These experiments provide evidence to
implicate membrane protein(s) of Mr. 45,000-66,000 as
components for NBMPR-sensitive nucleoside transporters in
lung-tissue.
Enzyme digestion experiments with endoglycosidase-F
are shown to increase the electrophoretic mobility of the
radiolabelled peak of lung membranes in both species,
enzyme treatment abolishing the difference in apparent Mr_
between the guinea pig and rat lung nucleoside transporter
polypeptides. A series of experiments in which
endoglycosidase-F treatment of[ H]NBMPR-radiolabelled
lung membranes is combined with limited trypsin digestion
are also described in an attempt to further explore the
nature of the molecular differences between the rat and
guinea pig lung nucleoside transport proteins and to define
the relationship between these transporters and those from
human and pig erythrocytes.
4.2 METHODS
4.2.1 Membrane Preparation
Rat and guinea pig lung crude membranes were
prepared as described in Chapter 2 (Section 2.2.1).
Haemoglobin-free erythrocyte membranes (ghosts) were
prepared by osmotic lysis as described by Dodge e_t_ al
(1963). Fresh blood from healthy volunteers was collected
by syringe into heparin (1000 units per ml of blood). Red
blood cells were washed three times with 20 volumes of a
medium containing 140 mM NaCl, 5 mM KC1, 20 mM Tris-HCl (pH
7.4 at 25°C), 2 mM MgCl, 0.1 mM EDTA (disodium salt) and
5 mM glucose. The buffy coat was discarded. Approximately
1 volume of packed cells were mixed with 20 volumes of 5 mM
sodium phosphate (pH 8.0 at 22°C) and left to stand for 20
min at 4'C. Ghosts were pelleted by centrifugation at
30,000g for 20 min using a Beckman L2-21 centrifuge. The
majority of supernatant was removed. The loosely packed
ghosts were then transferred to clean tubes, taking care to
leave behind the small hard button containing the residual
leukocytes and pltelets not removed with the buffy coat.
The membranes were washed three times with 20 volumes of
phosphate buffer, made back to the original cell volume in
the same buffer and stored at -70°C f.or up to 1 month.
4.2.2 Photoaffinitv Labelling of Membranes
Rat and guinea pig lung crude membranes (final
protein concentration 0.8 mgml) and human erythrocyte
'ghosts' (final protein concentration 2 mgml) were
equilibrated at room temperature for 30 min with a
3
saturating concentration of[ H]NBMPR (75 nM for
erythrocyte 'ghosts' and 25 nM for lung membranes) in the
presence and in the absence of 20 uM NBTGR as competing
non-radioactive ligand. Samples were then cooled to 4°C
and supplemented with 50 mM dithiothreitol, added as a
free-radical scavenger. Dithiothreitol does not interfere
3
with[ H]NBMPR binding (Jarvis ei.!., 1980).
Photolysis was carried out in conventional 3 ml
silica spectrophotometer cuvettes (10 mm light path) with
continuous stirring at 4°C using a 450-watt mercury arc
•«
lamp (Conrad-Hanovia Inc., Newark, New Jersey, U.S.A.). UV
exposure was at a distance of 6.5 cm from the lamp's silica
cooling sleeve for a period of 45 s. Previous control
experiments have shown that maximum labelling of human
erythrocyte membranes occured between 30 and 120 s exposure
to the mercury arc lamp (Wu al, 1983). Samples were•••
then diluted 10-fold with buffer containing 20 uM NBTGR and
.
allowed to stand at room temperature for 10 min before
recovery of the membrane fraction by centrifugation. The
• . • % «
membranes were washed twice more in NBTGR-containing buffer
and then extracted at room temperature with SDS-polyacryl-
amide gel sample buffer containing 100 mM Tris-HCl (pH
6.8), 1 mM EDTA, 10% (wv) SDS, 20% (wv) glycerol andi- m
0.004% (wv) bromophenol blue. Insoluble material was
removed by centrifugation (15,000g., 5 min).
4.2.3 Enzymatic Digestion
Enzyme treatment was performed after photolysis of
3
the membranes with[ H]NBMPR as described above (Section
4.2.2).
4.2.3a Trypsin
Human erythrocyte and rat and guinea pig lung
radiolabelled membranes in 50 mM Tris-HCl (pH 7.4 at 22°C)
were incubated with trypsin (0.5-5 ugmg protein) for 15
min at 1°C (Jarvis ei. sJL 1985). Proteolysis was stopped
by the addition of 20 volumes of 50 mM Tris-HCl containing
1 mM PMSF followed by centrifugation at 35,000g. for 15
min. The pellets were washed once more in PMSF-containing
medium and then dissolved in gel sample buffer (Section
4.2.2) or in endoglycosidase-F digestion buffer (see
Section 4.2.3b).
4.2.3b Endoglvcosidase-F
Treatment with endoglycosidase-F (20 unitsrag
protein) was carried out at 22°C for 18 hours with
agitation in 100 mM sodium phosphate (pH 6.0) containing
75 mM 5-mercaptoethanol, 50 mM EDTA, 0.5% (wv) Triton
X-100, 0.05% (wv) SDS. Enzymatic digestion was terminated
by addition of an equal volume of SDS-poly- acrylamide gel
sample buffer containg 100 mM Tris-HCl (pH 6.8), 2 mM EDTA,
75 mM DTT, 10% (wv)SDS, 20% (wv) glycerol and 0.004%
(wv) Bromophenol Blue (Lienhard et. al., 1984).
In some experiments, trypsin-treated membranes were
further digested with endo£lycosidase-F as described above.
4.2.4 SDS-polvacrvlamide Gel Electrophoresis
SD.S-polyacrylamide gel electrophoresis was carried
out in 12% 2 mra-thick slab gels by the method of Thompson
and Maddy (1982), using the Laemmli buffer system (1970).
Samples dissolved in gel sample buffer were not heated
before application to the gel. Radioactivity in the
various regions of the gel was determined by slicing the
gel into 2 mm fractions. The H-content of these slices
was measured by liquid scintillation counting in toluene
containing 0.4% (wv) Omnifluor and 3% (vv) Protosol (New
England Nuclear). Vials were allowed to stand at 37°C for
36 hours before counting. The recovery of applied
radioactivity from gels was typically 65-75%. Molecular
weight standards from the same slab gels.were stained with
Coomassie Blue and scanned at 633 nm using an LKB laser
densitometer.
4.2.5 Protein Determination
Protein was determined by the. method of Lowry qlL 2l1,
(1951).
4.3 RESULTS
4.3.1 Photolysis under Equilibrium Binding conditions
3
[ H]NBMPR photoaffinity labelling experiments
under equilibrium binding conditions resulted in
substantial radiolabelling of both rat and guinea pig lung
membrane protein. Representative experiments, comparing
the resulting radiolabelling patterns with that for human
erythrocyte membranes are presented in Figs. 4.1 and 4.2.
Photolysis was carried out in the presence of dithio-
threitol to minimise the possibility of nonspecific
labelling (Young and Jarvis, 1983; Wu ei al, 1983a; 1983b).
For both species, the radiolabelled protein migrated as
single symmetrical peaks on SDS-polyacrylamide gels with
apparent molecular weights in the same range as the human
erythrocyte nucleoside transporter (Mr. 45,000-66,000). The
rat lung radioactive peak was broader than that in the
guinea pig and had a significantly higher apparent
molecular weight (apparent Mel (average) 63,000 and 55,000,
I
in rat and guinea pig lung crude membranes, respectively)
(see also Table 4;2). Covalent incorporation of
3
C H]NBMPR into these proteins was abolished when
photolysis was carried out in the presence of NBTGR. The
minor high and low molecular weight peaks observed with the
erythrocyte membranes correspond to aggregates of the
transporter and low molecular weight degradation products,
•' V
respectively (Wu slL al, 1983). A corresponding low
Figure 4.1 Photoaffinitv labelling of rat lung crude























Membranes were equilibrated with saturating concentrations
of [3H]NBMPR in the presence and in the absence of 20 uM
NBTGR and exposed to UV light for 45 s. Unreacted
3,
[ H]NBMPR was removed by washing. Samples were subjected
0i
to SDS-polyacrylamide gel electrophoresis as described in
the text. [3H]Profiles and positions of molecular weight
%
standards are from the same slab gel. Membranes from rat
lung and human erythrocytes Phnt.nl n f rnt.
lung membranes in the presence of NBTGR f n r
human erythrocyte membranes in the presence of NBTGR
coplotted with the rat lung NBTGR counts (not shown).
Figure 4.2 Photoaffinity labelling of guinea pig lung
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Photolysis and SDS-polyacrylamide gel electrophoresis of
guinea pig lung crude membranes and human erythrocyte
'ghosts' in the presence of [3H]NBMPR were carried under
identical conditions to those described in the legend to
fig. 4.1. Guinea pig lung membranes in the absence
and in the presence of NBTGR Human erythrocyte
membranes in the absence of NBTGR
molecular weight peak, but in smaller amount, was observed
with guinea pig lung crude membranes. All preparations
exhibited nonspecific labelling in the lipid region of the
gel. It was calculated that approximately 10% of the
available high-affinity NBMPR binding sites in both the
lung membrane and erythrocyte preparations were photo-
affinity labelled under the present experimental
conditions.
4.3.2 Competition Experiments
Figs. 4.1 and 4.2 demonstrates that incorporation of
3
H-photoproduct into lung membrane protein under
equilibrium binding conditions is abolished in the presence
of NBTGR as competing nonradioactive ligand. Subsequent
experiments established that dipyridamole (50 uM) also
3
reduced[ H]NBMPR incorporation into the apparent Mr.
45,000-66,000 region of the gel (Figs. 4.3 and 4.4).
However, dipyridamole was much more effective in reducing
the radiolabelled peak in guinea pig lung crude membranes
than in those of the rat. This correlates with the species
difference in dipyridamole inhibition of reversible NBMPR
binding described in Chapter Two, with the rat being less
•
sensitive to dipyridamole inhibition. In contrast,,
adenosine, a physiological transported nucleoside,
inhibited radiolabelling of membrane protein in the two
species to a similar extent (Figs. 4.5 and 4.6).
Quantitative estimates of the extents of inhibition of Mr
Figure 4.3 Effect of dipyridamole on NBMPR photoaffinity





















Rat lung crude membranes equilibrated with 25 nM
[3H]NBMPR in the presence and in the absence of
50 uM dipyridamole, supplemented with 50 mM DTT and exposed
to high intensity UV light at 4°C for 45 s.
SDS-polyacrylamide gel electrophoresis was performed as
described in the text (Section 4.2.4).
Figure 4.4 Effect of dipyridamole on NBMPR photoaffinity



















Guinea pig lung crude membranes equilibrated with 25 nM
[3H]NBMPR in the presence and in the absence of
50 uM dipyridamole supplemented with 50 mM DTT and••
exposed to high intensity UV light at 4°C for 45 s.
SDS-polyacrylamide gel electrophoresis was performed as
%
described in the text.
Figure 4.5 Effect of adenosine on NBMPR photoaffinity






















Rat lung crude membranes equilibrated with 25nM [3H]NBMPR
in the presence and in the absence of 10 mM adenosine
supplemented with 50 mM DTT and exposed to high
3
intensity -UV light at 4 C for 45 s. SDS-polyacrylamide gel
electrophoresis was performed as described in the text.
Figure 4.6 Effect of adenosine on NBMPR photoaffinity






















Guinea pig lung crude membranes equilibrated with 25 nM
[3H]NBMPR in the presence ) and in the absence of
10 mM adenosine were supplemented with 50 mM DTT
and exposed to high intensity UV light at 4°C for 45 s.
ft
SDS-polyacrylamide gel electrophoresis was performed as
described in Section 4.2.4.
Table 4.1 Effects of adenosine, dipyridamole and NBTGR on
covalent NBMPR incorporation into protein of








Adenosine (10 mM) 17.6 18.3
Dipyridamole (50 uM) 56.4 17.2
NBTGR (20 uM) 3.2• 2.9
Data are taken from Figs. 4.1-4.6.
45,000-66,000 radiolabelling obtained with these agents
are detailed in Table 4.1.
4.3.3 Endoglvcosidase-F treatment
Endoglycosidase-F cleaves the glycosidic bond of
tL-acetyl-glucosamine (1-4) H.-acetylglucosamine linked to
asparagine of the core protein of high mannose structures.
3
Fig. 4.7 compares the SDS-polyacrylamide gel H-profiles
of radiolabelled rat and guinea pig lung crude membranes
and human erythrocyte membranes incubated (18h, 22C) in
the absence and in the presence of endoglycosidase-F. In
each case there was a significant sharpening of the
3
H-peak and a shift to a lower apparent molecular weight,
an indication that the nucleoside transporter of the three
species is a glycoprotein. Table 4.2 summarises the
electrophoretic mobilities of the rat and guinea pig
radiolabelled nucleoside transporters before and after
endoglycosidase-F treatment in comparison with that of the
human erythrocyte protein. Following endoglycosidase-F
treatment, the rat protein showed the largest decrease in
Mn such that the difference in apparent Mr. between the rat
and guinea pig nucleoside transporters was abolished, the
deglycosylated proteins from these two sources having the.
same apparent Mr. of 46,000 which in turn was within 1000
daltons of the deglycosylated human erythrocyte nucleoside
transporter (Table 4.2). These results indicate that the
a.
molecular difference between the rat and guinea pig lung
Figure 4.7 Effects of endoglvcosidase-F on the electrQ-
phoretic mobilities of the human erythrocyte
and rat and guinea pig lung nucleoside
transporters
92K 66K 45K 31K 21
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Human erythrocyte 'ghosts' and rat and, guinea pig lung
crude membranes radiolabelled with [3H]NBMPR were
incubated for 18 h at 22°C either in the absence (A) or in
the presence (B) of enzyme (see Section 4.3.3) and
electrophoresed as described in the text. 3H-Profiies
and positions of the Mil standards .are from the same slab
gel.
Symbols used: ) Human; rat anc guinea pig.
Table 4.2 Apparent molecular weights of rat and guinea pig



















nucleoside transporter is due to different degrees of
glycosylation.
4.3.4 Digestion with Trypsin
Digestion of human erythrocyte 'ghosts' with trypsin
(0.5 ug enzymemg of membrane protein, 15 min at 1°C)
generated a radioactive fragment with apparent molecular
weight values of 39,000 (Fig. 4.8), a result in agreement
with the data presented bv Jarvis et al (1986).
Preliminary experiments establishes that the NBMPR-labelled
proteins in guinea pig and rat lung membranes were more
resistant to trypsin cleavage than the human erythrocyte
transporter. Digestion of rat and guinea pig lung
membranes with trypsin (5 ug enzymemg protein) produced
radioactive fragments similar to those from human 'ghosts'
but with significantly higher apparent molecular weight
(apparent Mr. 44,000 and 41,000 for rat and guinea pig
respectively) (Fig. 4.8).
'
4.3.5 Endoglvcosidase-F Digestion of Trvpsinised Membranes
To further investigate molecular differences between
the rat and guinea pig lung nucleoside transporters, rat
and guinea pig lung membranes were subjected to sequential
trypsin and endoglycosidase-F digestion. Before
endoglycosidase-F treatment, the rat and guinea pig lung
trypsinised nucleoside transporter fragments ran as broad
c,
bands at Mr 44,000 and 41,000, respectively (see Section
Figure 4.8 Trypsin digestion of NBMPR-labelled human
erythrocyte 'ghosts' and rat and guinea pig
lung crude membranes
Membranes photolabelled with[ H]NBMPR were incubated -for
15 min at 1°C (see Section 4.3.4) either in the absence (A)
or in the presence (B) of trypsin and electrophoresed as-
described in the text. 3H-Profiles and positions of the
Mr. standards are from the same slab gel
Symbols used:Human, rat andguinea pig.
Figure 4.9 Effects of trypsin and endoglycosidase-F
digestion on NBMPR-iabelled human erythrocyte
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[3H]NBMPR-radiolabelled membranes were first treated with
trypsin and subsequently with endoglycosidase-F as
described in the text (section 4.3.5). A. control,
•-
incubations in the absence of trypsin and endogly¬
cosidase-F; B, trypsin then endoglycosidase-F.
Symbols used: human; rat and guinea pig
Table 4.3 Apparent moleonlar weight values for guinea Pig
and rat lung nucleoside transport polypeptides
treated with endoglvcosidase-F (Endo-F) and





















Data are taken from Figs. 4.7-4.9.
4.3.4 and Fig. 4.8). After endoglycosidase-F treatment,
the apparent Mr. values of these fragments decreased from
44,000 to 33,000 (rat) and 41,000 to 31,000 (guinea pig)
(Fig. 4.9). Likewise, the apparent Mr of the human
trypsinized fragment decreased from 39,000 to 30,000.
Combined results from the enzyme digestion experiments are
summarised in Table 4.3.
4.3.6 Photoaffinitv Labelling with Dipyridamole
Dipyridamole absorbs strongly in the UV. It was
therefore considered possible that dipyridamole might
function as a photoprobe of the nucleoside transporter in a
manner similar to that for NBMPR.
t«
A procedure similar to that described for NBMPR
(Section 4.2.2) was used in an attempt to photolabel lung
3
crude membranes with[ H]dipyridamole. Exposure of
3
[ H]dipyridamole (250 nM) to high-intensity UV light (450
Watt, 45 s) under equilibrium binding condition and in the
presence of 50 mM DTT did not result in detectable• «
radiolabelling of lung membranes (Fig. 4.10). In the same
.
experiment, exposure of membranes to UV light in the
3
presence of[ HJNBMPR (50 nM) under the same conditions
gave the normal radiolabelling pattern observed with this
ligand (see also Fig. 4.10)
Figure 4.10 Photoaffinitv labelling of guinea Pig and rat


























Photolysis and SDS-polyaerylamide gel electrophoresis of
guinea pig and rat lung crude membranes in the presence of
.
q 3
[ H]NBMPR or[ H]dipyridamole were carried under
identical conditions to those described in the legend to
Fig. 4.1. (see also 4.3.6). Guinea pig i or rat
3
lung crude membranes photo labe l'led with[ H]NBMPR.
3
Photolysis of membranes with[ Hldipyridamole n—
3
plotted in both species. H-Profiles and positions of M£
standards are from the same slab gel.
4.4 DISCUSSION
In this Chapter, I have sucessfully established the
use of NBMPR as a photoaffinity probe of the lung NBMPR-
sensitive nucleoside transporter. At the time these
experiments were performed, they were the first reported
attemDt to ohotolabel the NBMPR-sensitive nucleoside
transporter in a non-erythroid tissue (Shi ei al 1984).
Exposure of site bound[ H]NBMPR in rat and guinea pig
lung crude membranes to high intensity UV light under
equilibrium binding conditions resulted in substantial
radiolabelling of plasma proteins with apparent molecular
weights in the same range as the human erythrocyte
transporter. Radiolabelling was inhibited by NBTGR,
adenosine and dipyridamole. Adenosine was equally effective
as an inhibitor of radiolabelling in the two species (Table
4.1), a result which parallels the finding that adenosine
inhibits reversible NBMPR binding to lung membranes from
the rat and guinea pig with equal potency (see Fig. 2.2).
In guinea pig crude lung membranes, dipyridamole (50 uM)
decreased H-incorporation into the Mr. 45,000-66,000
region of the gel to 17% of control, while in the rat, the
same concentration of dipyridamole only reduced
radiolabelling to 57% of control (Table 4.1). This
difference correlates well with the Ki values established
in Chapter 2 for dipyridamole as an inhibitor of reversible
NBMPR binding (Ki 18 nM and 8.6 uM for guinea pig and rat,
respectively). These results therefore provide strong
evidence to implicate proteins of Mr. 45,000-66,000 in
NBMPR-sensitive nucleoside permeation in lung tissue.
The present series of photoaffinity labelling
experiments in lung were extended by Wu and Young (1984)
using liver membranes. Exposure of rat and guinea pig
liver membranes to high intensity UV light in the presence
of[ H]NBMPR again resulted in the selective NBTGR-
sensitive radiolabelling of membrane proteins which
migrated on SDS-polyacrylamide gels with apparent Mr. values
in the same range as that of the erythrocyte nucleoside
transporters (45,000-66,000). A similar species
differences in apparent Mr. to that described in the present
Chapter was also reported (apparent Mr 63,000 and 55,000 in
rat and guinea pig liver nucleoside transporters,
respectively).
Photolysis studies in nonerythroid cells have
subsequently been extended to a variety of other tissues
and cell types. Exposure of membranes from cultured mouse
S49 lymphoma cells, guinea pig cardiac musole and brain to
UV light in the presence of[ H]NBMPR has again been
shown to result in the covalent radiolabelling of membrane
proteins which migrate on SDS-polyacrylamide gels with an
apparent Mr of 45,000-66,000 (Almeida et. al., 1984; Kwan and.
Jarvis, 1984; Jarvis and Ng, 1985). Membrane proteins from
AE cells (Cohen g£ al, 1979), a nucleoside
transport-deficient clone isolated from a mutagenized
population of S49 cells, which lack high-affinity NBMPR
binding sites (Cass a£. JL, 1981), are not covalently
3
labelled by[ H]NBMPR (Almeida et al, 1984; Young et al,
1984). These results suggest that the NBMPR-sensitive
nucleoside transport activity in different tissues and
cells is catalyzed by proteins with similar molecular
properties.
In this Chapter, the rat and guinea pig species
difference in apparent Mr was further investigated in a
series of enzyme digestion studies using endoglycosidase-F
and trypsin. Endoglycosidase-F digestion demonstrated that
the rat and guinea pig lung nucleoside transporters are
both glycoproteins containing .-linked oligosaccharides.
The observation that the difference in apparent molecular
««
weight between the guinea pig and rat lung nucleoside
transporters is abolished after endoglycosidase-F treatment
strongly suggests that the Mr. difference can be accounted
for by differences in degree of glycosylation in the two
nucleoside tranporter proteins. Additional support for
this conclusion comes from subsequent s.tudies of the rat•'
and guinea pig liver nucleoside transporters, where the
difference in apparent Mr. is also abolished after
endoglycosidase-F digestion, both peaks shifting to the
%4
same lower apparent Mr. of 46,000 as reported in this
Chapter (Wu and Young, personal communication).
The human and pig erythrocyte nucleoside trans¬
porters have also been shown to be glycoproteins containingt•
.-linked oligosaccharide (Kwong al. al, 1986). A summary of
enzyme digestion experiments on these two erythrocyte
nucleoside transporters is summarised in Table 4.4. It was
found that the pig nucleoside transporter was resistant to
endo-jQi-galactosidase digestion( endo-3-galactosidase
hydrolyses internal B-galactosidase linkages of
oligosaccharides belonging to the poly-N-acety1lactosamine
series) and, in contrast to the present results, it was
found that endoglycosidase-F treatment actually magnified
the difference in apparent Mr. between the human and pig
erythrocyte nucleoside transporters (13,000 after enzyme
digestion compared with 9,000 before). These data provide
strong evidence that there are both polypeptide and
carbohydrate differences between the human and pig
•«
transporters, carbohydrate differences alone only in part
accounting for the different electrophoretic mobilities of
the two transporter proteins on SDS-polyacrylamide gels.
As seen in Fig. 4.7 (Table 4.2), the electrophoretic
mobility of the human erythrocyte nucleoside transporter
following endogylcosidase-F treatment coinicides (Me.%••
difference 1,000) with that of the deglycosylated rat and
.
guinea pig lung nucleoside transporters when electro-
phoresed on the same gel, evidence that the polypeptide
•«
structure of the human erythrocyte nucleoside transporter
is very similar to that of rat and guinea pig lung.
In complementary experiments with trypsin, it was
established that there is at least one trypsin cleavagei»
site present on the rat and guinea pig lung nucleoside
Table 4.4 Apparent molecular weights of erythrocyte
nucleoside transport polypeptides treated witl
endo-ft-galactosidase (end q-Q and endoglyco
sidase-F (endo-F)
Nucleoside Control Endo -J Endo-I
Transporter treated treated
Human 55,000 47,000 45,000
Pig 64,000 64,000 57,000
Data taken from Kwong aJL (1986)
transporters. The trypsin digestion patterns of the lung
and human erythrocyte nucleoside transporters were very
similar, trypsinisation resulting in a shift of the
radiolabeled peak to a lower apparent molecular weight
(30, 25 and 31% decrease in apparent Mr in rat, guinea pig
and human, respectively). The data presented in Table 4.3
and in Figs. 4.8 and 4.9 also establish that NBMPR and
carbohydrate are attached to the same half of the guinea
pig and rat transporter polypeptides. This is also the
case for the human erythrocyte nucleoside transporter
(Kwong gt. aJL, 1986), but contrasts with that for the human
erythrocyte glucose transporter where the carbohydrate and
cytochalasin-B attachment sites are located on different
halves of the transporter polypeptide (Cairns aJL, 1984;
Daziel and Rothstein, 1984). From Table 4.3, it can be
seen that the difference in apparent molecular weight
between the trypsinised rat and guinea pig lung nucleoside
transporters is similar before and after endoglycosidase-F
treatment (Mr. difference of 2,000 to 3,000).
Interpretation of the these data is presented in Chapter 7,
where molecular models for the rat and guinea pig
nucleoside transporters are proposed.
CHAPTER 5
LUNG PURIFIED PLASMA MEMBRANES:
PREPARATION AND CHARACTERIZATION
5.1 INTRODUCTION
The experiments reported in previous Chapters were
performed with crude membrane preparations from guinea pig
and rat lung tissue. These crude membrane preparations
contain plasma membrane as well as membranes from different
intracellular components such as mitochondria and
endoplasmic reticulum. Crude membrane preparations from
both species displayed high-affinity NBMPR binding activity
3
(Chapter 2) and exposure of site-bound[ H]NBMPR to high
intensity UV light resulted in the photoaffinity labelling
of lung proteins with apparent molecular weights similar to
that of the human erythrocyte nucleoside transporter(Mr.
45,000-65,000) (Chapter 4). It was established that there
l'
exists a marked species difference with respect to effects
of various vasodilators on reversible NBMPR binding to rat
and guinea pig membranes (Chapter 2, Section 2.3.1). Also,
there was a significant difference in the molecular weight
of the radiolabelled transporter in the two species
(Chapter 4, Section 4.3.1). In Chapter 3, guinea pig lung
crude membranes were used to demonstrate that NBMPR and
dipyridamole bind to the NBMPR nucleoside transporter with
the same stoichiometry.
Recently, Casale and coworkers (1984) reported a'
method of isolating purified plasma membranes from human
peripheral lung tissue. The present Chapter describes a
modification of that procedure which permits the4.
preparation of a highly enriched plasma membrane
preparation from guinea pig and rat lung. The objective of
these experiments was to make available more enriched lung
plasma membrane preparations with a higher specific
activity NBMPR binding. In Chapter 6, one application of
such purified membrane preparations is described-- the
reconstitution of functional lung nucleoside transporters
into proteoliposomes.
The experimental section of the present Chapter is
divided into two main parts. The first describes the
methodology used to prepare guinea pig and rat lung
purified plasma membranes and the second deals with the
detailed characterisation of the two purified lung membrane
preparations.
5.2 METHODS
5.2.1 Tissue and Plasma Membrane Preparation
Plasma membranes from both guinea pig and rat lung
were prepared as outlined in Fig.5.1. This method is
modified from that of Casale eJL slI, (1984). Unless stated
otherwise, all steps were performed at 0-4C.
Dunkin Hartley guinea pigs (700-900 g) or
Sprague-Dawley rats were anaesthetised with ether and the
lungs perfused in situ with heparinised salined to remove
trapped erythrocytes. Lung tissue was then removed from the
animals, washed twice in ice-cold saline and homogenized in
0.25M sucrose in 10 mM Tris HC1 (containing 0.5% (wv)BSA
and 0.5mM PMSF pH 7.4 at 22°C) using a Brinkman Polytron
PT-10 (setting 7, 1 min). Samples were centrifuged at
30,000 g for 10 min and the pellets washed twice with 10
volumes of 0.25M sucrose-buffered medium before suspension
in an equal volume of the same buffer. This crude lung
homogenate (H) was filtered through double-layered guaze
cloth and then centrifuged at 900 g for 10 min to remove
residual tissue fragments, unbroken cells, nuclei, and
large cellular debris (this fraction is designated PI).
The supernatant from this initial centrifugation (SI) was
sequentially centrifuged at 6000, 9000 and 20,000 g, each
for- 10 min (supernatants from which are designated S2, S3
and S4, respectively). MgCl was added to the final
supernatant (S4) to a 1 mM concentration in order to
enhance binding of ribosomes to smooth endoplasmic
reticulum, thereby allowing their separation from plasma
membranes by subsequent sucrose density gradient
centrifugation (Nijjar and Ho, 1980). 8 ml of MgCl-
supplemented S4 supernatant was applied to the top of a
discontinuous sucrose gradient made by layering from bottom
to top with 5 ml of 50% (WV), 10 ml of 15% (WV) and 10 ml
of 7.5% (WV) sucrose solutions. The gradient tube was
centrifuged at 35,000g: for 1 h in a SW 25.1 Beckman
ultracentrifuge swing-out rotor. Four distinct fractions in
the sucrose gradient (Fig. 5.1) were identified and
carefully removed. Each of the four fractions was
subsequently diluted 1:1 with 0.1M Tris-HCl and subjected
to centrifugation at 40,000£ for 2 h. In initial
experiments, all fractions were saved and assayed for
protein, the plasma membrane marker 5'-nucleotidase assay
and[ H]NBMPR binding. For preparative purposes, only B1
and F2 were collected. These two fractions were pooled and
diluted 1:1 with 0.1M Tris-HCl (pH 7.4) and centrifuged at
40,000g: for 2 h. The supernatant was discarded and the
pellet (which contained lung purified plasma4 membranes
(PMF)) resuspended in 50mM Tris-HCl(pH 7.4 at 22°C) and
stored at -70°C for up to 2 weeks. The purity of this PMF
preparation was assessed by measurements of its
5'-nucleotidase and specific NBMPR binding activities. The
protein content of fractions was determined by the method
of Lowry ei slL, (1951) with BSA as standard.
Figure 5.1 Outline of isolation procedure fLox the
preparation of lung plasma membranes
Crude lung homogenate (H)
900g : 10 min
Pellet (Pi; Supernatant (SI)
6.000s x 10 min
Pellet (P2) Supernatant (S2)
q nnnrf v 1 n min
Pellet (P3T Qnnornofsinf Q 3
Pellet (P4)
I
?n nnricf v in min
Supernatant (S4)
Add MgCl to 1 mM and
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layer onto discontinous sucrose
gradient















5.2.2 Plasma Membrane Enzyme Marker--5'-Nucleotidase Assay
The activity of 5'-nucleotidase (EC 3.1.3.5) was
3 3
assayed as the release of[ H]adenosine from [2- H]AMP
as described by Belsham e£ al, (1980). Samples (10-20 ul)
of lung homogenate or subcellular fractions were incubated
for 30 min at 30°C in a total volume of 500 ul containing
50 mM Tris-HCl (pH 8.0 at 22°C), 2mM MgCl and
3 2
0.1%(wv)Triton-100, with 5 mM [2- H]AMP (lmCiml,
11.7Cimmol). The incubation was terminated by addition of
lOOul of 0.15M ZnSO followed by lOOul of 0.15M-Ba(0H)
to precipitate the unhydrolysed AMP. After centrifugation
at 10,000g for 30 s, samples of the supernatant (0.4 ml)
were taken for the determination of radioactivity.
5.2.3 Equilibrium NBMPR Binding
Rat and guinea pig lung PMF in 50 mM Tris-HCl, pH
7.4 at 22°C (0.02-0.05 mg protein) were incubated with
3
graded concentration of[ H]NBMPR (final equilibrium
concentrations 0.05-5nM) in a total volume of 1 ml forr
30 min at 22°C in the presence and in the absence of 20uM
NBTGR. Incubations were terminated by filtration on glass
fibre filters and filters were processed for scintillation
•«
counting as described in Chapter 2. Specific binding was
calculated as the difference in binding in the presence and
in' the absence of NBTGR. Equilibrium concentrations of
3
unbound[ H]NBMPR were calculated from the differences
3
between the starting[ H]NBMPR concentrations and the
amounts of ligand bound to membranes and filters.
NBMPR binding capacities of fractions presented in
Tables 5.1 and 5.2 were determined as the difference in
3
[ H]NBMPR binding at a saturating concentration (5 nM) of
3
[ H]NBMPR in the presence and in the absence of 20 uM
NBTG-R as described above.
In competition experiments, graded concentrations of
each inhibitor were tested for inhibition of site-specific
3 3
[ H]NBMPR binding at 0.5nM[ H]NBMPR concentration.
Procedures were similar to those described in Chapter 2.
Inhibitors were added to membranes at the same time as
radioligand.
5.2.4 Photoaffinitv Labelling of Lung PMF
Rat or guinea pig lung PMF (final concentration
0.5-1.0 mg proteinml) in 50 mM Tris HC1 (pH 7.4 at 22°C)
were equilibrated at room temperature for 30 min with a
3
saturating concentration (25 nM) of[ H]NBMPR in the
presence and in the absence of 20 uM NBTGR as competing
nonradioactive ligand. Photoaffinity labelling of
membranes carried put as described in Chapter 4 (Section
4.2.2).
5.2.5 SDS-poIvacrvlamide gel electrophoresis
SDS-polyacrylamide gel electrophoresis was carried
out in 2 mm thick 12% slab gels as described in Chapter 4
(Section 4.2.4).
5.2.6 Protein determination
Protein was determined by the method of Lowry et. al.
(1951).
5.3 RESULTS
5.3.1 Lung Purified Membrane Preparation
The protein content, 5'-nucleotidase activities and
specific[ H]NBMPR binding capacities of the subcellular
fractions prepared from both rat and guinea pig lung by the
scheme illustrated in Fig. 5.1 are listed in Tables 5.1 and
5.2. In both species, the PMF (B1P,F2P) fraction accounted
for approximately 1% of the total homogenate protein and
had the highest 5'-nucleotidase specific activity of all
the fractions collected, the activity of this enzyme being
11.3 and 14.6 fold, respectively, greater than that in the
corresponding lung homogenates (H) (Table 5.3). Similarly,
the specific[ H]NBMPR binding activity was 13.7 fold and
15.8 fold higher in the rat and guinea pig lung PMF
fractions as compared to that in tissue homogenates from
the two species (Table 5.3).
5.3.2 NBMPR Binding Parameters in T.nng PMF
Fig 5.2 shows the concentration-dependence of
[ H]NBMPR binding- to rat and guinea pig lung PMF,
demonstrating the presence of both high-affinity saturable
(NBTGR-sensitive) and non-saturable (NBTGR-insensitive)
binding components in the two species. Specific binding
saturated at about 2.5 nM[ H]NBMPR. Scatchard analysis
of the data revealed a single population of binding sites,
with a Hill coefficient of 1.05 and 0.98 in the rat and
Table 5.1 Protein content, 5'-nucleotidase and NBMPR binding
activities of rat lung fractions















H 92.10+12.86 100.0 0.09+0.02 100.0 0.79+0.41 100.0
PI 19.50+ 2.34 21.2 0.11+0.02 25.0 0.52+0.06 14.0
P2 8.20+ 2.51 9.8 0.12+0.03 11.4 0.66+0.08 7.4
P3 8.30+ 1.20 9.1 0.15+0.02 14.6 1.20+0.14 13.7
P4 9.81+ 2.10 10.7 0.20+0.04 22.8 2.68+0.25 36,2
F1S 16.51+ 3.25 18.0 0.08+0.01 15.4 0.31+0.02 7.0
F1P 0.33+ 0.05 0.3 0.02+0.002 0.07 1.44+0.16 0.6
BIS 2.76+ 0.25 3.0 0 0 0 0
F2S 2.70+ 1.26 2.9 0 00 0
B2S 2.89+ 1.51 3.1 0 00 0
B2P 0.61+_ 0.16 0.7 0.50+0.06 3.9 3.90+0.81 3.6
PMF 0.93+ 0.24 1.0 1.02+0.18 11.1 10.80+2.02 13.8
Total
Recovery(%) 79.8 104.3 96.3
Distribution of protein content, enzyme and NBMPR activities in
subcellular fractions prepared from rat lung as described in Fig.5.1.
Protein content is expressed in mgg wet wt of starting lung tissue.
51-Nucleotidase enzyme activity is expressed in units, where 1 unit
represents the conversion of 1 umol of substrate (AMP) to products
(Adenosine+ phosphate) in 1 min at 30°. Values are means(+SEM) of
three separate preparations.
Table 5.2 Protein content 5'-nucleotidase and NBMPR binding
activities of guinea pig lung fractions
Fractions Protein 5'-nucleotidase Specific NBMPR
Binding
(maa Recovery Activity Recovery Activity Recovery
startina(%) (unitma(%) (omolema(%)
lung) protein) protein)
H 86.67+11.50 100.0 0.09+0.02 100.0 3.05+0.53 100.0
PI 20.56+ 3.92 23.7 0.09+0.02 22.9 6.79+1.50 52.6
P2 9.72+ 3.11 11.2 0.06+0.01 7.1 1.12+0.31 4.1
P3 5.83+ 2.40 6.7 0.22+0.03 15.6 3.55+0.52 7.8
P4 7.22+ 1.65 8.3 0.28+0.03 24.5 2.94+0.47 8:0
F1S 23.04+ 4.06 26.6 0.07+0.01 19.5 2.80+0.33 0.07
F1P 0.58+ 0.06 0.6 0.41+0.08 2.9 1.58+0.32 0.35
BIS 2.88+ 0.31 3.3 0.08+0.01 2.8 00
F2S 1.33+ 0.55 1.5 0 00 0
B2S 0.98 0.32 1.1 0.010.002 0.1 0 0
B2P 0.71+ 0.13 0.8 0.58+0.08 5.0 15.60+2.24 4.2
PMF 0.62+ 0.15 0.7 1.32+0.27 9.9 48.30+9.21 11.3«
Total
Recovery(%) 84.5 110.3 88.4
Distribution of protein content, enzyme and .NBMPR binding activities in
subcellular fractions prepared from guinea pig lung as described in
Fig.5.1. Protein content is expressed in mgg wet wt of starting lung
tissue. 5'-Nucleotidase enzyme activitv is expressed in units, where 1
unit represents the conversion of 1 umol of substrate (AMP) to products
(Adenosine+ phosphate) in 1 min at 30°C. Values are means (jSEM) of
three separate preparations.
Table 5.3 5' -Nucleotidase and NBHPR binding activities in








Rat Guinea pig Rat Guinea pig
H 0.09+0.02 0.09+0.02 0.79+0.41 3.05+0.53
PMF 1.02+0.18 1.32+0.27 10.80+2.02 48.30+9.21
Ratio 11.3+3.1 14.6+4.3 13.7+7.3 15.8+3.8
Data extracted from Tables 5.1 and 5.2.
guinea pig lung PMF, respectively. PMF from the two
species exhibited a similar dissociation constant (KcL) for
3
[ H]NBMPR binding but a significantly different number of
binding sites (Bmax) (Table 5.4). The Kd. values reported
here of 0.2-0.3 nM in lung purified membranes from the two
species compares favorably with their counterparts in crude
membrane preparations as described in Chapter 2 (KcL of
0.22 nM and 0.38 nM in the rat and guinea pig lung crude
membranes, respectively). Both species exhibited the same
3
amount of non-specific (NBTGR-insensitive)[ H1NBMPR
binding to PMF (2 pmolmg protein at 5 nM NBMPR)
5.3.3 Competition Experiments
••
High-affinity NBMPR binding activity in lung PMF was
inhibited by mM concentrations of the physiological
nucleosides, adenosine and uridine (Table 5.5). As
expected, adenosine was the more effective inhibitor,
consistent with the previous result obtained with lung
crude membranes (see Chapter 2, Section 2.3.1).
The properties of NBMPR binding to rat and guinea
pig lung PMF membranes were investigated further by
studying the effects of dipyridamole and other vasodilators
on high affinity binding activity in the two species!
Fig. 5.4 shows representative curves for dypridamole
inhibiton of NBMPR binding to lung PMF. Similar to the
findings in lung crude membranes, a large difference wasa..
found to exist between the two species with respect to
Figure 5.2 Concentration dependence qI NBMPR—binding to




















[3H]NBMPR binding to rat and guinea pig
lung purified membranes was measured in the absence
and in the presence of 20 uM NBTGR as competing
ft
ligand. -Values are means of duplicate estimates. Scatchard
and Hill plots of these data are shown in Fig. 5.3.
Figure 5.3 Seatohard arid Hill plots of site-SP?oi.fid HBHPR









































Scatchard (A) and Hill (B and C) plots of site specific
binding of NBMPR to rat and guinea pig lung PMF. These
»
plots were obtained using data for guinea pig and
rat lung PMF presented in Fig. 5.2.
Table 5.4 Binding parameters of NBTGR-sensitive NBMPR




Rat 0.24+0.10 12.5+2.03 1.05+0.15
Guinea pig 0.25+0.08 48.3+5.27 0.98+0.14
Values are means(+SEM) of four separate preparations.
Table 5.5 Inhibition of specific NBMPR binding to rat
and guinea Pig lung Purified membranes by
adenosine and uridine.
Inhibitor (M)% Control




























Inhibition of specific NBMPR binding by adenosine and
3
Uridine was determined at 0.5nM[ H]NBMPR as described in
he text. Values are means(±SEM) of three experiments.
Figure 5.4 Dipyridamole inhibition of NBMPR binding to rat




















The effects of varying concentrations of dipyridamole on
NBTGR-sensitive [3H]NBMPR binding to guinea pig and
rat lung purified membranes.' Data are expressed as
percentages of control values and are means(+SEM) of three
separate experiments.
Table 5.6 ICq of various vasodilators as inhibitor of





Dipyridamole 29.0 +3.2 0.07+0.008 414
Dilazep 0.17+0.02 0.01+0.002 17
Lidoflazine 10 0.53+0.06 19
Hexobendine 1.8+0.2 0.06+0.008 30
The IC50 for each drug was determined by'testing eight to
ten concentrations for inhibition of NBTGR-sensitive
[3H]NBMPR binding (0.5 nM). Values are means(+SEM) of
three experiments.
dipyridamole sensitivity. Table 5.6 summarises the IC
50
values of dipyridamole and the other vasodilators as
3
inhibitors of[ H]NBMPR binding to the PMF fraction in
the two species. In all instances, guinea pig lung PMF was
more sensitive to vasodilator inhibition than that of the
rat. The largest difference was for dipyridamole, a
difference of 414 fold. For the other vasodilators, the
range was 17- to 30-fold (Table 5.6).
5.3.4 Photoaffinitv Labelling of Lung Purified Membranes
Exposure of both rat and guinea pig lung purified
3
membranes to UV light in the presence of[ H]NBMPR under
equilibrium binding conditions resulted in substantial
••
radiolabelling of protein of Mr. 45,000-66,000. In
agreement with previous photoaffinity labelling experiments
with lung crude membranes (Chapter 4), the radiolabelled
peak of the nucleoside transporter in rat purified
membranes migrated with a higher apparent molecular weight
(apparent Mr. 63,000) than the guinea pig nucleoside
transporter (apparent Mr. 55,000) (Fig. 5.5). Radio-
labelling of PMF in both species was abolished when
photolysis was performed in the presence of 20 uM NBTGR as
competing nonradioactive ligand (Fig. 5.5).
Similar to findings reported in photoaffinity
labelling experiments in lung crude membranes, dipyridamole
(50 uM) reduced the radiolabelled peak much moret.
effectively in the guinea pig lung purified membranes than






















Lung purified membranes were photolabe1led with [3H]NBMPR
.•
and subjected to SDS-polyacrylamide gel electrophoresis as
described in METHODS. 3H-Profiles and positions of
I•
molecular weight standards are from the same slab gel-
Lung purified membranes from rat ) and guinea pig
Photolysis of membranes in the pres ence of 20 uM NBTGR
co-plotted in both species.
in the rat (Figs. 5.5 and 5.7, see also Table 5.7). Again,
as expected, adenosine, inhibited radiolabelling of lung
PMF in the two species to a similar extent (Figs. 5.6 and
5.7, see also Table 5.7).
Figure 5.6 Effects of dipyridamole and adenosine on NBMPR





















Rat lung PHF equilibrated with 25 nM [3H]NBMPR in the
absence and in the presence of 50 uM dipyridamole
or 10 mM adenosine were supplemented with 50 mM DTT
0
and exposed to high intensity UV light at 4 C for 45 s.
I
SDS-polyacrylamide gel electrophoresis was performed as
described in the text.
Figure 5.7 Effects of dipyridamole and adenosine on NBMPR
photoaffinity labelling of guinea-pig lung
purified membranes



















Guinea pie lung PMF equilibrated with 25 nM [3H]NBMPR in
the absence and in the presence of 50 uM dipyridamole
or 10 mM adenosine were photolabelled as
described in the text
Table 5.7 Effect of adenosine. dipyridamole and NRTGR on
covalent NBMPR incorporation into protein of






Adenosine (lOmM) 14.3 13.5
Dipyridamole (50 uM) 65.2 15.8
NBTGR (20 uM) 3.0 3.1
.
Data are taken from Figs. 5.5-5.7.
5.4 DISCUSSION
In this Chapter, a method of isolating purified
plasma membranes from rat and guinea pig lung tissue are
described. Lung is composed of many cell types (e.g.
smooth muscle cells, endothelial cells, epithelial cells,
fibroblasts, Clara cells, macrophages, mast cells and
leukocytes) and is always fibrous, thereby preventing
gentle homogenization from disrupting the majority of
cells. Vigorous homogenization results in the generation
of small fragments of plasma membrane which will sediment
at different centrifugation speeds. This may, in part,
account for the presence of 5'-nucleotidase activity in
fractions other than PHF. 5'-Nucleotidase is often used as
•«
a plasma membrane marker enzyme (Song and Bodansky,1967;
Nijjar and Ho,1980; Jain,1980). Although it is doubtful
that 5'-nucleotidase is exclusively present in the plasma
membrane, it is reported to be considerably enriched in
plasma membrane fractions isolated from different sources
(Kidwai et al, 1971).
In both species, the highest values for both
5'-nucleotidase activity and specific NBMPR binding
activity were in the PHF fractions, the two activities
%
co-purifying during the isolation procedure '-nucleo¬
tidase activity of 11- and 15-fold, and specific NBMPR
binding activity of 14- and 16-fold higher in the rat and
guinea pig lung PMF, respectively, compared to theL»
corresponding tissue homogenates) (Table 5.3). In the
guinea pig, specific NBMPR binding in the lung PMF was only
2.5-fold higher than in the crude membrane preparation used
in previous Chapters (48 and 19 pmolmg protein in PMF and
crude membranes, respectively) (Tables 5.4 and 2.1). As
described in Chapter 6, this increase in specific binding
activity of guinea pig lung PMF proved to be of crucial
importance for the successful reconstitution of the lung
nucleoside transporter into proteoliposomes. In the rat,
the specific NBMPR activity of the PMF fraction was 1.5
fold better than that of the crude membrane preparation
(12.5 and 8.1 pmolmg protein in PMF and the crude membrane
preparation, respectively) (Tables 5.4 and 2.1). The
reasons why the isolation procedures worked better for
guinea pig than rat are not clear.
Liver plasma membranes purified by Percoll density
gradients (Wu and Young, 1984) also exhibited a 10-15-fold
higher NBMPR-binding activity than the corresponding tissue
homogenate, and the recovery of high-affinity NBMPR binding
activity in the plasma-membrane fraction was broadly
similar to that obtained with the plasma-membrane marker
5'-nucleotidase. These results from lung and liver are
consistent with' a role of NBMPR-binding proteins in
cellular nucleoside transport. The fact that NBMPR binding
activity co-purified with the plasma membrane marker
5'-nucleotidase activity indicates that the NBMPR binding
protein is localised entirely or largely in the plasma
membrane. This is in contrast to the situation for glucose
transporters in insulin-responsive cells where the intra¬
cellular membrane pool of transport protein associated with
the microsomal membranes (Cushman and Wardzala, 1979).
Recruitment of these inactive transporters into plasma
membrane accounts for the stimulation of cellular glucose
transport by insulin.
Similar to findings in lung crude membranes (Chapter
2), high-affinity NBHPR binding to lung PMF membranes was
inhibited by mM concentrations of the physiological
nucleosides, adenosine and uridine. As in Chapter 2, there
was again a major species difference in vasodilator
sensitivity with respect to inhibition of NBMPR binding.
Photoaffinity labelling patterns of lung purified
membranes from the rat and guinea pig as presented in this
Chapter also resemble those observed in crude membrane
preparations (Chapter 4). In both rat and guinea pig lung
purified membranes, substantial radiolabelling was observed
in proteins of Mr. 45,000-66,000 and photoaffinity labelling
in both species was inhibited by adenosine and NBTGR.
Dipyridamole inhibition of covalent labelling was more
effective in guinea pig lung PMF than in the rat. Taken
together, these observations provide additional evidence
that lung NBMPR binding activity reflects a specific
association of ligand with NBMPR-sensitive nucleoside
transporters.
CHAPTER 6
RECONSTITUTION STUDIES OF THE NUCLEOSIDE
TRANSPORTER FROM GUINEA PIG LUNG PURIFIED PLASMA MEMBRANES
6.1 INTRODUCTION
In Chapters 2 to 4, I have presented a detailed
investigation of the NBMPR-sensitive nucleoside
transporters present in guinea pig and rat lung plasma
membranes using NBMPR as a specific ligand to probe
transporter structure and (indirectly) function. It is
therefore of utmost importance to establish that NBMPR
binding activities demonstrated in isolated membrane
preparations do indeed reflect ligand binding to elements
of functional nucleoside transporters. Physiologically,
lung is a major site for the removal of circulating
adenosine, a potent endogenous vasodilator (Berne 1,
1983; Bakhle and Chelliah, 1983; Hellewell and Pearson,
•«
1983). Despite its physiological and clinical importance,
the transport properties of lung nucleoside transporters
are poorly characterized. Transport experiments to date
have been largely limited to whole tissue perfusion where
detailed kinetic studies are impossible. The experiments
of Hellewell and Pearson (1983) demonstrated that
adenosine was efficiently taken up from the pig pulmonary
vascular bed and that the process was inhibited by
dipyridamole. In another approach, pig aortic endothelial
•»
cells in culture have been shown to take up adenosine very
rapidly by a high-affinity process that is selectively
inhibited by dipyridamole and NBMPR. These observations
have led to the conclusion that the pulmonary endothelium
possesses a high-affinity transport system for adenosine
removal (Pearson £i. slL, 1978). However, the endothelial
cell uptake studies can be criticised because of a failure
to determine true initial rates of transport. Nucleoside
uptake in these experiments therefore reflects both
membrane transport and subsequent intracellular nucleoside
metabolism. It is also unclear to what extent aortic
endothelial cells resemble those in the lung. Direct
isolation of lung endothelial cells is technically
difficult (Jain, 1980).
As detailed in the General Introduction to this
Thesis, NBMPR has been shown to interact specifically with
functional elements of the erythrocyte nucleoside
transporter and reversible ligand binding has been used as
••
a specific quantitative assay for transporter
polypeptide(s) (Jarvis and Young, 1982; Young and Jarvis,
3
1983). Photolysis experiments with[ H]NBMPR have
identified a membrane glycoprotein component of He.
45,000-65,000 to be the nucleoside transporter in
erythrocytes. Moreover, a partially purified band 4.5
preparation of human erythrocyte membranes has been shown
0
to be capable of catalysing NBTGR-sensitive uridine
transport when reconstituted into phospholipid vesicles.
In these reconstitution experiments, NBMPR-binding activity
co-purified with the nucleoside transport activity during0
preparation of the band 4.5 fraction from the initial
Triton X-100 membrane extract (Tse gt_ al, 1985). Similarly,
C.'
partially purified band 4.5 polypeptides from pig
erythrocytes have been shown to demonstrate NBTGR-sensitive
uridine transport activity when reconstituted into
phospholipid vesicles (Kwong£. 1, 1987).
Given the potential problems and limitations
encountered in whole organ perfusion studies and the
difficulty in obtaining intact cells directly from lung, my
approach towards characterizing nucleoside transport
activity in lung tissue was to attempt reconstitution of
the lung nucleoside transporter after detergent extraction
of the purified lung plasma membrane preparation detailed
in Chapter 5.
In the series of experiments described in this
Chapter, a-octylglucoside was used to solubilise the
nucleoside transporter from guinea pig lung plasma
membranes. Guinea pig lung purified membrane preparations
rather than those of the rat were used because of their
higher density of NBMPR binding sites as described in
Chapter 5. After removal of detergent, membrane proteins
were reconstituted into proteoliposomes and the kinetic
properties of carrier-mediated nucleoside transport
characterised in detail. As far as I am aware, these
experiments represent the first successful attempt to
reconstitute a nucleoside transporter from a non-erythroid
cell type or tissue.
6.2 METHOD
6.2.1 Tissue and Plasma Membrane Preparation
Purified plasma membranes from guinea-pig lung were
prepared as detailed in Chapter 5 (Section 5.2.1).
6.2.2 Solubilisation of Lung Plasma Membranes
Lung plasma membranes at a final protein
concentration of 1.5 mgml were solubilised at 4'C by
suspension in 46 mM -octylglucoside, 2 mM dithiothreitol
and 50 mM Tris-HCl (pH 7.4 at 4°C) with stirring for
30 min. a-Octylglucoside was used in preference to Triton
X-100 (Jarvis and Young, 1983) because it can be readily
removed by dialysis. The membranedetergent suspension was
then centrifuged at 130,000g for 1 h and the supernatant
retained. Detergent was removed by dialysis against four
changes, each of 2 1, of 10 mM Tris-HCl, 0.2 mM DTT (pH 7.4
at 4°C) over a period of 24 h. DTT was included to
maintain membrane thiol groups in the .reduced state. It
has previously been established that -SH groups are
essential for NBMPR binding and uridine transport activity
(see eg:. Tse and Young, 1985). The solubilised crude lung
membrane extract was stored at -70°C.
6.2.3 NBMPR Binding Measurements
6.2.3a Filtration method
High-affinity binding of NBMPR to guinea-pig lung
membranes was determined by the filtration assay described
in Chapter 2.
6.2.3b Centrifugal gel filtration method
High-affinity binding of NBMPR to solubilised lung
membrane extract was measured by centrifugal gel filtration
(Penefsky, 1977; Fry aJL, 1978). Briefly, columns of
Sephedex G-50 (fine), which had been pre-equilibrated with
10 mM Tris-HCl (pH 7.4 at 4°C), were prepared in 1 ml
(tuberculin) syringes. The columns were centrifuged at
lOOOg for 2 min in a swinging bucket rotor of a bench
centrifuge shortly before use. The prepared columns were
kept on ice. Typically, solubilised lung extract in 10 mM
Tris-HCl was diluted 3-fold in the same buffer and
incubated at room temperature (±20 uM NBTGR) for 30 min
3
with graded concentrations of[ H]NBMPR (final
equilibrium concentrations 0.25-45 nM) at a final protein
concentration in the region of 0.13 mgml. After
incubation, samples were cooled on ice for 10 min to
minimise subsequent dissociation of bound ligand from the
transporter. A 75 ul sample of the reaction mixture was
then applied to a centrifuged column. After the sample'had» -
entered the Sephedex, the syringe column was recentrifuged
as' described above and the eluate collected directly into a
scintillation minivial in the centrifuge bucket. Control1..
experiments established that protein recovered in the
eluate is 85%. High-affinity NBMPR binding activity was
defined as the difference in binding activity measured in
the presence and in the absence of 10 uM NBTGR.
6.2.4 Reconstitution of the Solubilised Lung Membrane
Extract
6.2.4a Preparation of washed asolectin
Crude asolectin (required for liposome preparation
described in the next section) was washed according to
Kagawa and Racker (1971). Briefly, 25 g of crude asolectin
was mixed with 250 ml acetone in a brown glass bottle with
a magnetic stirring hnr. Tha nnnt.fint.R of the hottle were
•
bubbled vigourously with N for 15 min while stirring.
2
The bottle was then capped and stirring continued
overnight. The extracted lipid was collected by
centrifugation and the pellet dissolved in 100 ml anhydrous
diethyl ether. This material was again centrifuged and the
supernatant evaporated to dryness in a rotatory evaporator.
The residue was dissolved in 100 ml chloroform: methanol
(4:1) to give a concentration of 100-200 umoles
phospholipidml. This final washed asolectin preparation




6.2.4b Preparation of liposomes
Acetone-washed asolectin (40 umol in
chloroformmethanol) was placed in a 13 X 10 ram pyrex tube
and dried under a stream of nitrogen. The dried asolectin
was re-dissolved in 0.5 ml diethyl ether and dried again
under N to remove traces of chloroform and methanol.
2
Aft.pr nil hhf? organic solvents had been evaDorated. the
pellet was suspended in 0.5 ml 10 mM Tris-HCl (pH 7.4 at
40). The tube was covered by parafilm and sonicated to
«•
clarity (10 min at 20-30'C) in a bath type sonicator
(G112-SP1, Laboratory Supply Company Inc., Hicksville, NY)
containing 0.02% (wv) Triton X-100 in distilled water
(Kasahara and Hinkle, 1977).
6.2.4c Reconstitution of the lung nucleoside transporter
Solubilised lung extract was reconstituted into
phospholipid vesicles using the method described previously
by Kasahara and Hinkle (1977) for reconstitution of the
human erythrocyte glucose transporter as modified by Tse et
al (1985). Solubilised lung membrane extract (0.2 mg
protein) was added to sonicated vesicles (10 umol, see
Section 6.2.4b) in a final volume of 0.4 ml. The
phospholipid:protein ratio (umolmg) was typically kept in
the range 50-80: 1. The mixture was rapidly frozen in dry
iceethanol, slowly thawed at room temperature and then
sonicated briefly (5 s). These reconstituted proteo-»
liposomes were used for uridine uptake studies.
6.2.5 Transport Measurements in Reconst ituted—PrctPQ-
Liposomes
Zero-trans influx and equilibrium exchange influx of
uridine were measured at 25rC. Uptake (defined as the
appearance of nucleoside in the intravesicular space) of
[ C]uridine by liposomes and reconstituted vesicles was
measured by a centrifugal gel filtration method essentially
identical to that described in Section 7.2.3b (Penefsky,
1977; Fry al, 1978; Baldwin ai. al, 1981). Briefly,
columns of Sephedex G-50 (fine), which had been
pre-equilibrated with 20 uM NBTGR, 10 mM Tris-HCl (pH 7.4
at 22%C), were poured to the 1 ml mark in disposable 1 ml
(tuberculin) syringes. The columns were centrifuged at
lOOOg for 2 min in the swinging bucket rotor of a bench
centrifuge shortly before use. The prepared columns were
kept on ice. Uptake was measured at 25C. All other
procedures were carried out at 4'C in a cold room.
Zero-trans influx incubations were initiated by adding
45 ul of reconstituted vesicles(+ 20 uM NBTGR) to 45 ul of
[ C] uridine (2 uCiml, final concentration of 50 uM) in
the same 10 mM Tris-HCl buffer. Uptake at different time
intervals was terminated by rapid addition of 20 ul of an
ice-cold stopping solution containing 20 uM NBTGR in Tris
buffer, and a 75 ul sample of the reaction mixture was
immediately applied to a centrifuged column. After the
sample had entered the gel, 20 ul of stopping solution was
added to the syringe column which was then recentrifuged as
described above, and the eluate collected directly into a
scintillation minivial in the centrifuge bucket.
Radioactivity present in the eluate was measured by liquid
(h
scintillation spectrometry with appropiate quench and
background correction. Blank values for uptake assays were
determined by centrifugal gel column processing of samples
taken immediately after mixing ice-cold NBTGR-treated
14
vesicles and ice-cold[ C] uridine. These blanks were
subtracted from measurements of uridine uptake by
reconstituted vesicles. Apparent initial rates of uridine
14
uptake from graded concentrations of[ C]uridine (0.05-2
mM) were measured following a 20 s incubation in the
presence and in the absence of 20 uM NBTGR.
For equilibrium exchange influx, reconstituted
vesicles were 'loaded' with non-radioactive uridine
(0.05-15 mM) by incubation with uridine-containing Tris
buffer for 2 h at 25°C by which time equilibration between
intravesicular and extravesicular uridine had occured (Tse
et al. 1985). To initiate equilibrim exchange influx, 45
ul of 'loaded' reconstituted vesicles were mixed with an
.
equal volume of prewarmed 10 mM Tris buffer containing the
14
same concentration of radioactive[ C]uridine (2
••
uCiml). Uptake (20 s incubation for initial rate
measurements) was terminated by rapid addition of 20 ul
ice-cold stopping solution containing 20 uM NBTGR in Tris
buffer. A 75 ul sample of the reaction mixture was
a.•
immediately applied to centrifuged Sephadex 1 ml column and
processed as described above for zero-trans influx.
6.2.6 Phospholipid Assay
f•
The phospholipid content of washed asolectin was
measured by phosphate analysis. The washed asolectin
was diluted 10-fold with chloroform: methanol (4:1).
0.05-0.2 ml diluted asolectin was then placed in the
bottom of 18 x 150 mm pyrex test tube and 0.2 ml of
Mg(N0) (10% (wv) in ethanol) was added. Using s
3 2
wire test tube holder, the tube was heated over a bunser
burner with rapid mixing to prevent 'bumping'. Heating
was continued until brown gas was no longer released anc
the sample was white.
•«
The sample was cooled and 0.5 ml IN HC1 was added.
The tube was covered with a glass marble and heated in a
boiling water bath for 20 min. The sample was cooled again
•»
and 10 ml of color reagent (90 ml water10 ml ammonium
molybydate solution (10% (wv in 10 ml H SO )5 g
2 4
FeSO .7H 0) was added. For standards, 0.2-2 umoles»
4 2
inorganic phosphate were added to 0.5 ml IN HC1 followed by
.
10 ml of color reagent. The tubes were allowed to stand
for 20 min at room temperature before reading the
absorbance at 660 nm.
6.2.7 Protein Determination




6.3.1 Solubilization of Purified Lung Membranes
Kwong slL sJL (1986) have established that a-octyl¬
glucoside is the preferred detergent compared with Triton
X-100 for extraction of high-affinity NBMPR binding
component(s) from human and pig erythrocyte 'ghosts'. The
same detergent was used in the present study to solubilise
lung membranes.
In contrast to erythrocyte membranes (Kwong aJL»
1986), solubilisation of purified lung plasma membranes
with a-octylglucoside did not lead to an increase in the
specific activity of NBMPR binding i.e. there was no
selective solubilisation of the nucleoside transporter
under the condition used. Thus, extraction of lung plasma
membrane protein by a-octylglucoside (46 mM) resulted in
solubilisation of 70-80% of the total plasma membrane
protein and a similar percentage of NBMPR binding activity
(Table 6.1). As expected, the remainder tof the protein and
NBMPR binding activity was recovered in the insoluble
.
a-octylglucoside residue. The average specific activity of
reversible high-affinity NBMPR binding to crude lung
membrane extracts, measured after detergent removal, was
35+4 pmolmg protein (mean of 4. experiments), a value
similar to that of the starting plasma membranes. NBMPR
binding was abolished in the presence of detergent but was
quantitatively recovered following detergent removal by
Table 6.1 Solubilisation of NBMPR-binding activity from


















Lung plasma membranes were solubilised with 46 mM
n-octylglucoside, 50 mM Tris-HCl (pH 7.4 at 40C) and 2 mM
dithiothreitol. The 130,000g supernatant was then dialysed
free of detergent and assayed for protein and high-affinity
NBMPR-binding activity (at a saturating concentration of
.
radioactive ligand, 25 nM) as described in the text. Values
are means (+SEM) of four separate experiments.
dialysis (1 and 35 pmolmg of protein before and after
detergent removal).
6.3.2. Characterization of the Solubilised Lung Membrane
Extract
Fig. 6.1 shows concentration-dependence curves of
3
[ H]NBMPR binding to solubilised lung membrane extract
measured at equilibrium (30 min incubation) in the presence
and in the absence of 20 uM NBTGR. Binding activity is
plotted against the calculated free concentrations of
3
unbound ligand in the medium.[ H]NBMPR binding to
membrane extract was NBTGR-sensitive and saturable with an
apparent KcL of 1.1 nM as determined by Scatchard analysis.
»
This affinity constant compares favourably with an apparent
3
Kd of 0.2 nM for[ H]NBMPR binding to guinea-pig lung
purified membranes described previously (Chapter 4, Section
3
4.3.2a). The Bmax value for NBTGR-sensitive[ H]NBMPR
binding in the experiment shown in Fig. 6.1 was 33 pmolmg
protein.
Table 6.2 demonstrates that high-affinity NBMPR
.
binding activity in solubilised lung membrane extracts was
inhibited by the physiological nucleosides adenosine and
•
uridine. As expected, adenosine was more effective than
3
uridine (IC 2 and 8 mM respectively, 5 nM[ H]NBMPR),
50
in -agreement with their relative affinities for the
nucleoside transporter in guinea lung membranes asi•
described in Chapters 2 and 4 (IC of 0.8 and 7 mM,
50
Figure 6.1 Concentration dependence of NBMPR—binding tQ








































The amounts of[ H]NBMPR bound reversibly to lung
membrane extract were measured by centrifugal gel
filtration in the presence and in the absence of
20 uM NBTGR and are plotted against the equilibrium
concentrations of free NBMPR. The inset shows a Scatchard
plot of the data (corrected for the NBTGR-insensitive
component- of binding). Maximum binding (33 pmolmg
protein) and apparent Kd (1.1 nM) were determined by linear
regression analysis. 0
Table 6.2 Effects of nucleosides on high-affinitv binding






















Binding of[ H]NBMPR (initial conc'entration 5 nM)
was measured at room temperature (30 min incubation)
in the absence and in the presence of various
concentrations of competing nucleoside(+ 20 uM NBTGR
to correct for non-specific binding). High-affinity
binding activity in the absence of tested nucleosides
was 15 pmolmg of protein. Values are means+S.E. of
triplicate estimates.
0.9 and 8.5 mM for adenosine and uridine in guinea pig lung
crude and purified plasma membranes, respectively) as well
as in a variety of other cell types (Young and Jarvis,
1983). The IC concentrations for lung membrane extract
were used to determine apparent Ki. values from the
relationship
where [L] is the radioligand concentration and KdL its
binding affinity. Calculated inhibitor constants (Ki) were
0.5 and 2 mM for adenosine and uridine, respectively. The
calculated apparent Ki value for uridine compares well with
its apparent Km (1.1 mM) of equilibrium exchange influx in
reconstituted lung proteoliposomes (see below).
6.3.3 Reconstitution Studies of the Crude Lung Membrane
Extract
6.3.3a Zero-trans Influx
Fig. 6.2 shows a representative, time course of
uridine uptake (50 uM, 25°C), measured in the presence and
in the absence of 20 uM NBMPR. Uptake was inhibited by
NBMPR. The NBMPR-sensitive component of transport
exhibited a half-time for equilibration of approximately
50 s (Fig. 6.2 inset) while the NBMPR-insensitive component
of' uptake was linear with respect to time. Fig. 6.3 shows
concentration dependence curves(+ 20 uM NBMPR) for
zero-trans uridine influx into vesicles reconstituted with
Figure 6.2 Time course of uridine uptake into vesicles
reconstituted with n-octylglucoside solubilised

































Solubilised lung membrane extract was reconstituted into
.
«
phospholipid vesicles as described in the text. Uridine
o
uptake (50 uM, 25 C) was assayed in the absence and
in the presence of 20 uH NBMPR The inset shows the
time course of NBMPR-sensitive uridine transport is
the difference between uridine uptake in the absence and in
the presence of NBMPR). Error bars are S.E. of triplicate
estimates.
m
Figure 6.3 Concentration dependence of aero-trans uridine
influx into vesicles reconstituted with crude


































Apparent initial rates of zero-trans influx of uridine by
reconstituted vesicles were measured in the presence
and in the absence of 20 uM NBMPR as described in
METHODS. The inset shows an Eadie-Hofstee plot of NBMPR-
sensitive uridine transport (vs vs£). Apparent Km. and
Vmax values, as estimated by linear regression analysis,
were 0.14 mM and 0.97 nmolmg in 20 s, respectively. Error
bars are S.E. of triplicate estimates.
crude lung membrane extract over the concentration range of
0.05-2 mM. Rates of NBMPR-sensitive uridine transport were
saturable and conformed to simple Michaelis-Menten kinetics
(apparent Km 0.14 mM and Vmax 0.97 nmolmg protein in
20 s). In contrast, rates of NBMPR-insensitive uridine
uptake were linear with respect to uridine concentration
over the same range.
6.3.3b Equilibrium exchange influx
In equilibrium exchange experiments, substrate
concentrations are identical on both sides of the membrane.
Reconstituted vesicles were therefore pre-equilibrated with
varying concentrations of non-radioactive uridine.
Equilibrium exchange influx was initiated by adding
14
[ C]uridine, at the same concentration, to the preloaded
vesicles. Representative concentration-dependence curves
t
for equilibrium exchange influx of uridine are shown in
Fig. 6.4. NBMPR-sensitive equilibrium exchange influx of
uridine was saturable and conformed to simple Michaelis-
Menten kinetics. Estimated apparent Km and Vmax values
.
were 1.1 mM and 7.1 nmolmg of protein in 20 s,
respectively, as determined from the inset vs vs y plot
(see also Table 6.3). In contrast, the NBTGR-insensitive
component of uridine equilibrium, exchange exhibited a
linear concentration dependence. The Vmax of
NBMPR-sensitive equilibrium exchange uridine influx wasA.i
7.3-fold greater than the Vmax observed for zero-trans
Figure 6.4 Concentration dependence of uridine equilibrium
exchange influx by vesicles reconstituted with

















































Reconstituted vesicles were pre-equilibrated with varying
concentrations (0.05-15 mM) of non-radioactive uridine as
described in METHODS. Apparent initial' rates of uridine
equilibrium exchange influx (20 s flux) were measured in
the presence
»
and in the absence of 20 uM NBMPR
The inset shows a vs vs. Y. plot of apparent initial rates
•
of NBMPR-sensitive uridine equilibrium exchange influx.
Estimated apparent Km and Vmax values were 1.1 mM and
7.1 nmolmg of protein in 20 s, respectively. Error bars
are S.E. of triplicate estimates.
influx measured at the same temperature and was paralleled
by a corresponding increase in apparent Kin. Thus, there
was no significant difference in the VmaxKm ratio under
these two experimental conditions (Table 6.3). A full
fY-1.
analysis of these kinetic data is presented in the next
sect ion.
6.3.3c Characterization of the reconstituted nucleoside
transporter in terms of the simple carrier model
Kinetic parameters for zero-trans (zt) influx and
equilibrium exchange (ee) influx of uridine are summarised
in Table 6.3. For a carrier-mediated system to be
compatible with the simple carrier model as defined by Lieb
(1982) and Stein (1986), VmaxKm ratios for all
experimentally determined flux measurements must be equal.
It has been well established that glucose and nucleoside
transporters orientate randomly when reconstituted into
proteoliposomes by freeze-thaw sonication (Baldwin sJL,
1980; Wheeler and Hinkle, 1981; Tse and .Young, 1987). On
this basis, it is predicted that the reconstituted system0
.
would exhibit kinetic symmetry with respect to zero-trans
influx and efflux. Therefore, assuming that V12=V21, it
was possible to calculate the simple carrier resistance
parameter (Roo, Ree, R12, R21; see legend to Table 6.3) for
the reconstituted lung system (Table 6.3). This analysis
clearly demonstrates that the loaded carrier moves at a1•
much faster rate than the empty carrier, the mobilities
Table 6.3 Kinetic parameters for uridine equilibrium exchange and
zero-trans influx in vesicles reconstituted with
solubilized plasma membrane extract from guinea pig lung
Parameter measured
Vmax Km Bmax VmaxKm Turnover
(nmolmg protein (pmolmg (ulmg protein number





0.97 0.14 28 6.93 1.7
7.1 1.1 28 6.45 12.7
Simple carrier resistance parameters
-1
(nmolmg protein in 20 s)
v.Y —1
(ms)
R12=R21=(V12) 1.03; nR12 588
ee -1
Ree=(V) 0.14; nRee 79
Roo=R12+R21-Ree 1.92; nRoo 1097
Independent estimates of simple carrier affinity parameter K




. K=K (ReeRoo) 81
Mean 78
Experimental details are described under 'METHODS'. Data from
experiments illustrated in Figs. 6.2 and 6.3 are summarised in this
Table. Solution 1 has been arbitrarily chosen to be the intravesidular
solution. Resistance and affinity parameters according the simple
carrier model were calculated according to the method of Lieb (1982).
Simple carrier resistance parameters, R12' and Ree are the reciprocals
of. the Vmax values for zero-trans influx and equilibrium exchange,
respectively. Turnover time value (nR) represents the average time it
takes a single transport cycle under the appropiate experimental
situation. nRoo measures the turnover time of emptv carrier and
nRoo=nR12+nR21-nRee while n is the total concentration of transporter.
Turnover number refers to the number of substrate molecules transported
per site per s.
(carrier 'mobility' implies macromolecular movement, e.g. a
conformational shift, and does not denote actual
translocation of the carrier) of the loaded and empty
carriers differing by 14-fold (RooRee=14).
Turnover numbers (i.e. the numbers of substrate
molecules transported per site per s) and turnover time
values (nR, i.e. the average time it takes a single
transport system to complete a single transport cycle under
t-.hfi ADDroDiate experimental situation, n being derived from
assays of high-affinity NBMPR binding activity (Lieb, 1982;
Stein, 1986)) for the reconstituted system were calculated
and presented in Table 6.3. nRoo measures the turnover
time of empty carrier and nRoo=nR12+nR21-nRee. Since n is
•«
a constant, the turnover time value for the empty carrier
is again 14-fold greater than the equivalent value for the
empty carrier. From the apparent Km. values, it was
possible to calculate the simple carrier affinity constant
(K) for the reconstituted lung system (Table 6.3). Th«
two independent estimates of K were similar, the mean bein
78 uH.
6. 3. 3d Inhibitor studies of NBMPR-sensi t.i ve uridine uptake
bv reconstituted vesicles
A series of inhibition experiments were performed to0
investigate the ability of the transported nucleosides
uridine, adenosine and inosine and the vasodilators,
a.
dilazep and dipyridamole to inhibit NBMPR-sensitive uridine
Table 6.4 Effects of transported nucleosides and nucleoside
transport inhibitors on uridine transport into
vesicles reconstituted with n-octvlglucoside
fx
solubilised guinea-pig lung plasma membranes
Uridine Uridine























































Rates of NBMPR-sensitive uridine transport (50 uM) by
vesicles (20 s flux, 25°C) were measured as described in' •
the text. Inhibitors were pre-incubated with recon-
stituted vesicles for 15 min at 25°C before addition of
permeant. Values are means(+SEM) of three separate
determinations.
uptake by the reconstituted vesicles. Results presented in
Table 6.4 confirmed that NBMPR-sensitive uridine uptake by
the reconstituted vesicles was inhibited by the nucleoside
permeants inosine and adenosine. Adenosine was a more
effective inhibitor of the reconstituted transporter than
inosine (IC 0.07 and 0.10 mM respectively, 50 uM
[ C] uridine), in agreement with their relative
affinities for the nucleoside transporter in other cell
types. As expected from the concentration-dependence
experiments reported in Sections 6.3.3, cold uridine acted
as an apparent inhibitor of tracer uridine influx.
NBMPR-sensitive uridine transport in the reconstitited
vesicles was also inhibited by dilazep, dipyridamole and
NBTGR. IC values were 10 and 15 nM for dilazep and
dipyridamole respectively. These values correspond well
with IC values determined for inhibition of
high-affinity NBMPR binding to guinea-pig lung purified
membranes (10 and 70 nM for dilazep and dipyridamole,
respectively) (Chapter 4, Section 4.3.2b). The above
results therefore suggest that high-affinitv binding of
NBMPR to lung membranes represents a specific interaction
with element(s) of the NBMPR-sensitive nucleoside
transporter, a conclusion consistent with previous reports
in erythrocytes (Young and Jarvis, 1983.).
6.3.3e Control experiments
Control experiments were performed to establish






Reconstituted vesicles 8.7+0.1 3.9+0.2 4.8+0.22
Lipid only 3.8+0.2 3.9+0.2 0
Protein only 0 00
Uridine uptake by vesicles (50 uM, 20 s flux at 25°C) was
measured as described in the text. In the preparation of
'reconstituted vesicles', crude n-octylglucoside extract
was reconstituted with added soybean phospholipids. For the
'lipid only' and 'protein only' controls, reconstitution
was performed in the absence of added protein and lipid,
respectively. Each transport assay contained 15.3 ug oft
9-
protein and 0.77 ..umol of lipid (reconstituted vesicles)
or 15.3 ug of protein (protein only) or 0.77 umol of
phospholipids (lipid only).
9
whether added phospholipid was essential for reconstitution
of nucleoside transport activity. Table 6.5 demonstrates
that the NBMPR-sensitive uridine transport activity of the
crude lung membrane preparation was totally dependent upon
the presence of added phospholipid, membrane extract alone
having no detectable NBMPR-sensitive uridine uptake
activity. Liposomes alone only exhibited NBMPR-insensitive
uptake of nucleoside, reflecting simple diffusion of
isotopic permeant across the lipid bilayer (see also
Section 6.3.4).
6.3.4 Nucleoside Uptake into Liposomes
Uridine was used as the permeant for the••
reconstitution experiments described in this Chapter.
Uridine was selected in preference to other nucleosides
because its kinetics of transport into intact erythrocytes
•
have been extensively studied. The kinetic parameters
obtained in the lung reconstituted system could therefore
be compared directly with published values for the
reconstituted erythrocyte nucleoside transporter. In the
.
present series of experiments, I have compared the uptake
of inosine, adenosine and uridine into liposmes. Fig. 6.5
compares the time courses of uridine, inosine and adenosine
uptake measured in vesicles prepared in the absence of
protein.„ The estimated initial rates of nucleoside
permeation into protein-free liposomes were 3.7, 10.1 and
52.3 pmolumol phospholipid per min for inosine, uridine
and adenosine, respectively, giving ratios of 1: 2.7: 14.0
with respect to inosine. This uptake of nucleosides into
protein-free liposomes represents simple diffusion across
the vesicle membrane and correlates well with their
respective octano1water partition coefficients (adenosine
0.10; uridine 0.037; inosine 0.0087) (Jarvis and Young,
1982).




























Inosine uridine and adenosine uptake (50 uH)
were measured at 25°C by the centrifugal gel filtration ft•
method as described in 'METHODS'. Liposomes were prepared
in the absence of protein by the standard reconstitution
i
procedure. Each assay contained 0.52 umol lipid. Values
are means of duplicate estimates.
6.4 DISCUSSION
Adenosine is removed on passage through the
pulmonary circulation of guinea-pig and rat in. vivo (see
Chapter 1) and it has also been demonstrated that vascular
endothelium (and smooth muscle cells) in culture take up
adenosine from the culture medium (Dieterle at. X, 1978;
Pearson at 2LL 1978). Because of adenosine's participation
in diverse physiological processes, its removal from the
vascular space into cells could have important
physio]ogical consequences. Apart from the studies
mentioned above, the lung's role in adenosine transport has
been limited to indirect studies of NBMPR binding.
High-affinity binding sites for the nucleoside transport •«
inhibitor NBMPR have been demonstrated in lung tissue (see
Chapters 2 and 4). The fact that occupation of sites by
NBMPR can be inhibited by physiological nucleosides
(adenosine and uridine) and other recognized nucleoside
transporter inhibitors such as dipyridamole provides only
indirect evidence that NBMPR is bindiRg to functional
elements of lung nucleoside transporter.
In the present series of experiments, I have been
able to demonstrate using the freeze-thaw-sonication
procedure of Kasahara and Hinkle (1977) and Tse SlL
(1985) that crude DL-octylglucoside- extract of guinea-pig
purified plasma membranes is capable of catalysing
NBMPR-sensitive uridine transport when reconstituted into
phospholipid vesicles. This reconstituted membrane system
also exhibited high-affinity NBMPR binding activity. The
choice of using n.-octylglucoside as detergent rather than
Triton X-100 was because a-octylglucoside can be completely
removed by dialysis, in contrast to Triton X-100 which has
a low critical micelle concentration (Yu e£. L, 1973) and
has therefore to be removed by adsorption onto poly¬
styrene beads (Biobeads SM 2). Detergent removal by this
method is associated with significant absorption of
protein onto the beads (Jarvis and Young, 1981). Purified
plasma membranes from guinea pig lung was used in
preference to rat lung because of a higher specific NBMPR
binding activity i.e. more binding sites (see Chapter 5).
Attempts to reconstitute the nucleoside transporters from
«
crude lung membranes from either species were unsuccessful
because of the lower density of NBMPR binding site (data
not shown).
The solubilised crude membrane extract exhibited a
mean high-affinity NBMPR binding activity of 35+4 pmolmg
protein (Fig. 6.1 and Table 6.1) and an apparent Kd. of»'
1.1 nM. This binding was inhibited by adenosine and
.
uridine. When this preparation was reconstituted into
proteoliposomes, NBMPR-sensitive uridine transport was
«•
demonstrated (Fig. 6.2). This transport was inhibited .by
adenosine and inosine, confirming that the transporter
exhibits broad specificity for both purine and pyrimidine
nucleosides. Specific (NBMPR-sensitive) uridine transport
in the reconstituted vesicles was also inhibited by dilazep
and dipyridamole, both being potent inhibitors of
nucleoside transport in many other cell types. IC
50
values for inhibition of NBMPR-sensitive transport by these
vasodilators in reconstituted lung membrane vesicles
correlates with their apparent Ki values as inhibitors of
high-affinity NBMPR binding to intact lung membranes
(Chapter 3, Section 2.3.1 and Chapter 5, Section 5.3.3).
For uridine, Ki values for inhibition of NBMPR binding
(Chapter 2, Section 2.3.1) correlates well with the
apparent Km. of NBMPR-sensitive equilibrium exchange influx
of uridine (1.1 mM, see Section 6.3.3b). These results
therefore provide strong evidence that the lung NBMPR
binding protein is identical to the lung NBMPR-sensitive
nucleoside transport protein.
Liposomes exhibit a 5-fold greater diffusion
permeability to adenosine than to uridine, this being a
consequence of adenosine's higher lipid solubility (Section
6.3.4). Physiologically, this means that cells are
significantly permeable to adenosine,«even in the absence
of a nucleoside carrier. Experimentally, the large
.
magnitiude of NBTGR-insensitive adenosine uptake into
liposomes makes this nucleoside unsuitable as a permeant
for reconsititution studies. As might therefore be
expected, attempts to directly demonstrate carrier-
mediated, adenosine transport by the reconstituted guinea
pig lung nucleoside transporter were unsuccessful (data not
shown).
In permeation studies with vesicles, it is important
to differentiate between transport and binding of permeant,
particularly since binding might also be blocked by
inhibitors of transport. The uridine uptake processes
described in reconstituted lung vesicles evidently
represent transport since uridine uptake by the vesicles
was time-dependent, and uptake rates saturated as uridine
concentrations were increased (Figs. 6.2 and 6.3).
Furthermore, the numbers of uridine molecules taken up in
vesicles that had incorporated the lung nucleoside
transporter greatly exceeded the number of available
NBMPR-binding sites in the preparation. The number of
uridine molecules taken up per s in reconstituted vesicles
•«
assayed under equilibrium exchange influx conditions is
13 times the number of available high-affinity NBMPR
binding sites (Table 6.3), calculated assuming that each
transporter binds one molecule of NBMPR. Therefore,
NBTGR-sensitive uridine transport as measured in the
present experiments reflects carrier-mediated nucleoside
permeation into the reconsitituted vesicles rather than
binding. In addition, reconstitution of nucleoside
transport activity from lung plasma membranes extract also
«-
exhibited an absolute requirement for added phospholipid
(Table 6.5), further strong evidence for carrier-mediated
nucleoside permeation into the reconstituted vesicles
rather than binding.
The kinetic studies presented in this Chapter
demonstrate that the simple carrier model of Lieb (1982)
and Stein (1986) can be applied to uridine transport in the
reconstituted lung system, VmaxKm ratios of uridine uptake
under zero-trans influx and equilibrium exchange influx
conditions being the same (Lieb, 1982; Stein, 1986). The
relative magnitudes of the two resistance parameters
demonstrates that the loaded and empty carriers exhibit a
14-fold difference in mobility (i.e. RooRee=14, Table
6.3). This compares favourably with a difference of
21-fold for reconstituted human erythrocyte band 4.5
polypeptides measured at 15°C (Tse and Young, 1987) and
implies that the movement of the empty carrier is the rate
determining step of uridine transport in reconstituted •«
vesicles. However, unlike erythrocytes, the mobilities of
substrate-loaded and empty carriers are equal in intact
cultured cells (see Chapter 1). Variation in membrane
lipid composition between erythrocytes and other cell types
may offer a potential explanation for these cell-type
differences in kinetic behaviour (Tse and Young, 1987a, b).«••
The estimated mean K value of 78 uM measured at 25'C
for the reconstituted lung transporter is slightly higher
than the K value of 120 uM obtained for reconstituted human
«
erythrocyte band 4.5 polypeptides measured at 15°C (Tse and
Young, 1987). The lung value would be expected to be
numerically even smaller at lower temperature (Plagemann
.and Wohlhueter, 1984b). K is not a direct measure ofA.
carrier affinity, but is a composite of both mobility and
affinity rate constants. Therefore, the difference in K
between the reconstituted guinea pig lung and human
erythrocyte transporters might reflect differences in
either carrier mobility, affinity or both.
In conclusion, n-octylglucoside can be used to
solubilise the nucleoside transporter from guinea pig lung
membranes. It was established that the lung transporter
could be reconstituted into liposomes and that the
resulting proteo1iposomes exhibited NBMPR-sensitive uridine
transport.
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The preceding Chapters describe ligand binding and
photoaffinity labelling studies of the rat and guinea pig
lung nucleoside transporters as well as detailed kinetic
analyses of the reconstituted nucleoside transporter
solubilised from guinea-pig lung plasma membranes. This
final Chapter attempts to draw these investigations
together and also presents a discussion of the molecular
similarities and differences between erythrocyte nucleoside
transporters and those from rat and guinea pig lung.
7.2 FUNCTIONAL PROPERTIES Q£ LUNG NUCLEOSIDE
TRANSPORTERS
7.2.1 Ligand Binding Studies
As described in Chapters 2 and 5, I have been able
to demonstrate the presence of saturable, high-affinity
binding sites from NBMPR in crude and purified membrane
preparations from both rat and guinea-pig lung. Kd for
NBMPR binding to these sites in both species (0.2-0.4 nM)
was very similar to the corresponding binding of inhibitor
to erythrocytes and other cell types (apparent Kd 0.1-1 nM)
(Jarvis and Young, 1980; Cass ai. al, 1981). Similar to
findings in erythrocytes, NBMPR binding to lung membranes
was inhibited by transported nucleosides and by
dipyridamole and other vasoactive compounds. The
observation that guinea pig lung membranes possess a 2-fold
higher density of NBMPR binding sites than the rat
(approximately 19 vs. 8 pmolmg protein (Table 2.1) is
consistent with previous in. vivo perfusion studies by
Kolassa (1971) which found that guinea pig lung was
able to remove 50% more adenosine than rat lung. Thus, the
higher density of NBMPR binding sites in guinea pig
reflects a larger nucleoside transport capacity in removing
adenosine during passage through the pulmonary circulation.
There was also a large species difference in
dipyridamole sensitivity with respect to inhibition of
ft.•
NBMPR binding to rat and guinea pig lung crude membranes,
with apparent Ki. values in the two differing by 280-fold
(Table 2.4 and Fig. 2.3). Again, this correlates with
previous reports that adenosine uptake by intact rat lung
is approximately 100 times less sensitive to dipyridamole
inhibition than guinea pig lung (Kolassa gi ajL., 1971;
Bakhle and Chelliah, 1983). My finding that high-affinity,
3
saturable[ H]dipyridamole binding sites are absent from
rat lung membranes is also consistent with the intact lung
studies. Lung NBMPR and dipyridamole binding sites
therefore have the properties expected of nucleoside
transporter proteins in this tissue. Also, pharmacokinetic
experiments in mice have shown that accumulation of the
cytotoxic nucleoside tubercidin in lung tissue is inhibited
by preadminstration of NBMPR-phosphate, a prodrug form of
NBMPR (Kolassa al., 1982). There is therefore good
evidence that high-affinity NBMPR and dipyridamole binding
to guinea pig and rat lung membranes reflects a specific
association with functional nucleoside transporters.
3
High-affinity binding of[ H]dipyridamole to guinea pig
lung membranes was inhibited by NBMPR, transported
.
nucleosides and Tidoflazine. As discussed in detail in
Chapters 2 and 3, there was a good correlation between
3
(a) inhibition constants for inhibition of[ H]NBMPR and
3
[ H]dipyridamole binding and (b) between inhibition
constant for inhibition of ligand binding to lung membranes
and inhibition of NBMPR-sensitive nucleoside transport in
other cell types.
7.2.2 Reconstitution Studies
Kinetic and inhibitor studies suggest that NBMPR
binds to the permeation site of the erythrocyte nucleoside
transporter (see e.g. Jarvis and Young, 1987). In lung,
the demonstration that solubilised guinea pig lung membrane
extract exhibits both NBMPR binding activity as well as
NBMPR-sensitive uridine transport activity when
reconstituted into proteoliposomes (Chapter 6) provides
additional support for the view that reversible NBMPR
binding studies on lung membranes do indeed reflect
properties of NBMPR-sensitive nucleoside transporters in
this preparation.
The estimated turnover number of 1.7 molecules of
«•
uridine transportedsites under zero-trans influx
conditions for the reconstituted lung systerm (Chapter 3,
Table 6.3) was 2.5-fold lower than the corresponding
turnover number for the reconstituted human erythrocyte
nucleoside transporter (4.4 molecules of uridine
transportedsites) (Tse and Young, 198.7a). However, this
difference is rather small compared with published data for
intact erythrocytes vs. other cell types (Table 1.1). Thus,
in erythrocytes, the turnover number for uridine transport
at 25°C varies from 140-180 moleculessites .in
erythrocytes from various spec.ies compared to 8-30
moleculessites in cultured non-erythroid cell, a
difference of 4.5-23 fold. Thus, low turnover numbers aret.
not an intrinsic property of NBMPR-sensitive nucleoside
transporter from non-erythroid cells and tissues. The
turnover number of the guinea pig lung nucleoside
transporter in situ remains to be determined. As for
differences in the relative mobilities of loaded vn
unloaded carrier (Chapter 6, Section 6.3.3c), differences
in turnover number between different cell types might
possibly reflect variations in membrane lipid composition
(Tse and Young, 1987a). Recently, Tefft nt. ni (1986) have
demonstrated that the transport activity of the
reconstituted glucose transporter can be modulated by
altering the composition of the lipid bilayer.
The reconstituted guinea pig lung nucleoside
transporter exhibited broadly similar kinetic properties
•
to the human erythrocyte protein. Therefore, the present
results suggest that these two transporters are
functionally similar. Moreover, the two transporters also
exhibit similar apparent molecular weights on
SDS-polyacrylamide gels (see Chapter 4). It is therefore
anticipated that the lung and erythrocyte transporters
from these two species exhibit extensive structural
homology. In this context, it should be noted that the
amino acid sequences of the human liver and erythrocyte
•'
glucose transporters have recently been shown to be
highly homologous, and perhaps identical (Mueckler ei al.
1985).
7.2.3 Physiological and Pharmacological Aspects
The lung processes the entire blood volume every 20
seconds or so in man, and because it has a relatively large
capillary surface area, it has a unique opportunity to
exert a control function over the contents of arterial
blood. The other cell type in a position to modulate the
contents of arterial blood are erythrocytes. The relative
abilities of lung endothelium and erythrocyte to remove
adenosine from plasma will depend on their relative
nucleoside transport capacities. For example, rat and
guinea pig lung purified membranes possess a much higher
density of NBMPR binding sites than that found in
erythrocyte 'ghosts' from these species (48 and 13 pmolmg
protein in guinea pig and rat lung purified membranes,
respectively, compared with 0.1 and 1 pmolmg protein in
guinea pig and rat erythrocyte membranes, respectively).
These considerable differences in transporter density
between lung and erythrocytes are consistent with a
physiological role of guinea pig and rat lung in the
removal of circulating adenosine. In contrast, in vivo and
.
in vitro studies of the removal of adenosine from the
rabbit pulmonary circulation indicate that rabbit lung does
%
not contribute to the uptake of adenosine in vivo. blood
cells being primarily responsible for adenosine removal
during single passage through the rabbit pulmonary
circulation (Catravas, 1984). Rabbit erythrocytes have aI
high density of NBMPR binding sites (approximately 9,500

sites per cell, compared with 300 for rat and 27 for guinea
pig) (Clanachan et, aJL, 1983; Jarvis et jil, 1982). In man,
where there is also a high density of NBMPR binding sites
4
in erythrocytes (approximately 10 sites per cell)
(Jarvis fii. aJL, 1982), the relative contributions of lung
endothelial cells and erythrocytes to the removal of
adenosine during passage through the pulmonary circulation
has not been determined, but would, on the basis of the
present investigation, be expected to be dominated by
erythrocytes.
7.3 DO DIPYRIDAMOLE AND NBMPR BIND TO THE SAME SITE?
Although the inhibitory effect of dipyridamole on
nucleoside transport was first observed more than 20 years
ago, the mechanism by which this clinically available drug
achieves this effect is largely unknown and in dispute (see
Chapter 1). Kinetic experiments and inhibitor studies of
[ H]NBMPR and[ H]dipyridamole binding described in
this Thesis (Chapters 2 and 3) were carried out to clarify
the mechanism of dipyridamole interaction with the
NBMPR-sensitive lung nucleoside transporter.
Dipyridamole was found to be a competitive inhibitor
of NBMPR binding to lung membranes of both the guinea pig
and rat, and nucleosides and NBMPR were found to block
high-affinity[ H]dipyridamole binding to guinea pig lung
membranes. These observations are consistent with the view
that dipyridamole competes directly with nucleosides (and
NBMPR) for the permeation site of the transport system. In
support of this conclusion is the finding that dipyridamole
was found to be a potent competitive inhibitor of uridine
eauilibrium exchange influx into guinea Die ervthrocvtes
(Jarvis, 1986) with an apparent Ki. value of 1 nM (c. f. an
apparent K± of 0.7 nM for high-affinity dipyridamole
binding to human erythrocyte membranes) (Jarvis, 1986).
Dipyridamole binding to human erythrocyte membranes is also
blocked by nucleosides and nucleoside transport inhibitors.
Furthermore, inhibition of dipyridamole binding by uridine
and adenosine were apparently competitive with inhibition
constants similar to previous estimates of apparent Km
values for equilibrium exchange transport of these
nucleosides (Plagemann fii. 1, 1982; Jarvis ei. aJL 1983).
Also, previous studies have shown that dipyridamole
competitively interacts with NBMPR for the NBMPR-binding
site on human erythrocytes (Hammond ei sJL, 1981). Finally,
although the chemical structures of dipyridamole and NBMPR
appear to have little in common (Figs. 1.2 and 1.4), X-ray
diffraction studies point to similarities in the
three-dimensional crystal structures of the two molecules
(Jarvis, 1986). There are therefore strong grounds to
consider that NBMPR and dipyridamole bind to the same site
on the nucleoside transporter. Although NBMPR is a
««
competitive inhibitor of nucleoside zero-trans influx and
equilibrium-exchange influx, it is a non-competitive
inhibitor of zero-trans nucleoside efflux (Jarvis a_L,
1983a), indicating that the ligand binds preferentially to
the outward facing conformation of the transporter (Jarvis
et al. 1983a; see also Fig. 1.3). Similarly, dipyridamole
is a non-competitive inhibitor of zero-trans uridine efflux
from Guinea pig ervthrocvtes (Jarvis. 1986V
The kinetic and inhibitor binding studies of NBMPR
and dipyridamole binding presented in this Thesis• f
(Chapters 2 and 3) and also the other studies detailed
above would also be consistent with a more complex model of
nucleoside transport in which dipyridamole binding at one
site induces a conformational change in the transporter,
thereby allosterically altering the affinity of permeant
and NBMPR at their binding site. Support for this view
comes from the finding that high micromolar concentrations
of dipyridamole decrease the rate of NBMPR dissociation
from both rat and guinea pig lung membranes (Section
2.3.2a) and also that micromolar concentrations of NBMPR
dramatically increased the rate of dipyridamole
dissociation. Generally, changes in the rate of
dissociation are indicative of site to site interactions.
Hence, these dissociation data are inconsistent with a
simple single site model for NBMPR and dipyridamole binding
to the nucleoside transporter. Instead, they provide
compelling evidence for the existence of topographically
separate allosteric sites. Independent studies with other
systems have confirmed that high concentrations of
dipyridamole decrease the rate of NBMPR dissociation from
the transporter (Jarvis si aJL, 1983; Hammond and Clanachan,
1985). This effect has been argued by some investigators
to simply reflect nonspecific interactions with the
transporter or other membrane components following
partition of the lipophilic inhibitor into the membrane.
In this context, it has been pointed out that dipyridamole
is not a specific inhibitor of nucleoside transport (see
Chapter 1. Section 1.3.2c). However, the effect of NBMPR
on dipyridamole dissociation is more difficult to dismiss
in this way.
A model of the guinea pig lung nucleoside
transporter consistent with the experimental data presented
in this Thesis and that in the literature are presented in
Fig. 7.1. The major features of the guinea pig nucleoside
transoorter model are as follows: (a) NBMPR binds to the
outward-facing conformation of the nucleoside permeation
site, binding of NBMPR allosterically reducing the affinity
of dipyridamole for binding to its site. (b) the
dipyridamole binding site is also located on the external
membrane surface in view of the finding that dipyridamole
inhibition of nucleoside transport in guinea pig
erythrocytes is competitive with respect to zero-trans
influx of nucleoside, but non-competitive with respect to
nucleoside efflux. (c) binding of dipyridamole to its
binding site allosterically decreases the affinity of the
permeation site for both nucleoside permeants and NBMPR.
This model of the guinea pig lung nucleoside transporter is
considered to also be applicable to NBMPR-sensitive
nucleoside transporters in other cell types and tissues.
With respect to the rat lung nucleoside transporter, it is...
proposed that the dipyridamole binding site is in its low
0
affinity state, even when the permeation site is unoccupied
by NBMPR.













The nucleoside transporter is drawn as a dimer in its
outward-facing conformation. Each monomer represents a
Mr. of 55,000 dalton polypeptide containing ohe nucleoside
permeation site and one dipyridamole-binding site to be
consistent with the 1:1 stoichiometry for NBMPR
dipyridamole binding reported in Chapter 3, Section 3.3.2.
dipyridamole-binding site (high-affinity)
dipyridamole-binding site (low-affinity)
NBMPR binding site permeation site (high-affinity)
NBMPR binding site permeation site (low-affinity)
dipyridamole nucleoside; NBMPR
7.4 MOLECULAR PROPERTIES AND TRANSMEMBRANE TOPOLOGY OF
NUCLEOSIDE TRANSPORT PROTEINS
As detailed in Chapter 4, the technique of
3
photoaffinity labelling with[ H]NBMPR established that
the nucleoside transport proteins in both rat and guinea
pig lung membranes migrate on SDS-polyacrylamide gels with
apparent molecular weights in the range 45,000-66,000 (see
Chapter 4, Section 4.3.1), with the rat radiolabelled peak
migrating at a higher Mr. than that of the guinea pig. The
guinea pig radioactive peak had the same apparent Mr. as the
human erythrocyte nucleoside and glucose transporters and
also nucleoside transporters in other cell types and
species. In other words, the guinea pig Mr. (average) of
55,000 represents the normal situation. In addition to the
rat, two further exceptions are known. The first is pig
erythrocytes where the apparent Mr. (average of the
radiolabelled nucleoside transporter is 64,000 (Kwong et.
SlL, 1986). The second exception concerns a Novikoff
hepatoma variant (Novikoff-UA cells) where nucleosidec
transport is not inhibited by nanomolar concentrations of
NBMPR (Gati ei JL, 1986). Surprisingly, these cells
possess NBMPR binding sites which upon photoaffinity
3
labelling with[ H]NBMPR have an apparent Mr. in the range 0
72,000-80,000 (Gati q± al, 1986). The functional
significance of NBMPR binding sites in this cell line is,
at present, unclear.
The finding that photolabelled nucleoside
transporters present in rat liver and lung have the same
apparent Mr. of 63,000 (Wu and Young, 1984; Chapter 4,
Section 4.3.3), while those of guinea pig lung and liver
have a common apparent Mr. of 55,000 (Wu and Young,' 1984;
Chapter 4, Section 4.3.3) suggests a degree of structural
homology between nucleoside transporters present in
different tissues of the same species. Recent studies with
rat erythrocytes also demonstrate that the rat radioactive
peak in the band 4.5 region has a higher apparent molecular
weight than that of the human erythrocyte transporter
(Jarvis and Young, 1986). As reported in Chapter 4,
Section 4.4, the apparent Mr. difference between rat and
human and guinea pig nucleoside transporters can be
••
accounted for by more extensive glycosylation of the rat
protein. Thus, endoglycosidase-F reduces the apparent Mr.
of the human and guinea pig transporters from Mr. 55,000 to
46,000 (guinea pig lung) and 45,000 (human erythrocyte),'
while in the rat, the Mr for the lung nucleoside
transporter reduces from Mr 63,000 to 46,000.
As detailed in the General Introduction, the human
9'
erythrocyte nucleoside and glucose transporter proteins
have indistinguishable electrophoretic mobilities on
SDS-polyacrylamide gels. More significantly,' the
deglycosylated polypeptides exhibit almost identical
apparent molecular weights of 44,000 and 45,000,
respectively (Kwong 1, 1986). It has been suggested
4.«
that these similarities reflect some degree of structural
homology between the two proteins (Kwong 1986;).
Exploration of the transmembrane topology of the nucleoside
and glucose transporters shows additional evidence of
molecular similarities between the two carrier proteins.
Current information on the transmembrane arrangement
of the human erythrocyte glucose transporter is derived
from proteolytic studies of the erythrocyte transporter
(Cairns al, 1984; Deziel and Rothstein, 1984; Shanahan
and D'Artel-Ellis, 1984; Janmohamed£±_ al, 1985) and
hydropathy plots' of the polypeptide amino acid sequence
determined by gene cloning experiments of the equivalent
transporter in HepG2 cells (Mueckler et. al., 1985). The
polypeptide is believed to go through the membrane 12 times
(Mueckler e_fc. sJL., 1985), schematically represented by four
membrane spanning domains in Fig. 7.2. The N- and
C-terminals are exposed to the cytoplasm, with the site of
carbohydrate attachment close to the N-terminal on the
outside of the membrane. Cytochalasin-B, a competitive
inhibitor of glucose transport can, like NBMPR, be used to
photolabel the transporter (Baldwin et al_, 1981; Kasahara
and Hinkle, 1977). The cytochalasin-B binding site is
located on the inside of the membrane on the C-terminal
half of the transporter (Deziel and Rothstein, 1984;
Janmohamed aL, 1985). An important feature of the model
is the presence of a large central cytoplasmic loop which
contains two trypsin cleavage sites differing in position
by the equivalent of approximately 800 daltons. With
regard to possible sites of glycosylation, the recently
rJ)
determined amino acid sequence of the human HepG2 hepatoma
glucose transporter contains two asparagine residues, one
of which (Asn411) is located within a postulated
membrane-spanning domain of the transporter (Muekler e£ aJL,
1985), and its location is consistent with the site of
glycosylation of the erythrocyte glucose transporter
determined by enzyme and chemical cleavage studies (Cairns
et al, 1984).
In contrast to the glucose transporter, the NBMPR
attachment site to the human erythrocyte nucleoside
transporter is located on the outer surface of the
transporter relatively near the site of carbohydrate
attachment, with a trypsin cleavage site located on a
cytoplasmic domain of the transporter (Kwong et a!, 1985).
As detailed in Chapter 4, the human and pig erythrocyte
nucleoside transporters are both glycoproteins but with
different carbohydrate structures. The polypeptide
structures of the two transporters also differ, the
deg.lycosylated pig protein migrating on SDS-polyacrylamide
gels with an apparent molecular weight of 57,000 compared
with 44,000 for the deglycosylated human transporter (Kwong
aJL, 1986). Proteolytic digestion experiments suggest 9'
that the human and pig nucleoside transporters are similar
with respect to their arrangement in the erythrocyte
membrane, the loci of enzyme cleavage sites also being
similar. Simplified models of the transmembrane topology
of the human and pig erythrocyte nucleoside transporters,
based on that of the human erythrocyte glucose transporter
are presented in Fig. 7.2. (Kwong at. al, 1986, 1987). The
postulated polypeptide difference between the human and pig
nucleoside transporters is that the pig protein has a
larger cytoplasmic loop (Kwong al, 1987).
Trypsin treatment of the radiolabelled guinea pig
lung nucleoside transporter yielded a glycosylated
transporter fragment of similar Mr. as the corresponding
human erythrocyte cleavage product. Trypsin treatment
reduced, but did not abolish the Mr. differences between the
rat and the guinea pig and human nucleoside transporter
(3,000 ys. 8,000, see also Table 4.3). This Mr. difference
f•
was still apparent after endoglycosidase-F treatment (Table
4.3). On the basis of these data, it is concluded that the
rat has 2 sites of glycosylation and that in addition,
there is a 2,000-3,000 dalton difference in the site of
trypsin cleavage in the rat compared with human and guinea
pig, the rat cleavage site being nearer to the C-terminal.
••
It is interesting that the rat trypsin cleavage site
correspond in position to the second trypsin cleavage site
on the glucose transporter. It remains to be established
whether trypsin also cleaves the human and guinea pig« 9'
nucleoside transporters at this site. 9
Figure 7.2 Schematic representation ol the transmembrane
.Th
arrangement of the human erythrocyte glucose (A)
and nucleoside (EQ transporters and nig.
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The ligand binding and molecular studies described
in this Thesis on nucleoside transport proteins in rat and
guinea pig lung membranes should serve as useful starting
points for future in depth comparisons of nucleoside
transporters in different cell types and tissues. The
following approaches could be employed to further
investigate lung NBMPR-sensitive nucleoside transport
systems:
(1) It has been assumed in this Thesis that lung
NBMPR-sensitive nucleoside transporters are present in
highest density in endothelial cells. This could be
experimentally verified using the technique of
autoradiography in combination with electron microscopy to
visualise nucleoside transporter sites in lung cryostat-
sectioned tissue slices. Both NBMPR and dipyridamole would
be suitable radioligands for such experiments. Isolation
and culture of lung endothelial €cells would permit
purification of the transporter.
(2) The photoaffinity labelling experiments using NBMPR
described in this present study provide evidence that
NBMPR-sensitive nucleoside transporters from different
•sources have broadly similar molecular weights to that of
the human erythrocyte system. It is envisaged that this
technique will continue to prove useful in the molecular
characterization of NBMPR-sensitive nucleoside transporters
from different cell types and tissues. Unfortunately,
however, NBMPR cannot be used as a photoprobe for
NBMPR-insensitive nucleoside transporters. Development of
appropiate photolabile substrate analogue probes would be
useful for this purpose and could also be applied to
molecular studies of sodium-dependent nucleoside transport
proteins. Such substrate probes would also finally resolve
the controversial problem of whether NBMPR binds to the
permeation site on the NBMPR-sensitive nucleoside
transporter or to a separate modifier site.
(3) Reversible[ H]dipyridamole binding studies should
be further undertaken to characterise further the
relationship between the NBMPR and dipyridamole binding
sites.[ H]Dipyridamole may also have use in the study
of NBMPR-insensitive nucleoside transporters.
(4) The reconstitution methodology described in this
Thesis should be used further to explore functional and
pharmacological characterization of lung NBMPR-sensitive
nucleoside transporters. Reconstitution studies along with
transport experiments in intact cells should be undertaken
to explore the possible existence of NBMPR-insensitive and
sodium-dependent nucleoside transporters in lung tissue.
(5) The purified guinea pig and rat lung nucleoside
transporter should be subjected to controlled proteolysis
(e.g. trypsin digestion) and the resulting polypeptides
separated and analysed for N-, C-terminals, amino acid
composition and sequence. Lung nucleoside transporter
amino acid sequences would, of course, be compared closely
with corresponding sequences derived from the erythrocyte
nucleoside and glucose transporters, thus establishing the
extent of structural homology between erythroid and
non-erythroid systems and providing considerable additional
information concerning structure-function relationships
between nucleoside and glucose transporters and between
dipyridamole-sensitive (guinea-pig, human) and
dipyridamole-insensitive nucleoside transporters (rat).
(6) In addition to its use as a means of exploring the
structure of the NBMPR-sensitive nucleoside transporter,
3
[ H]NBMPR photolabelling has also been exploited in
screening tests for monoclonal antibodies directed against
the carrier protein (Jarvis at. aJL, 1985b; Good at. aJL,
1987). Another way to explore molecular similarities
between lung and- erythrocyte NBMPR nucleoside transporters
will be to test monoclonal antibodies directed against the






[G- H]NBMPR (specific radioactivity, 17-37 Cimmol
3
and 98% radiochemically pure) and[ H]Dipyridamole
(specific radioactivity, 110 Cimmol and 96%
radiochemically pure) were purchased from Moravek
14
Biochemicals, Brea, CA. [2- C]Uridine (specific
radioactivity, 53 mCimmol and 98% radiochemically pure),
3
[2- H]AMP (ImCiml, 11.7Cimmol) and calibrated
3
ri-[ H]Hexadecane standard were purchased from the
Radiochemical Centre, Amersham, Buckinghamshire, United
Kingdom.
A 1.2 Chemicals
NBTGR was a generous gift from Professor A.R.P.
Paterson, University of Alberta Cancer Research Group.
Dipyridamole (2,2' ,2' ',2'''-(4,8-dipiperedinopyrimido [5,4-
djpyrimidine-2,6-diyldinitrilo) tetraethanol) (Persantin
injection) was provided by Boehringer Ingelheim, Bracknell,
•
Berkshire, United Kingdom. NBMPR purchased from Sigma» 9
Chemical Co., Kingston-upon-Thames, Surrey, U.K. Dilazep,
Lidoflazine and Hexobendine were generously given by Roche
. Pharmaceuticals, Switzerland. Molecular weight standards4..
for SDS-polyacrylamide gel electrophoresis, ammonium
persulphate and TEMED, acrylamide (99.9% pure) were from
Bio-Rad Laboratories, Richmond, California, USA. Sodium
dodecyl sulphate (lauryl) (sequanal grade) was from Pierce
Chemical ComDanv. Rockford. Illinois. USA. Dithiothreitol,
a-Octylglucoside, PHSF, POPOP, PPO, Sephadex G-50 (fine),
inosine, trypsin (type XIII), Triton X-100, were from
Sigma, St. Louis, MO, USA. Endoglycosidase-F, Protosol and
Omnifluor were from New England Nuclear, Boston, MA, USA.
Soybean phospholipid (asolectin) was obtained from
Associated Concentrates, Woodside, NY, USA. All other
reagents were of analytical grade.
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